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Abstract 
The activity patterns of 5-HT-releasing neurons canbe positively correlated with 
behavioural state and motor function and the central 5-HT system modulates motor 
activity at the cellular level.  The rat facial motor nuclei are densely innervated by 5-
HT releasing afferents and 5-HT-mediated modulation of ion channels on the soma 
and dendrites can markedly influence the excitability of facial motoneurones and 
their integration of excitatory postsynaptic potentials (EPSPs).  5-HT facilitates facial 
motoneuron excitation by inhibiting a ‘leak’ potassium (K+) conductance (gK+Leak) 
and enhancing the hyperpolarisation-activated cation current, Ih.  These actions of 5-
HT have been confirmed using whole-cell voltage-clamp recordings from visually 
identified facial motoneurones in an acute brainstem slice preparation.  
Pharmacological approaches have been used to identify the receptors which mediate 
the actions of 5-HT in facial motoneurones.  The inhibition of gK+Leak by 5-HT can 
be blocked by the 5-HT2A receptor antagonist, R96544 (0.3 – 1µM) and the 
enhancement of Ih by 5-HT is sensitive to the 5-HT7 receptor antagonist, SB269970 
(0.3 – 10 µM).   
Noradrenaline was also found to inhibit gK+Leak, via activation of α1 adrenoceptors, 
and the molecular identity of the amine-sensitive ‘leak’ K+ channels has been 
investigated.  TASK-1 and TASK-3 are pH-sensitive two-pore domain K+ channels 
that can be modulated by amines and provide ‘leak’ K+ conductances in several 
central neurones.  The mRNAs for these channels have been reported to be present in 
the rat facial motor nucleus. The gK+Leak in facial motoneurones is sensitive to 
changes in external pH and has a pK of ~7.1, which is intermediate between the 
 v 
values for homomeric TASK-1 and TASK-3 channels (7.5 and 6.8 respectively).  
The TASK-1 selective inhibitor anandamide (10 µM), its stable analogue 
methanandamide (10 µM), the TASK-3 selective inhibitor ruthenium red (10 µM) 
and Zn2+ (100-300 µM) all failed to alter the actions of noradrenaline or changing 
external pH.  These findings argue against principal contributions to gKLeak by 
homomeric TASK-1 or TASK-3 channels.  Isoflurane, a volatile anaesthetic that 
enhances heteromeric TASK-1 / TASK-3 currents, potentiated gKLeak supporting a 
predominant role for heterodimeric TASK-1 / TASK-3 channels in the gKLeak in 
facial motoneurones.  
Evoked fast excitatory synaptic transmission in the facial motor nucleus has been 
characterised and NMDA and non-NMDA receptor-mediated components of this 
synaptic transmission have been identified.  Through a combination of analysis of the 
paired pulse ratio, rate of failure to generate a response and the frequency and 
amplitude of miniature excitatory postsynaptic currents (mEPSCs) this study 
provides evidence to suggest that glutamate release from pre-synaptic terminals in 
the facial motor nucleus is depressed by 5-HT.  This action of 5-HT is mediated by 
activation of presynaptic 5-HT1B receptors as this effect is mimicked by the 5-HT1B 
receptor agonist, CP93129 (10 µM) and can be blocked by the 5-HT1B receptor 
antagonist, isamoltane (1 µM).   
These studies indicate that the modulation of synaptic integration in the facial motor 
nucleus involves activation of distinct pre- and post-synaptic 5-HT receptor subtypes.  
These findings not only increase our understanding of the cellular mechanisms for 
 vi 
the 5-HT modulation of motor activity but may also be relevant to the role of 5-HT 
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This thesis addresses several aspects of rat facial motoneurone (FM) excitability in 
an attempt to further understanding of the mechanisms by which motoneurones 
process the thousands of inputs they receive to produce the functional output of 
muscle fibre contraction.  The activity of central 5-HT and NA neurones show 
positive correlations with motor activity and both neurotransmitters modulate FM 
excitability.  The ionic mechanisms by which this modulation is exerted are further 
investigated in this thesis and the findings are summarised here.   
It has previously been determined that FMs possess ion channels (Ih and gKLeak) in 
their membranes that control their intrinsic excitability. The modulation of Ih and 
gKLeak underlies the excitatory actions of exogenously applied 5-HT and NA 
(Larkman and Kelly 1992; Larkman and Kelly 1997; Larkman and Kelly 1998).   
The inhibition of gKLeak in neonatal FMs by 5-HT and NA is confirmed in Chapter 3 
and the molecular identity of the FM gKLeak was further investigated.  gKLeak was 
found to be sensitive to changes in external pH suggesting the channel is a member 
of the TASK family of leak K+ channels and the pH-sensitivity was found to be 
intermediate between the reported values for homomeric TASK-1 and TASK-3 
channels (Talley, Lei et al. 2000; Karschin, Wischmeyer et al. 2001).   
The pharmacology of gKLeak was also investigated.  Ruthenium red is known to block 
TASK-3 homomeric channels but was found to have no effect on the FM gKLeak 
(Czirjak and Enyedi 2003).  Human TASK-3 channels have also been shown to be 
blocked by Zn2+, however, the gKLeak in rat FMs was not found to be sensitive to 
Zn2+ (Leonoudakis, Gray et al. 1998; Clarke 2003).  Anandamide has been reported 
 xvii
to block homomeric human TASK-1 channels at low micromolar concentrations (and 
homomeric TASK-3 channels at higher concentrations), however, it failed to block 
the FM gKLeak (Maingret, Patel et al. 2001).  Metabolic degradation of anandamide 
can occur in some in vitro preparations but this can be prevented with arachidonyl 
trifluoromethyl ketone (ATFK) (Barbuti, Ishii et al. 2002).  Neither anandamide, in 
the presence of ATFK, or the metabolically stable analogue of anandamide, 
methanandamide, significantly blocked gKLeak in FMs (Maingret, Patel et al. 2001).  
The pharmacological activity of ruthenium red and methanandamide was validated 
using cultured cerebellar granule neurones which have been shown to posses both 
TASK-1 and TASK-3 homomeric channels (Maingret, Patel e  al. 2001; Han, Truell 
et al. 2002; Kang, Han et al. 2004).  These pharmacological studies provided 
evidence against a homomeric TASK-1 or TASK-3 identity for the FM gKLeak. 
TASK-1 and TASK-3 subunits have also been shown to form functional heteromeric 
channels (Czirjak and Enyedi 2002; Talley and Bayliss 2002).  The non-selective 
TASK-1 and TASK-3 channel inhibitor, bupivacaine, partially occluded the NA- and 
low pH-induced inhibition of the FM gKLeak (Leonoudakis, Gray et al. 1998; Kim, 
Bang et al. 2000).  The anaesthetic isoflurane inhib ts currents mediated by 
homomeric TASK-1 channels and enhances currents carried by homomeric TASK-3 
and heteromeric TASK-1 / TASK-3 channels (Berg, Talley et al. 2004).  Isoflurane 
increased gKLeak in four out of five FMs (it was inhibited in the rmaining FM).  The 
inhibition by bupivacaine, enhancement by isoflurane and the intermediate pH-
sensitivity indicates that gKLeak may be mediated by TASK-1/TASK-3 heteromeric 
channels.  The observation that gKLeak in one FM is inhibited by isoflurane suggests 
there may be heterogeneity of channel composition within the FM population. 
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Chapter 4 investigates the receptor subtypes that mediate the different actions of 5-
HT in FMs (inhibition of gKLeak and enhancement of Ih) and the adrenoceptor 
involved in the inhibition of gKLeak.  Earlier studies suggested that a 5-HT2 receptor 
subtype mediated the inhibition of gKLeak by 5-HT (Rasmussen and Aghajanian 
1990).  The 5-HT2A receptor antagonist, R96544, significantly reduced the 5-HT-
induced inhibition of gKLeak supporting the involvement of this receptor subtype in 
the effects of 5-HT (Ogawa, Sugidachi et al. 2002).  The enhancement of Ih by 5-HT 
has previously been shown to involve a direct action of cAMP on the channel, 
however, the receptor subtype that activates adenylate cyclase to produce the cAMP 
was unknown.  5-HT7 receptors positively couple to adenylate cyclase activity and 
here it is shown that a recently developed 5-HT7 receptor antagonist, SB269970, 
blocked the enhancement of Ih by 5-HT suggesting 5-HT7 receptors mediate this 
excitatory action of 5-HT (Hagan, Price et al. 2000; Lovell, Bromidge et al. 2000).  It 
is also determined that the inhibition of gKLeak by NA was mimicked by the α-
adrenoceptor agonist, phenylephrine, and blocked by the α1-adrenoceptor antagonist, 
prazosin.   
The mechanism by which receptor activation leads to closure of the channel carrying 
gKLeak is also discussed in Chapter 4.  5-HT2A and α1-adrenoceptors couple to Gq 
proteins that stimulate phospholipase-C (PLC) activity, thereby increasing the 
hydrolysis of phosphatidylinositol biphosphate (PIP2) in the membrane, however, 
altering the downstream pathways of PLC (increased Ca2+ from internal stores and 
protein kinase C activity) has no effect on FM gKLeak (Alberts, Johnson et al. 2002).  
Mice lacking PLC-β1 showed a reduced NA-induced current, whereas the 5-HT-
induced current was not significantly reduced.  In addition, immunohistochemical 
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techniques were utilised to demonstrate the presenc of PLC-β in the wild-type 
mouse FMN.  Although PLC-β1 activity appears important for the action of NA in 
the FMN, the actions of NA appear not to be dependent on the transduction pathways 
that follow PLC activation (increased [Ca2+] i and PKC activation, respectively) 
(Larkman and Kelly 1998; Larkman, Perkins et al 2003).  Depletion of PIP2 from the 
membrane has been proposed as a mechanism that underlies the inhibition of several 
two pore K-channels (including TASK-1 and TASK-3 channels) and KCNQ2/3 
channels (Suh and Hille 2002; Zhang, Craciun et al. 2003; Lopes, Rohacs et al. 
2005).  It is possible that a similar mechanism underlies the inhibition of gKLeak in rat 
FMs though a direct action of the G protein α subunits cannot be ruled out (Chen and 
Talley 2006).    
How these postsynaptic actions of 5-HT and NA modulate synaptic transmission in 
FMs is of interest.  Chapter 5 characterises fast synaptic inputs into FMs as the initial 
stage in understanding how 5-HT and NA modulates synaptic transmission in these 
neurones.  Excitatory postsynaptic currents (EPSCs) were evoked by placing a 
stimulating electrode close to the dendrites of a FM. Minimal stimulation intensities 
were applied and evoked EPSCs that fluctuated in amplitude and occasionally failed 
to evoke a response.  The AMPA/kainate glutamate rec ptor antagonist, NBQX, 
reduced the mean EPSC amplitude (Sheardown, Nielsen t al. 1990).  An additional 
component of the EPSCs was revealed under conditions optimised for NMDA 
glutamate receptor activation and this component was reduced by the NMDA 
receptor antagonist, AP-5 (Olverman, Jones et al. 1984).  These findings indicate that 
fast excitatory synaptic transmission in the FMN is mediated by the activation of 
non-NMDA and NMDA glutamate receptors.  The identities of the receptor subtypes 
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involved were further investigated.  The lack of inward rectification of the current-
voltage relationship of the EPSCs indicates the involvement of AMPA receptors 
containing the GluR2  subunit (Sato, Kiyama et al. 1993).  In addition, the 
NR1A/NR2B receptor antagonist, ifenprodil, reduced the NMDA-mediated EPSC 
confirming the involvement of this receptor subtype (Williams 1993).   
The modulation of glutamate-mediated synaptic transmis ion by 5-HT is the focus of 
Chapter 6.  The mean EPSC amplitude was found to bereduced in the presence of 5-
HT.  While postsynaptic 5-HT receptor activation could account for this effect on the 
EPSC, it is well established that 5-HT receptors can also function as heteroceptors to 
modulate the release of glutamate from the presynaptic terminal nucleus (Bobker and 
Williams 1989; Boeijinga and Boddeke 1996; Bouryi and Lewis 2003). Therefore, in 
Chapter 6, three techniques traditionally used to assess whether an effect is mediated 
presynaptically have been employed to address the synaptic location of this action of 
5-HT (Stuart and Redman 1991).  Analysis of the ratof failure to generate an EPSC 
(at a constant stimulus intensity) revealed that 5-HT receptor activation reduced the 
mean EPSC amplitude by increasing the failure rate.  5-HT application was also 
found to alter the amplitude ratio of two closely separated EPSCs (paired-pulse 
facilitation ratio) and alter the frequency but not the amplitude of miniature 
(spontaneous) EPSCs.  These findings are consistent with a presynaptic location for 
the inhibitory action of 5-HT on glutamate-mediated EPSCs in the FMN.      
Members of the 5-HT1 receptor family mediate the majority of inhibitory actions of 
this neurotransmitter so the involvement of 5-HT1 receptor subtypes in the reduction 
of EPSC amplitude was investigated.  The reduction in EPSC amplitude and  the 
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associated increase in failure rate at minimal stimulation intensities were mimicked 
by the 5-HT1B receptor agonist, CP93129, and inhibited by the 5-HT1B receptor 
antagonist, isamoltane (Waldmeier, Williams et al. 1988; Macor, Burkhart et al. 
1990).  Contrastingly, the 5-HT1A agonist, 8-OH-DPAT, did not reduce the EPSC 
amplitude and the 5-HT-mediated reduction in amplitude was not altered in the 
presence of the 5-HT1A receptor antagonist, WAY 100635 (Critchley, Childs et al. 
1994).  These findings indicate that 5-HT reduces EPSC amplitude through 





How does a neurone process the various inputs it receiv s to produce a functional 
output?  This is a fundamental question in neuroscience and one that has prompted a 
great deal of investigation attempting to increase the understanding of how neurones 
function.   
1.2 Neuronal signaling 
During his studies of neuronal anatomy in the late nineteenth century Ramớn y Cajal 
proposed that the dendritic network (and soma) represents the input site of a neurone 
and that the axon represents the output site (Yuste and Tank 1996).  Although some 
exceptions to this rule have emerged as our understanding of neuronal activity has 
advanced, Cajal’s theory on the direction of signaling within a neurone remains 
valid.    
In the 1950s Hodgkin, Huxley and Katz investigated the ionic basis of nerve 
conductance in the giant squid axon (Hodgkin and Huxley 1952).  They determined 
that action potentials in this peripheral nerve are generated by a transient inward Na+ 
current causing the axonal membrane to become less negatively charged (during the 
rising phase of the action potential or “spike”) and that membrane repolarisation was 
mediated by a sustained outward K+ current (Hodgkin and Huxley 1952).  They also 
described the specific increase in Na+ and K+ permeability of the membrane during 
these periods, which has subsequently been identified as a result of the opening of 
voltage-dependent Na+ and K+ channels in the membrane (Hodgkin and Huxley 
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1952; Purves 2001).  The axon potential flows down the axon due to an inactivation 
of the voltage-dependent Na+ channels (Purves 2001).  Recordings from mammalian 
spinal motoneurones provided evidence that central erve fibres propagate action 
potentials by the same mechanism as peripheral nerves (discussed in (Llinas 1988)). 
The mechanism underlying action potential initiation is now well understood.  
Neurotransmitters released from the presynaptic nerve terminal interact with specific 
ionotropic receptors on the postsynaptic membrane (Purves 2001).  Binding of the 
neurotransmitter to the receptor induces a conformation l change increasing the 
conductance of specific ion species through the recptor channel (Purves 2001).  
Neurotransmitters which result in conductance changes that result in membrane 
depolarisation (e.g. glutamate by increasing cation c ductance) are excitatory and 
those that induce a membrane hyperpolarisation (e.g. GABA by increasing Cl- 
conductance) are inhibitory (Kupfermann 1979; Purves 2001).  These excitatory and 
inhibitory postsynaptic potentials (EPSPs and IPSPs, re pectively) were first 
identified by intracellular electrophysiological recordings from spinal motoneurones 
and it was proposed that dendrites passively summate incoming EPSPs and IPSPs 
and the net change in somatic membrane potential could trigger action potential 
firing in the axon if it depolarised the membrane above the voltage-dependent Na+ 
channel threshold (Coombs, Eccles et al. 1955; Coombs, Eccles et al. 1955; 
Whitehead and Rosenberg 1993; Yuste and Tank 1996; Purves 2001).   
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1.3 Dendrites as passive electrical cables 
Dendrites were traditionally thought of as passive electrical cables and in 1959 Rall 
applied the cable theory to describe the passive flow of electric currents in dendritic 
networks (Rall 1959; Yuste and Tank 1996).  Rall defined membrane resistance 
(Rm), membrane capacitance (Cm), internal (cytosolic) resistance (Ri), cable length 
(λ) and the dendritic-to-soma conductance ratio (ρ) and derived equations using these 
basic parameters to describe the flow of currents i model dendritic networks 
receiving distinct input patterns (Yuste and Tank 1996). 
The majority of synaptic inputs occur in the dendritic network of neurones and the 
distance from the site of synaptic input to the soma can vary greatly within a single 
neurone.  In theoretical neuronal models with only passive dendritic parameters 
inputs received in the distal dendrites are found to be attenuated in amplitude and 
have a longer time course when measured in the soma (Magee 2000; Williams and 
Stuart 2000). The high dendritic resistance causes a continuous voltage drop between 
the synapse and the soma, resulting in reduced EPSP amplitude (Magee 2000).  The 
inputs received in the distal dendrites will appear smaller in amplitude compared to 
those received by more proximal dendrites due to increased amplitude filtering (Rall, 
Burke et al. 1967; Cook and Johnston 1999; Magee 2000).  Thus in order for inputs 
received in distal dendrites to evoke a large enough change in the membrane 
potential at the site of action potential initiation several EPSPs would have to be 
evoked within a certain time period, this is termed temporal summation.  
Contrastingly, inputs received more proximal to the soma would appear to decay less 
before reaching the site of action potential initiation and would therefore be less 
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dependent on temporal summation (Rall, Burke et al. 1967).  The kinetic decay of 
EPSPs is also subject to filtering and inputs received in distal dendrites have a 
prolonged time course at the soma (Magee 2000).  This results in the inputs received 
in the distal dendrites (which would be lower in amplitude) having a prolonged time 
period for temporal summation to occur. 
In this model of passive dendritic function the location of a synaptic input would 
strongly influence its effect on the postsynaptic cell, however, location-dependence 
of synaptic inputs is rarely observed experimentally (Magee 2000; Williams and 
Stuart 2000).  Although dendrites do possess the basic cable properties described 
above and are capable of passive current flow it has become apparent that they also 
possess many dominant active properties that shape neuronal inputs and may remove 
the location variability of synaptic efficacy. 
1.4 Active properties of dendrites  
1.4.1 Dendritic potentials 
Early evidence for active dendrites came from direct electrophysiological recordings 
of dendritic action potentials in cerebellar Purkinje eurones and cortical pyramidal 
neurones (Spencer and Kandel 1961; Llinás, Nicholson et al 1968; Takagi 2000).  
Purkinje neurones were found to produce Ca2+ spikes in the dendrites and Na+ spikes 
in the soma (Llinás and Sugimori 1980).  This finding was supported by the 
discovery of voltage-sensitive Ca2+ channels in the Purkinje neurone dendrites by 
Ca2+ imaging techniques (Yuste and Tank 1996).  Na+ and Ca2+ spikes were recorded 
from the dendrites of hippocampal and cortical pyramidal neurones of the 
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hippocampus and cortex and the presence of voltage-sensitive Ca2+ channels was 
also confirmed using Ca2+ imaging techniques (Yuste and Tank 1996).   
The function of these active properties of the dendrites is not yet entirely clear but it 
has been proposed that due to the voltage-sensitive nature of these conductances they 
could increase the amplitude and duration of EPSPs (Yu te and Tank 1996).  It has 
also been proposed that dendritic action potentials may play a role in long term 
plasticity of synapses by coincidence detection of the spike with incoming synaptic 
inputs (Yuste and Tank 1996). 
1.4.2 The hyperpolarisation-activated current 
The hyperpolarisation-activated cation current, Ih, has emerged as playing a crucial 
role in the integration of synaptic inputs in many types of neurones and its role in 
integration in neocortical and CA1 hippocampal pyramidal neurones has been 
particularly well documented (Magee 1998; Cook and Johnston 1999; Williams and 
Stuart 2000; Gulledge 2005).  In these neurones Ih removes the location dependence 
of the time course of synaptic inputs (Magee 1999; Williams and Stuart 2000).  
When Ih is present there is an increase in membrane conductance due to the channels 
being activated at the resting membrane potential this increases the decay rate of 
EPSPs (Magee 1999; Williams and Stuart 2000).  In addition, the voltage-dependent 
inactivation of Ih that occurs during EPSPs produces a net outward current which 
further prevents EPSP decay (Magee 1999; Williams and Stuart 2000).  Expression 
of Ih channels was found to increase with distance from the soma (with high 
expression observed in the distal dendrites).  Thisresults in a location-independence 
of EPSP time course at the soma (Magee 1999; Williams nd Stuart 2000).  This is 
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directly supported by the finding that blocking Ih unmasks temporal summation 
similar to that predicted by passive neuronal models (Magee 1999; Williams and 
Stuart 2000).   
1.5 Modulatory neuronal inputs  
1.5.1 Neuromodulation by G protein-coupled receptors 
In addition to inputs which evoke EPSPs and IPSPs many neurones receive 
modulatory inputs.  Some of these inputs release neurotransmitters that can induce 
changes in neuronal excitability but do not directly cause action potential firing.  
However, these changes in neuronal membrane excitability can result in more or less 
fast synaptic input being required to evoke action potential firing.  Several 
modulatory neurotransmitters mediate their effects through activation of membrane 
receptors that are coupled to intracellular signalli g pathways through guanosine 
triphosphate (GTP) binding proteins (G proteins) (Purves 2001; Alberts, Johnson et 
al. 2002).   
Ligand binding to a G protein coupled receptor induces a conformational change that 
leads to activation of the G protein causing it to release its bound GDP (guanosine 
diphosphate) allowing GTP to bind in its place (Alberts, Johnson et al. 2002).  The 
GTP bound Gα subunit releases the Gβγ subunit complex activating both subunits 
allowing them to modulate their target proteins. 
The vast diversity in G-protein coupled receptors, their intracellular signaling 
pathways and target effector proteins gives rise to several combinations for neuronal 
modulation and some of which are addressed in this the is. 
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1.5.2 Presynaptic modulation of synaptic transmission  
As described previously EPSPs and IPSPs  occur as a re ult of neurotransmitters 
binding to postsynaptic receptors and opening an intrinsic ion channel (Kupfermann 
1979; Purves 2001).  The release of neurotransmitter from the presynaptic nerve 
terminal into the synaptic cleft requires the fusion f a vesicle filled with the 
neurotransmitter with the presynaptic membrane.  Altering this release process is 
therefore a potential mechanism for neuromodulation. 
The fusion of a neurotransmitter filled vesicle with the presynaptic membrane is 
dependent on Ca2+ entry into the nerve terminal (Purves 2001).  When an action 
potential reaches the nerve terminal it depolarises th  membrane and this potential 
change activates voltage-gated Ca2+ channels allowing Ca2+ entry into the terminal 
(Purves 2001).  The increase in intracellular [Ca2+] ctivates the vesicle’s Ca2+-
dependent fusion machinery causing it to fuse with the membrane and release its 
contents into the synaptic cleft (Purves 2001).  The Ca2+ entry into the terminal is 
crucial for neurotransmitter release therefore the activity of the voltage-gated Ca2+ 
channels represents a potential target for neuromodulation. 
One mechanism for modulating Ca2+ entry into the terminal is to alter the activity of 
the voltage-gated Ca2+ channels.  The first studies describing a G protein-mediated 
inhibition of Ca2+ currents were in dorsal root ganglion (DRG) neurones of 
embryonic chicks, however, it was also proposed that e Ca2+ current inhibition 
could occur at central nerve terminals where it would reduce neurotransmitter release 
(Dunlap and Fischbach 1978; Dunlap and Fischbach 1981).  In the embryonic chick 
DRG neurones high voltage-activated (mainly N type) Ca2+ channels were found to 
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be inhibited following activation of G protein-coupled GABAB, 5-HT and adrenergic 
receptors and it was subsequently determined that this inhibition was sensitive to 
pertussis toxins, implicating members of the Gi protein family (that are negatively 
coupled to adenylate cyclase) (Dunlap and Fischbach 1978; Dunlap and Fischbach 
1981; Tedford and Zamponi 2006).  It subsequently emerged that inhibition of Ca2+ 
channels occurred following activation of several types of Gi protein-coupled 
receptors (Mirotznik, Zheng et al. 2000; Tedford and Zamponi 2006).  Gi protein-
mediated inhibition did not appear to be dependent on changes in cAMP levels 
(cAMP is generated by adenylate cyclase activity) and in 1996 it was demonstrated 
that the Gβγ subunit directly inhibits the channel (Herlitze, Garcia et al. 1996; Ikeda 
1996). 
As previously described, the Ca2+ entry into the nerve terminal is through voltage-
gated Ca2+ channels, therefore an alternative mechanism for modulating presynaptic 
vesicle release is to prevent activation of these voltage-gated channels by altering the 
membrane potential.  When an action potential reachs t e nerve terminal it normally 
depolarises the membrane above the threshold for activation of the Ca2+ channels, 
however if the resting membrane potential of the terminal is sufficiently 
hyperpolarised the membrane may not reach the Ca2+ ch nnel threshold.  Membrane 
hyperpolarisation would occur as result of increased K+ conductance and several K+
channels have been identified as targets for G protein mediated modulation.  K+ 
conductances in the hippocampus were shown to be enhanced following 5-HT1 
receptor activation (Andrade, Malenka et al. 1986; Andrade and Nicoll 1987; Colino 
and Halliwell 1987).  5-HT1 receptors are Gi protein coupled receptors and this 
increase in K+ channel conductance was found to occur due to a direct interaction of 
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the Gβγ subunit with the channels (Andrade, Malenka et al. 1986; Andrade and Nicoll 
1987; Colino and Halliwell 1987).  Similarly, activation of Gi protein-coupled 
muscarinic acetylcholine receptors in the heart result in the Gβγ subunit activating G 
protein coupled inwardly rectifying K+ (GIRK) channels (Logothetis, Kurachi et al. 
1987; Reuveny, Slesinger et al. 1994).   
It is interesting to note that while K+ channels appear to be activated by Gβγ subunits, 
the voltage-gated Ca2+ channels are inhibited by the Gβγ subunit.  Nevertheless, both 
mechanisms result in reduced Ca2+ entry into the terminal and the subsequent 
reduction in vesicle fusion causes a less neurotransmitter to be released into the 
synaptic cleft and an inhibition of synaptic transmi sion.  
Modulation downstream of Ca2+ entry into the terminal has also been observed at the 
reticulospinal-motoneurone synapse in the lamprey (Blackmer, Larsen et al. 2001).  
At this synapse the Gβγ subunits appear to interact directly with the fusion machinery 
to prevent vesicle fusion with the membrane and neurotransmitter release, however, 
this mechanism of inhibition has not yet been observed in the mammalian central 
nervous system (Blackmer, Larsen et al. 2001). 
1.5.3 Postsynaptic modulation 
Action potential initiation is dependent on the net potential change induced by 
incoming EPSPs and IPSPs depolarising the membrane above a certain threshold (for 
activation of the voltage-gated Na+ channels), thus, altering the resting membrane 
potential will affect the net potential change and could have profound effects on the 
efficacy of synaptic transmission.  Activation of G protein-coupled receptors which 
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target the ionic conductances that contribute to the neuronal resting membrane 
potential represents a postsynaptic mechanism for neuromodulation. 
1.5.4 K+ channel modulation 
Several types of K+ channels are important in the regulation of neuronal excitability 
and those that can be regulated by G protein activity are potential candidates for 
mediating neuromodulation. 
Members of the twin-pore (2P) domain K+ channel family provide ‘leak’ potassium 
conductances in several types of neurones (reviewed by (Goldstein, Bockenhauer et 
al. 2001; Patel and Honore 2001; Bayliss, Sirois et al. 2003)).  ‘Leak’ potassium 
conductances (gKLeak) are defined as having little or no voltage-dependence and 
hence contribute to the neuronal resting membrane potential (Goldstein, 
Bockenhauer et al. 2001; Patel and Honore 2001; Bayliss, Sirois et al. 2003).  
Several members of this family have been shown to be sensitive to G protein 
modulation.  
In cerebellar granule neurones (CGNs) the mechano-gted TWIK-related K+ (TREK) 
channels are inhibited by activation of group 1 metabo ropic glutamate receptors 
(mGluRs) (Chemin, Girard et al. 2003).  The Group 1 mGluRs are coupled to Gq 
proteins which stimulate phospholipase C activity (Alberts, Johnson et al. 2002; 
Chemin, Girard et al. 2003).  Phospholipase C activity generates the intracellular 
messengers inositol trisphosphate (IP3) and diacylglycerol (DAG) from 
phosphatidylinositol bisphosphate (PIP2) (Alberts, Johnson et al. 2002).  It appears 
that the diacylglycerol (DAG) directly inhibits TREK channels in CGNs (Chemin, 
Girard et al. 2003).  It was also found that the TWIK-related acid-sensitive K+ 
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(TASK) channels members of the K2P family are inhibited in CGNs following 
activation of the group 1 mGluRs (Bayliss, Sirois et al. 2003; Chemin, Girard et al. 
2003).  This inhibition did not appear to be dependent on the intracellular messenger 
molecules associated with Gq protein activation but rather due to a depletion of 
phospholipids from the membrane (Chemin, Girard et al. 2003).  Inhibition of TASK 
channels has also been observed following activation of the M3 muscarinic receptor 
which is also coupled to Gq proteins (Bayliss, Sirois et al. 2003). 
G protein modulation of other K+ channels can also regulate neuronal excitability.  
Members of the Kir 2.0 (inwardly rectifying) family of K
+ channels such as Kir 2.1 
(IRK1) have been found to be inhibited following activation of the M1 muscarinic 
receptor by a mechanism involving the Gαq subunit (Firth and Jones 2001). 
1.5.5 Ih modulation 
In addition to its role in normalising temporal summation of EPSPs previously 
described, Ih, contributes to the resting membrane potentials in ma y neuronal types.  
Resting membrane potentials of neurons are typically between -50 mV to -100 mV 
and Ih is active within the range (Pape 1996).  As Ih does not inactivate at 
hyperpolarised potentials, the sustained depolarising current helps set the resting 
membrane potential depolarised to the K+ equilibrium potential (Pape 1996).  
Increasing the activity of Ih therefore represents a potential modulatory mechanism 
for increasing neuronal excitability. 
Ih is carried by hyperpolarisation-activated cyclic nucleotide-gated cation channels 
(HCN1-4) (Ludwig, Zong et al. 1998; Santoro, Liu et al. 1998) and  cAMP has been 
shown to modulate HCN channel activity in a variety of neurones including CA1 
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hippocampal neurons (Chen, Wang et al. 2001; Bickmeyer, Heine et al. 2002) 
neurones of the hypoglossal nuclei (Bobker and Williams 1989) and rat facial 
motoneurones (Larkman and Kelly 1992).  This modulation of HCN channels is 
mediated by a direct action of cAMP on the channel and is not dependent on 
activation of protein kinase A and protein phosphorylation (Larkman and Kelly 
1995; Kaupp and Seifert 2001).   
cAMP is synthesised from ATP by adenylate cyclase and the activity of this enzyme 
can be stimulated the Gs protein and inhibited by Gi proteins (Alberts, Johnson et al. 
2002).  Neurotransmitters that activate Gs protein coupled receptors (such as 5-HT4, 
5-HT6 and 5-HT7 receptors and  β-adrenoceptors) could potentially enhance Ih and 
increase neuronal excitability (IUPHAR 2000).  In contrast those that activate Gi
receptors (such as 5-HT1 receptors) could suppress Ih and have an inhibitory effect on 
neuronal excitability. 
In the hippocampus Ih can be enhanced by the activation of 5-HT4 receptors and 
inhibited activation of 5-HT1A receptors (Bickmeyer, Heine et al. 2002).  Although 
this occurs in different neuronal compartments, it represents a system in which a 
neurotransmitter can modulate the same conductance via different G protein 
pathways to have opposing effects on neuronal excitability (Bickmeyer, Heine et al. 
2002) 
It has also been determined that 5-HT increases facial motoneurone excitability by 
enhancing Ih and although it was determined that this occurred as a result of a direct 
action of cAMP on the channel, the 5-HT receptor mediating this action has not yet 
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been identified and is addressed in Chapter 4 of this thesis (Larkman and Kelly 1992; 
Larkman and Kelly 1997; Larkman and Kelly 1998).  
1.6 Motoneurones 
1.6.1 Motoneurones as models for investigating input processing 
The output of the CNS is manifested by motor behaviour and motoneurones provide 
the link between these two systems.  Motoneurones signal the contraction of the 
muscle fibres they innervate, a functional output that is well understood and can be 
accurately measured.  This relatively well-defined functional output of motoneurones 
and their suitability for electrophysiological recordings makes them useful models 
for investigating the mechanisms by which the thousand  of inputs they receive are 
accurately processed. 
1.6.2 Facial Motoneurones  
The superficial and some deep muscles of the rat face are innervated by the seventh 
cranial nerve (VII) and the cell bodies of the motor c mponent of this nerve are 
located in the facial motor nucleus (FMN, VII nucleus).  The facial motor nuclei are 
organised into subnuclei within the lateral, intermdiate and medial columns and the 
position of facial motoneurones (FMs) within the nuclei loosely represent the 
position of their target muscles on the face (Hinrichsen 1984; Friauf 1985; Paxinos 
1985).  For the purpose of this thesis FMs were not distinguished by location within 
the nucleus. 
Exogenously applied 5-HT and NA have modulatory actions on FMs and  in vivo the 
FMN is has been found to be densely innervated by 5-HT-releasing terminals 
 14 
(Takeuchi, Kojima et al. 1983; Senba 1985; Larkman and Kelly 1992; Larkman and 
Kelly 1997; Larkman and Kelly 1998).  These findings encouraged the investigations 






Chapter 2 Methods 
2.1 FM Electrophysiology 
2.1.1 Animals 
Male and female Wistar rats (or PLC-β1-/- mice and their littermate controls where 
stated) aged between postnatal days 4 and 16 (P4-P16) were used to prepare acute 
brainstem slices.  All procedures were approved by the UK Animals (Scientific 
Procedures) Act 1986 and performed under UK Home Office License.  Animals were 
obtained from an in house breeding colony maintained  a 12 hour light-dark cycle, 
in which breeding pairs were provided with food and water ab libitum.   
2.1.2 Brainstem Slice Preparation 
Motoneurones appear to be particularly sensitive to the lack of oxygen and 
mechanical damage that occurs during slice preparation. To increase the number of 
healthy neurones brainstem slices were cut in a modified artificial cerebrospinal fluid 
(ACSF) (Solution 2.1, Section 2.6) in which 50% of the NaCl was substituted with 
sucrose. This solution has the advantage of reducing the passive chloride entry into 
neurones that occurs during periods of hypoxia (Rothman 1985; Aghajanian and 
Rasmussen 1989).  This passive chloride influx leads to cation and water entry which 
results in cell swelling and lysis (Rothman 1985).  Lactate was included in the 
modified ACSF as there is evidence to suggest that i  is the preferred substrate for 
energy production in hypoxic conditions (Schurr, West t al. 1988; Larrabee 1995; 
Magistretti 2005).  150 ml of the modified ACSF was cooled on ice to <4°C and 
oxygenated with a 95% O2, 5% CO2 gas mixture (BOC Gases, Manchester, UK).  
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Following cutting, slices were incubated in the modifie  ACSF with added Ca2+ (1 
mM) as prolonged periods of reduced glutamate receptor activity can also reduce the 
viability of slices.  A modified Gibb slice incubation chamber (Figure 2.1) was filled 
with 250 ml of the modified ACSF to which 1 mM CaCl2 had been added and 
warmed to 30°C in a water bath (Edwards, Konnerth et al. 1989).   
To support the brainstem during the slicing procedur  a small block of agar (2%) was 
glued (cyanoacrylate adhesive, Fisher Scientific UK) close to the front edge of the 
cutting stage of a microslicer (DTK-100, Dosaka EM Co Ltd, Japan).  A thin razor 
blade (Mackay and Lynn Ltd, Edinburgh, UK) was put into the blade holder of the 
microslicer and the chamber surrounding the cutting sta e was filled with ice to keep 
the ACSF cold during slicing. 
Animals were decapitated using UK Home Office approved procedures.  The skull 
was exposed and carefully removed and the brain was bathed in ice-cold modified 
ACSF (Solution 2.1, Section 2.6) using a glass dropper made from a Pasteur pipette 
and a rubber teat.  A thin razor blade was used to separate the midbrain and hindbrain 
at the level of the cerebellum (Figure 2.2).  The hindbrain was gently eased away 
from the skull into a small beaker containing pre-oxygenated ice-cold modified 
ACSF.  Cutting the cranial nerves on the underside of the brainstem as it is removed 
appeared to enhance motoneurone survival.  The isolated hindbrain was left in the 
ice-cold modified ACSF for approximately 30 seconds to cool, this slowed 
metabolism in the tissue reducing cell death.  This also had the added advantage of 
firming the tissue, which aided the slicing procedure.  A small amount of 
cyanoacrylate adhesive was spread onto the cutting s age of the microslicer behind 
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the piece of agar.  The hindbrain was removed from the beaker using a 5 ml plastic 
spoon and placed cut surface down on a piece of ACSF-soaked filter paper 
(Whatman International Ltd, Maidstone, UK) on an upturned Petri dish on ice.  The 
cerebellum was dissected from the brainstem using a thin razor blade and removed 
using a small spatula.  The isolated brainstem was then positioned on a spatula dorsal 
side up using a fine artist’s paintbrush.  Excess solution was removed using a small 
piece of filter paper and the brainstem stuck onto the cutting stage, cut edge down.  
The cutting stage was then put into the chamber of the microslicer and immediately 
filled with pre-oxygenated modified ACSF.  The blade was locked at a cutting angle 
of 15° and moved into position in front of the brainstem at the level of the beginning 
of the facial nucleus.   
Prior to cutting (and during if required) any blood vessels on the surface of the 
brainstem were dissected away using fine jewellers forceps (No. 5, A. Dumont & 
Fils, Switzerland) and microscissors (OC-498, Aesculap, Tuttlingen, Germany).  
Very dense connective tissue impedes light transmission through the slice and 
reduces the ability to visually identify facial motoneurones. Therefore, slice 
thickness (between 100 – 140 µm) was dependent on the age of the animal and the 
relative density of the connective tissue in the nucle s.  Slices were cut at the lowest 
speed on the microslicer and the blade was set to oscillate at the highest frequency.  
After slices were cut they were immediately transferred to the incubation chamber.   
 
The low Na+ concentration in the modified ACSF is not suitable for 
electrophysiological studies thus recordings were made in normal ACSF (Solution  


























Figure 2.1. Modified Gibb incubation chamber (Edwards, Konnerth et al. 1989).  
A. The slice holder was made from 1 cm segments of a 5 ml syringe glued 
together and a nylon grid attached to the bottom.   
B. The slice holder was held in a 250 ml beaker with a segment cut from a 50 ml 
syringe.  The solution was oxygenated with a 95% O2, 5% CO2 gas mixture 
through the syringe piece.  The slices were held down in the slice holder by the 
bubbles rising to the surface through the syringe and pushing solution down on 
















Figure 2.2.  Position of cut to isolate brainstem. 
Following removal of the skull-cap a razor blade was used to make a cut at the 
position of the dashed line and separating the hindbrain and the midbrain. 
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The viability of the slices seemed to be enhanced if the sucrose concentration was 
reduced gradually over the incubation period (following the protocol in Table 2.1) 
rather than immediately transferring them from a high sucrose to zero sucrose 
solution.  At the end of the incubation period the slice chamber was removed from 
the water bath and maintained at room temperature.  Slices were transferred to the 
recording chamber when required where they were held down by a nylon grid 
(Figure 2.3) (Edwards, Konnerth et al. 1989) and continuously perfus d with 
oxygenated normal ACSF at a rate of 3 – 5 ml min-1.   
2.1.3 Patch-clamp Electrophysiology 
The patch-clamp technique was developed by Neher and S kmann and first utilised 
to resolve the single channel activity of acetylchoine-activated channels in cell-
attached patches (Neher, Sakmann et al. 1978).  The advantages of the patch-clamp 
technique over conventional intracellular recordings was that it allowed recordings to 
be made from cells that were too small to impale.  The equipment and set up for 
patch clamp recordings was as described in Figure 2.4.  Voltage protocols were 
generated by the PC, converted by the CED 1401 interface and the DAC output sent 
to the patch-clamp amplifier.  The recording electrode was connected to the 
headstage of the amplifier which delivered the voltage commands to the recorded 
cell and recorded any current changes (when in the voltage clamp configuration).  
The patch-clamp amplifier was connected to pre-amplifiers to enable the output to be 
split and sent back to the computer (via the CED 1401 interface) and the 
oscilloscopes for real time monitoring of current changes (which was particularly 
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Figure 2.3. Nylon grid. 
Slices were held in place in the recording chamber by U-shaped piece of platinum 
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Figure 2.4. Equipment for patch-clamp electrophysiology. 
 
Oscilloscope (DSO) 400 Gould Electronics Ltd, Essex, UK. 
 
Digital tape Recorder DTR-1404 Bio-logic Scientific Instruments. 
 
Whole cell/patch clamp amplifier  List Medical, D-6100 Darmstadt, Germany. 
L/M-EPC 7B 
 
1401 Interface Cambridge Electronic Design, Cambridge, UK.  
 





configuration, see Section 2.1.5).  The connections t  the oscilloscopes were via the 
DAT recorder to ensure all data was recorded and could be played back at a different 
frequency if required for data analysis.  All equipment and the anti-vibration table 
(on which all recordings were made) were connected to the ground on the patch-
clamp amplifier.   
The amplifier operating modes are detailed in Figure 2.5.  The Vp-offset control was 
used to zero the potential difference that occurs between the bath and internal 
solutions (Section 2.1.5).  The required holding potential was applied using the V-
Hold command and the V-step function was rarely used as ramp and step changes 
were configured using the Signal software package (v rsion 2.15, Cambridge 
Electronic Design (CED) Ltd, Cambridge, UK). 
2.1.4 Cell Cleaning 
The development of thin acute slices allows recordings to be made from visually 
identified motoneurones, significantly increasing the success rate of recordings.  
However, even in thin slices there is still a sufficient amount of connective tissue and 
cell debris in the facial nucleus to impede formation of high resistance seals without 
prior cleaning of the cell surface.  Healthy cells are first identified using a x40 
immersion objective on an Zeiss upright microscope and Nomarski differential 
optics.   
Motoneurone cleaning was performed as described by (Edwards, Konnerth et al. 
1989).  A cleaning electrode was made from a glass electrode (GC120F-10, Harvard 











































puller (PP-83, Narishige Scientific Instruments, Toky , Japan).  The tip of the 
electrode was then broken to 5 -10 µm in diameter using a micro forge (MF-830, 
Narishige Scientific Instruments, Tokyo, Japan).  A suction line was connected to the 
end of the cleaning electrode and it was then positioned above the identified 
motoneurone using a fine manipulator (M0-103, Narishige Scientific Instruments, 
Tokyo, Japan).  ACSF was then drawn into the tip of the cleaning electrode and the 
debris above the cell was loosened by blowing ACSF out of the cleaning electrode.  
Care was taken to avoid damaging the dendrites as this can result in death of the 
motoneurone (Edwards and Konnerth 1992).  The debris was then removed by 
carefully sucking it into the cleaning electrode and the procedure repeated until the 
surface of the motoneurone was clear. 
2.1.5 Whole-cell patch clamp recordings  
Patch electrodes were pulled from borosilicate glass (7.5 cm segments of GC150TF-
15, Harvard Apparatus Ltd, Kent, UK) to a resistance of 6 -12 MΩ when filled with 
standard internal solution and a tip diameter of approximately 0.5 – 1 µm.  Prior to 
making electrodes the ends of the glass were fire-polished to prevent damaging the 
AgCl wire of the pipette holder.  The glass was then cleaned in 100% ethanol, rinsed 
in distilled H2O and dried in an oven to minimise the dust particles on the glass that 
could potentially block the tip of the electrode.  Patch-pipettes were pulled using a 
Narishige patch-pipette puller (PP-83).  The capacitan e of the electrode that occurs 
when it is deeply immersed in the ACSF in the recording chamber is reduced by 
coating the shank of the electrode with Sylgard (Dow Corning Limited, Coventry, 
UK).  The tip of the electrode was then heat polished using a micro forge (MF-830, 
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Narishige Scientific Instruments, Tokyo, Japan).  Tip polishing smoothes the surface 
of the tip and can help remove small dust particles from the electrode.  Electrodes 
were filled with internal solution (Solution 2.3, Section 2.6) using an electrode filler 
made from a 20 ml syringe, a 25 mm, 0.22 µm filter and a cannula (0.7 mm outside 
diameter) cut to the desired length.  The internal solution was occasionally diluted to 
90% to help maintain cell health during the recording period.  Filling of electrodes 
was aided by the filament that runs the length of the glass.  A small amount of 
internal solution was put on the end of the electrode and allowed to back fill the tip, 
this reduced the formation of air bubbles in the tip.  The electrode was then 2/3 filled 
with the internal solution and any air bubbles in the electrode were dispersed by 
gentle flicking. 
The filled electrode was put in the pipette holder attached to the headstage connected 
to the amplifier (EPC7B, List Medical, Darmstadt, Germany).  Positive pressure was 
applied to the tip of the electrode by blowing through a suction line attached to the 
headstage and locked with a three-way valve.  The electrode was then immersed in 
the ACSF in the recording chamber under the control of a fine manipulator (MX-1, 
Narishige Scientific Instruments, Tokyo, Japan).  The reference point for the 
headstage was an AgCl pellet connected to the recording chamber by an agar bridge.  
Agar bridges were made by taking a small length of electrode glass (GC150TF-15, 
Harvard Apparatus Ltd, Kent, UK) and bending it to a 90º angle using a Bunsen 
burner.  The glass was then filled with agar (2%) made up in normal ACSF.  Using 
the bridge rather than putting the AgCl pellet directly prevented a junction potential 
arising at the AgCl and bath solution interface.  It also allowed the composition of 
the bath solution to be changed slightly without generating a potential that would add 
 29 
to the holding potential.  The current output was zeroed using the offset control on 
the amplifier.  Inputs commands were configured on a personal computer using the 
commercially available software package Signal (version 2.15, Cambridge Electronic 
Design (CED) Ltd, Cambridge, UK).  Formation of a high resistance (GΩ) seal was 
monitored by measuring the current responses to a -10 mV, 10 ms step from the 
holding potential, performed in the voltage-clamp configuration.  When the electrode 
was first put in the bath the current deflection observed gave a measure of the 
resistance of the electrode.  The electrode was then manoeuvred to just above the 
visually identified cell and the electrode slowly lowered until it touched the cell 
soma.  This was either monitored by looking down the objective or more routinely by 
observing a 10 – 20% increase in resistance (a decrease in the current deflection in 
response to the voltage command).  The positive pressu  was then removed 
resulting in a further increase in resistance.  A GΩ seal was obtained by gently 
sucking on the suction line until there was no deflection on the current trace and the 
cell was in the cell-attached configuration.  Any stray capacitance of the electrode 
was compensated for using the controls on the amplifier.  The holding potential was 
then applied to the electrode using the amplifier.  An 8 mV junction potential was 
routinely taken into consideration when calculating the holding potential to be 
applied (Neher 1992).  The electrode was left in the cell-attached mode for a few 
seconds to enhance seal formation after which short sharp bursts of suction were 
applied to remove the piece of membrane in the tip of the electrode and break 
through into the whole-cell configuration.  The current response to a -10 mV, 10 ms 
voltage step was measured to monitor the series resistance, which was compensated 
for by up to 70%.  Gentle suction was applied and maintained throughout the 
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recording to help prevent any loose pieces of membrane or dust particles from 
blocking the tip. 
2.2 Experimental Protocols 
2.2.1 Modulation of Ih in FMs 
FMs were voltage-clamped at -60 mV and changes in conductance mediated by Ih 
were measured using a voltage step to -100 mV (Figure 2.6A).  This step was 
followed by a ramp to 0 mV to monitor any changes in gKLeak.  The step and ramp 
were preceded by a -10 mV, 10 ms step to monitor any changes in series resistance.  
Initial investigations into the receptor subtype that mediates the enhancement of Ih by 
5-HT were performed in 12 K+ ACSF (Solution 2.4, Section 2.6) in which the 
external [K+] was increased to 12 mM.  This solution resulted in a shift in the K+ 
equilibrium potential to a more depolarised value.  Under these conditions inhibition 
of gKLeak by 5-HT was observed as an outward current whereas the enhancement of 
Ih was still observed as an inward current.  The amplitude of Ih was also enhanced 
under these conditions.  5-HT was bath applied in the superfusing ACSF.  A 15 sec 
application (flow rate = 3 – 5 ml min-1) of 5-HT (10 µM) was routinely administered 
and the voltage command was applied when the observed inward current was 
maximal.  After a control 5-HT response was obtained antagonists were bath applied 
for 10 mins.  5-HT was then co-applied in the presence of the antagonist.  A voltage 
step protocol was occasionally used to monitor Ih activation and inactivation over a 

























Figure 2.6.  Voltage protocols to monitor changes in Ih in FMs. 
A. Voltage ramp protocol 
B. Voltage step command used to monitor changes in actvation and inactivation 













2.2.2 Modulation of gKLeak in FMs 
Experiments designed to investigate the modulation of gKLeak were performed on 
slices pre-incubated for a minimum of 30 mins with ZD-7288 (10 µM), to block Ih.  
ZD-7288 blocks the pore of Ih channels at an intracellular site, therefore, ZD-7288 
(10 µM) was included in the internal solution to maint in an effective blocking 
concentration throughout the recording period (Shin, Rothberg et al. 2001).  FMs 
were held at -50 mV and changes in conductance mediated by gKLeak were measured 
using a voltage ramp from -100 mV to 0 mV (Figure 2.7).  This ramp was preceded 
by a step to -100 mV to monitor the ZD-7288 mediated block of Ih.  Series resistance 
monitored by a -10 mV, 10 ms step at the beginning of the sweep.  5-HT or NA was 
routinely applied in normal ACSF for 15 sec (flow rate = 3 – 5 ml min-1) and the 
voltage command (Figure 2.7) applied when the respon e was maximal.  External pH 
was modified using a pH ACSF (Solution 2.5, Section 2.6) titrated to the required pH 
with NaOH and oxygenated with 100% O2 (BOC Gases, Manchester, UK) (Talley, 
Lei et al. 2000).  pH-induced current changes were measured by applying a voltage 
ramp (Figure 2.7) when the current reached steady-state.  Anandamide, bupivacaine, 
methanandamide and ruthenium red were all bath-applied through the superfusing 
ACSF (Section 2.7 for drug details).  Slices were incubated in ATFK containing 
ACSF for a minimum of 10 mins prior to co-application with anandamide.  Zn2+ was 
also applied through the ACSF, however, this ACSF did not contain any NaH2PO4 to 














External solutions containing isoflurane were prepad as previously reported 
(Simon, Hapfelmeier et al. 2001; Ranft, Kurz et al. 2004). Briefly, a saturated 
solution of isoflurane (15 mM, (Scheller, Bufler et al. 1997)) was prepared by adding 
an excess of anaesthetic to ACSF in a sealed glass bottle and stirring for 3 h at room 
temperature.  Simon et al, 2001 found that dilutions between 1:30 to 1:7.5 of this 
stock solution resulted in a final aqueous concentration of 0.2 – 0.3 mM after 
bubbling with oxygen and delivery to the recording chamber. A 1:10 dilution was 
routinely used in the experiments described in this the is  
2.2.3 Evoked EPSCs and EPSPs 
EPSCs and EPSPs were evoked using stimulating electrod s made from borosilicate 
glass (7.5 cm segments of GC150TF-15, Harvard Apparatus Ltd, Kent, UK) pulled 
to a resistance of 10 – 12 MΩ and had a tip diameter of 0.5 - 1 µm.  The glass 
stimulating electrodes were filled with normal ACSF (Solution 2.2, Section 2.6) and 
attached to one piece of a bipolar stimulating wire on the headstage of a fine 
manipulator (MX-1, Narishige Scientific Instruments, Tokyo, Japan).  The other part 
of the stimulating wire was put directly into the rcording chamber to complete the 
circuit.  Stimulation was applied using an isolated stimulator (DS2, Digitimer Ltd, 
Welwyn Garden, UK).  Prior to making recordings from FMs the stimulating 
electrode was manoeuvred close to the surface of the slice to reduce the disruption to 
the seal caused by movement of the set up.  EPSPs were evoked in the current-clamp 
configuration and series resistance was monitored using a 100 pA, 10 ms current 
step. The properties of the stimulating pulse were controlled by the isolated 
stimulator and were routinely 0.02 µs in duration and 3 – 10 V in intensity.  For 
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initial searching of a response EPSCs were evoked at a frequency of 0.5 Hz and at an 
intensity of ~10 V.  The stimulating electrode was lowered onto the surface of the 
slice at various positions until an EPSC was observed.  Occasionally the recording 
electrode and stimulating electrode were filled with Lucifer Yellow (2 mg/ml) so the 
location of the stimulating electrode with referenc to the FM could be visualised 
under fluorescence microscopy (Figure 2.8).  The int nsity of the stimulus was then 
reduced to 0 V and gradually increased until a respon e was observed.  This type of 
minimal stimulation has previously been utilised toisolate single synapses 
(Lawrence, Grinspan et al. 2004).  Once an appropriate stimulus intensity was 
selected EPSCs and EPSPs were evoked at a frequency of 0.05 Hz and a minimum of 
10 sweeps were obtained under each condition.  Two stimuli 50 ms apart were 
applied to monitor paired pulse facilitation/depression.  Control responses were 
obtained in normal ACSF and 5-HT, 8-OH-DPAT, AP-5, CP93129, ifenprodil, 
isamoltane, NBQX and WAY 100635 were applied through the superfusing ACSF.  
The NMDA receptor-mediated response was revealed by blocking the AMPA 
receptor-mediated response with NBQX (20 µM) and removing the voltage 
dependent Mg2+ block by either depolarising to +20 mV or removing M 2+ from the 
ACSF (Solution 2.6, Section 2.6).  The Na+ channel blocker, QX314 (5 mM), was 
included in the internal solution when holding the FM at depolarised voltages was 









Figure 2.8 Positions of recording and stimulating el ctrodes. 
The recording electrode (1) was filled with Lucifer Yellow (2 mg/ml) prior to 
making whole-cell recordings from the FM.  The dye iffused into the FM and was 
visualised with fluorescence microscopy.  The stimulating electrode (2) was also 















2.2.4 Miniature EPSCs          
FMs were held at -70 mV, action potential-dependent EPSCs were blocked by 
including tetrodotoxin (0.3 µM) and picrotoxin (50 µM) in the normal ACSF 
(Solution 2.2, Section 2.6) and the resulting ‘mini’ EPSCs represent spontaneous 
release of vesicles.  A -10 mV, 10 ms voltage step was applied every minute to 
monitor series resistance and 5-HT and CP93129 were bath applied until the 
response reached steady-state. 
2.2.5 PLC-β1-/- mice 
Voltage-clamp recordings from FMs from PLC-β1-/- mice and their littermate 
controls were made using exactly the same procedure as for rat FMs (Section 2.1).  
The 5-HT- and NA-induced currents in these FMs measured following the protocol 
described in Section 2.2.3.   
The non-selective PLC-β inhibitor, U73122, (10 µM) was applied to the superfusing 
ACSF following obtaining a control response to 5-HT or NA in PLC-β1-/- mice 
littermate controls. 
2.3 Cerebellar Granule Neurone Electrophysiology 
2.3.1 Cerebellar Granule Neurone Cultures 
Cerebellar granule neurone (CGN) cultures were prepared by Mr Thomas Wishart 
from male and female Wistar rats aged P7 using UK Home Office approved 
procedures.   
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Dissociated granule cells were seeded on poly-D-l sine coated glass cover slips at a 
density of 7.5 x 105 cells cm-2.  The neurones were then cultured at 37ºC, 5% CO2 in 
supplemented modified Eagle’s medium (MEM, Gibco, Invitrogen, Paisley, UK) 
without Ca2+ and Mg2+ (Solution 2.7, Section 2.6).  Cytosine-arabinoside (10 µM) 
was added after 24 hours to prevent glial cell growth.  Electrophysiology was 
performed between 8 – 14 days in vitro (DIV). 
Prior to making electrophysiological recordings the coverslips with the cultured 
CGNs were transferred to the recording chamber and perfused with the pH ACSF 
(Solution 5 titrated to pH 7.4) at a rate of 3 – 5 ml min-1.  Although the cultures can 
be maintained for several hours without oxygenation, the ACSF was oxygenated 
with 100% O2 (BOC Gases, Manchester, UK) in order to maintain the experimental 
conditions used for slice experiments.   
2.3.2 Perforated patch recordings from CGNs 
The small size of CGNs can lead to fast dialysis of the cytoplasm and subsequent 
rundown in TASK-channel conductance when conventional whole-cell patch clamp 
recordings are made.  To reduce this rundown the perforated-patch configuration was 
used to record from CGNs.  Perforated-patch recordings were obtained by including 
the polyene antibiotic, amphotericin B, in the inter al solution.  The antibiotic forms 
small channels in lipid membranes that are only permeable to monovalent ions.  This 
prevents movement of multivalent ions and dialysis of larger non-electrolytes such as 
glucose (Rae, Cooper et al. 1991).  Perforated-patch re ordings were made from 
CGNs at room temperature using the same set-up as for whole-cell recordings.  Patch 
electrodes were made as for whole-cell recordings and the tip was filled with a 
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minimal amount of standard internal solution (Soluti n 2.3, Section 2.6).  The 
electrode was then filled with standard internal soluti n with added amphotericin B 
(250 µg/ml).  The amphotericin B containing internal solution was not filtered and 
was protected from light to maintain the efficacy of the antibiotic.  The tip of the 
electrode was filled with standard internal solution as the amphotericin B prevented 
formation of a high resistance seal.  The procedure fo  obtaining a GΩ seal with 
CGNs was identical as that described for FMs.  Once in the cell-attached 
configuration a holding potential of -20 mV was applied and the cell left until the 
antibiotic formed sufficient channels in the membrane that the access resistance fell 
and stabilised.  The time required for the change i access resistance to be observed 
depended on the volume of the standard solution in tip and the diffusion rate of the 
antibiotic (Rae, Cooper et al. 1991). 
2.4 Experimental Protocol 
2.4.1 Modulation of TASK channels in CGNs 
CGNs were held at -20 mV and conductance changes were m asured using voltage 
ramps from -20 to -110 mV, 900 milliseconds in duration (Figure 2.9).  External pH 
was modified using a pH ACSF (Solution 2.5, Section 2.6) titrated to the required pH 
with NaOH and oxygenated with 100% O2 (BOC Gases, Manchester, UK) (Talley, 
Lei et al. 2000).  pH-induced current changes were measured by applying a voltage 
ramp (Figure 2.9) when the current reached steady-state.  Anandamide and 
ruthenium red were bath-applied through the superfusing ACSF and voltage 























2.5 Data Analysis  
2.5.1 Data Acquisition 
All current recordings were filtered by 10 kHz, 8-pole Bessel low-pass filter in the 
patch-clamp amplifier.  The sampling frequency for data acquisition varied between 
configurations.  Test pulses for obtaining GΩ seals were sampled at 3 kHz whereas 
all ramps were sampled at 200 Hz.  The sampling rate for EPSCs and EPSPs was 10 
kHz and continuous current records were sampled at 10 Hz.  Signal files were saved 
to disc immediately following recordings being made.  Outputs from the current and 
voltage channels were also recorded onto digital audio-tapes (DAT, Maxwell) 
through a digital tape recorder (DTR 1404, Bio-logic Scientific Instruments) to allow 
playback of data at different sampling frequencies and further offline analysis.    Data 
was exported from Signal files as text files, which were then opened with Microsoft 
Excel (Microsoft Corporation) for further analysis.   
2.5.2 Miniature EPSCs 
Recordings were played back into the computer into an EDR file using John 
Dempster’s Electrophysiology Data Recorder software (version 2.4.3, University of 
Strathclyde).  The files were then converted to an ABF format using Justin Lee’s 
ABF File Utility v2.1.74.  ABF files were analysed using Justin Lee’s Mini Analysis 
Program (version 6.0.7, Synaptosoft Inc.) in an EVT format.  EPSCs were identified 




The Nernst equation was used to predict the K+ quilibrium potential, 
EK = RT / F ln [K] o / [K] i  (Equation 1) 
where R is the gas constant,  T is the temperature (Kelvin scale) and F is the Faraday 
constant.  
Single exponential fits to the activation and deactiv tion of subtracted NA-sensitive 
current traces were performed using Signal software (v2.0, CED, Cambridge, UK) 
according to the equation, 
It  = A + Be 
-t/τ (Equation 2)      
where It is current amplitude at time t, A and B are constants and τ is the time 
constant. 
The pH-sensitivity of FM membrane current could be described by a modified (4 
parameter logistic) Hill Equation, 
y  =  ymin + (ymax - ymin ) / [1 + (pH / pK)
b]  (Equation 3)   
where y is the holding current or input conductance, ymax the maximum response, ymin 
the minimum response and b = -(b’ * pK) / 0.434 where b’ is the Hill coefficient 
expressed as a function of H+ concentration.  
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2.6 Solutions 












pH = 7.4 when bubbled with 95% O2, 5% CO2 










pH = 7.4 when bubbled with 95% O2 : 5% CO2 











pH to 7.4 with KOH 
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pH = 7.4 when bubbled with 95% O2 : 5% CO2 
 




























Solution 2.7.  Supplemented modified Eagle’s medium (MEM, Gibco, 
Invitrogen, Paisley, UK). 
Compound Concentration  
 MEM   
 Fetal calf 
serum 
10% 
 Glucose 9.2 mM 
 Glutamine 0.56 mM  










Drug  Supplier (cat. #) Concentrations 
Used 
5-hydroxytryptamine creatine sulphate (5-HT) Sigma (H7752) 10 µM 
8-Hydroxy-DPAT hydrobromide  (8-OH-DPAT) Tocris (0529) 10 µM 
amphotericin B solubilized Sigma (A9528) 250 µg/ml  
in internal solution 
anandamide  (Arachidonylethanolamide) Tocris (1339) 10 – 20 µM 
AP-5  (AP-V or D-(-)-2-Amino-5-phosphonopentanoic acid) Tocris (0106) 50 – 100 µM 
Arachidonyl trifluoromethyl ketone (ATFK or  AACOCF3) Tocris (1462) 10 µM 
Bupivacaine hydrochloride Sigma (B5274) 100 µM 
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Drug  Supplier (cat. #) Concentrations 
Used 
CP93129 dihydrochloride  
 
Tocris (1032) 10 µM 
Ifenprodil hemitartrate Tocris (0545) 10 µM 
Isoflurane  See Methods 2.2.3 
Isamoltane hemifumarate Tocris (0992) 1 µM 
Lucifer Yellow Sigma 2 mg/ml   
in internal solution 
(R)-(+)-Methanandamide  Tocris (1121) 10 – 20 µM 










5 -10 µM 
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Drug  Supplier (cat. #) Concentrations 
Used 
Phenylephrine hydrocholride Sigma (P6126) 30 µM 
Prazosin Tocris (0623) 0.5 µM 
Propranolol Tocris (0624) 10 µM 
QX314  
 
Tocris (1014) 5 mM 
R96544 Tocris (1742) 0.3 – 1 µM 
Ruthenium red Sigma (R2751) 10 µM 
SB29970A Tocris (1612) 0.3 – 10 µM 
Tetrodotoxin citrate  Tocris (1069) 0.3 µM 
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Drug  Supplier (cat. #) Concentrations 
Used 
U73122 Tocris (1268) 5 – 10 µM 
WAY 100635 maleate salt Sigma (W108) 1 µM 
ZD-7288 Tocris (1000) 10 µM 




2.8 PLC-β1 Immunohistochemistry 
2.8.1 Tissue preparation 
This work was performed in collaboration with Dr Peter Kind, The University of 
Edinburgh.   
Wild type littermates of PLC-β1-/- mice were perfused with 4% paraformaldehyde 
using UK Home Office approved procedures.  The brain was removed, the hindbrain 
isolated and kept overnight in 4% paraformaldehyde.  The hindbrain was then 
transferred to 30% sucrose and left overnight or until the tissue sunk.  48 µm sections 
were cut on a freezing microtome and transferred to phosphate buffered saline (PBS). 
2.8.2 Immunohistochemistry 
Immunohistochemistry was performed using published procedures (Hannan, Kind et 
al. 1998).   
Sections were blocked for 30 min with 5% (v/v) normal goat serum (NGS), 0.5% 
(v/v) Triton X-100, in PBS.  The sections were then incubated overnight at 4°C with 
a  primary antibody that specifically recognizes PLC-β1 (rabbit polyclonal; Santa 
Cruz Biotechnology, Santa Cruz, CA, USA), diluted (1 in 2000) in 1% NGS, 0.5% 
Triton X-100 in PBS.  Sections were washed three times in 0.5% Triton X-100 in 
PBS for 10 min at room temperature with shaking.  The sections were then incubated 
with biotin-conjugated secondary antibody (anti-rabbit, donkey derived, Vector 
Laboratories, Bretton, UK) at room temperature for 2 hours with shaking.  After 
washing the sections 3 times as above they were incubated with Vectastain ABC 
Elite avidin detection reagent (Vector Laboratories, Bretton, UK) for 1 h.  Following 
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a further three washes, colour detection was achieved by the addition of a solution 
containing 0.5 mg/ml 3,3′-diaminobenzidine (DAB, Sigma–Aldrich), 0.6% (w/v) 
Ni(NH4)(SO4) and 0.03% H2O2. The colour reaction was stopped with PBS, and 
sections were dehydrated and mounted under coverslips with DePeX (Merck, 
Lutterworth, UK).  
Sections were examined and bright-field photomicrographs were prepared using a 






The monoamine neurotransmitters 5-HT and NA are generally accepted to promote 
adult FM excitation by depolarising the postsynaptic membrane (VanderMaelen and 
Aghajanian 1980; Vandermaelen and Aghajanian 1982; Larkman, Penington et al. 
1989; Larkman and Kelly 1992).  The ionic mechanisms that underlie the membrane 
depolarisation by 5-HT have been previously determined as an enhancement of the 
hyperpolarisation activated cation current, Ih, and a decrease in a leak potassium (K
+)
conductance (gKLeak) (Larkman and Kelly 1992; Larkman and Kelly 1997; Larkman 
and Kelly 1998).  In addition, NA promotes FM membrane excitation by inhibiting a 
potassium conductance but does not enhance Ih (Larkman and Kelly 1992). The 
primary aim of this study was to investigate the biophysical and pharmacological 
properties of the amine-sensitive gKLeak in neonatal rat FMs. Some of this work has 
been published and a reprint of the manuscript appers in Appendix A (Larkman and 
Perkins 2005). 
3.1.1 Leak K+ conductances 
‘Leak’ K+ conductances (gKLeak), characterised by no or weak voltage-dependence 
and fast kinetics, provide a major determinant in regulating excitability of many 
neuronal types.  It has been widely suggested that members of the twin-pore (2P) 
domain K+ channel family provide molecular correlates for physiologically identified 
“leak” K+ conductances (reviewed by (Goldstein, Bockenhauer et al. 2001), (Patel 
and Honore 2001)). Unlike other K+ channel subunits which have one pore domain 
and either two or six transmembrane domains, the K2P channel subunits have 4 
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transmembrane segments and 2 pore-forming domains (Figure 3.1, (Lesage and 
Lazdunski 2000)).  The K2P subunits form functional channels as homomeric or 
heteromeric dimers (Lesage, Guillemare et al. 1996; Lesage and Lazdunski 2000; 
Berg, Talley et al. 2004). The 15 known members of this family can be grouped into 
six subfamilies:  the two pore domain weakly inwardly rectifying K+ (TWIK) 
channels (TWIK1, TWIK2 and KCNK7); TWIK-related K+ (TREK) channels 
(TREK1, TREK2 and TRAAK); TWIK-related alkali-activated K+ (TALK) channels 
(TALK1, TALK2 AND TASK2); the TWIK-related spinal cord K+ (TRESK) 
channel and TWIK-related acid-sensitive K+ (TASK) channels (TASK1, TASK3 and 
TASK5) (Bayliss, Sirois et al. 2003; Mathie 2007).  
3.1.2 TASK channels 
TASK-1 channels were the first K2P molecular correlates of background or ‘leak’ K
+ 
conductances to be cloned (Duprat, Lesage et al. 1997; Leonoudakis, Gray et al. 
1998).  This was followed by the discoveries of four ther members of this family 
(TASK 2-5) although TASK 2 and 4 have reclassified as members of the TALK 
subfamily (TASK4 is also named TALK2) (Kim, Bang etal. 2000; Ashmole, 
Goodwin et al. 2001; Decher, Maier et al. 2001; Gabriel, Abdallah et al. 2002).   
In young rat hypoglossal motoneurons and adult turtle spinal motoneurons it has 
been proposed that members of the TASK group of 2P channels, underlie an amine-
sensitive gKLeak (Talley, Lei et al. 2000; Perrier, Alaburda et al. 2003).  The presence 
of TASK-1 (KCNK3) and TASK-3 (KCNK9) mRNA has been demonstrated in the 














Figure 3.1.   Structure of K2P receptor subunit. 
The K2P receptor contains four transmembrane segments (M1-4) and two pore 
forming loops (P1-2) and also has an extracellular self-interacting domain (SID).  
The subunits dimerize to form functional channels.  Modified from (Lesage and 
Lazdunski 2000). 
 





gKLeak in FMs (Talley, Lei et al. 2000; Karschin, Wischmeyer et al. 2001; Vega-
Saenz de Miera, Lau et al. 2001).  Nevertheless, a motoneuron specific inwardly 
rectifying K+ channel, Kir2.4, has also been proposed to underlie the amine-sensitive 
K+ current in hypoglossal motoneurons and this may also be expressed by neonatal 
rat FMs (Karschin, Dissmann et al. 1996; Karschin and Karschin 1997; Topert, 
Doring et al. 1998). 
TASK-1 and TASK-3 channels mediate openly rectifying currents with fast kinetics 
that can be distinguished by the pH at which they ar  half-maximally activated (pK) 
(Duprat, Lesage et al. 1997; Leonoudakis, Gray et al. 1998; Kim, Bang et al. 2000; 
Rajan, Wischmeyer et al. 2000).  In addition, the endogenous cannabinoid, 
anandamide, preferentially blocks TASK-1 channels while the polycationic 
compound, ruthenium red (RR) selectively blocks TASK-3 channels (Maingret, Patel 
et al. 2001; Czirjak and Enyedi 2003).  TASK-1 and TASK-3 also appear to form 
functional heterodimeric channels with emergent prope ties distinct from the 
respective homomeric channel (Czirjak and Enyedi 2002; Talley and Bayliss 2002; 
Kang, Han et al. 2004).  In this respect, acetylcholine inhibits a gKLeak in cultured rat 
cerebellar granule neurones with properties similar, but not identical, to TASK-1 
(Watkins and Mathie 1996; Millar, Barratt et al. 2000).  Single-channel studies have 
demonstrated the presence of homomeric TASK-1, homomeric TASK-3 and 
heteromeric TASK-1 / TASK-3 channels in these cells (Han, Truell et al. 2002; 
Kang, Han et al. 2004).  
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3.1.3 Hyperpolarisation-activated cation current 
The channels which mediate Ih belong to the voltage-gated K
+ channel superfamily 
but Ih has the unique property of being a slowly developing inward current which is 
activated by membrane hyperpolarisation and not depolarisation like other members 
of this superfamily. 
Four mammalian genes for the subunits which can form the hyperpolarisation-
activated cyclic nucleotide-gated cation channel (HCN1-4) have been cloned 
(Ludwig, Zong et al. 1998; Santoro, Liu et al. 1998).  HCN channels are tetrameric 
and each subunit has six transmembrane segments (S1-S6) with a pore-forming loop 
between S5 and S6 (Figure 3.2) (for reviews see (Kaupp and Seifert 2001; Accili, 
Proenza et al. 2002; Robinson and Siegelbaum 2003)).  The GYG sequence motif 
that acts as a selectivity filter in K+ channels is present in this loop region, however, 
the other amino acids in this region also allow for movement of Na+ through the 
channel pore (Heginbotham, Lu et al. 1994; Pape 1996; Ludwig, Zong et al. 1998; 
Santoro and Tibbs 1999; Kaupp and Seifert 2001). 
3.1.4 Voltage gating of HCN channels 
Similar to other voltage-dependent channels, HCN channels have a voltage-sensor 
motif (Arg or Lys at every third position) in the fourth transmembrane segment (S4, 
Figure 3.2) (Ludwig, Zong et al. 1998).  However, as HCN channels are activated by 
hyperpolarisation the mechanism by which this voltage-sensor activates the channel 
must differ from other voltage-dependent channels (which are activated by 
depolarisation).  Potential mechanisms for this include coupling between the 


























Figure 3.2.  Structure of HCN subunit. 
The subunit is comprised of six transmembrane segments (S1-S6) and a pore forming 
loop between S5 and S6.  S4 contains the voltage sensor and the intracellular C-
terminal region contains the cyclic nucleotide-binding domain (CNBD) (Modified 










conventional voltage-gated channels, depolarisation of the membrane could stabilise 
the channel in the closed state or the channel could be inactivated at depolarised 
potentials and hyperpolarisation removes this inactv tion (Kaupp and Seifert 2001; 
Rosenbaum and Gordon 2004). 
3.1.6 Heterogeneity of Ih 
There are four known genes encoding the Ih channel subunits (HCN1-4), which can 
form homomeric channels ((Ludwig, Zong et al. 1998; Santoro, Liu et al. 1998), for 
review see (Santoro, Chen et al. 2000)).  There is also evidence for the existence of 
functional HCN1/2 heteromeric channels (Chen, Wang et al. 2001; Ulens and Tytgat 
2001).  Within the facial motor nucleus there are at least two classes of 
motoneurones that can be distinguished by the voltage-dependence of their Ih, 
suggesting more than one type of functional channel exists within this nucleus 
(Larkman and Kelly 1992) 
3.1.7 HCN subunits in the facial motor nucleus 
The distribution of the mammalian HCN channel subunits (HCN1-4) has been 
determined by in situ hybridization and Northern blotting (Ludwig, Zong et al. 1998; 
Santoro, Liu et al. 1998).  HCN1 and HCN2 mRNA are highly expressed in the 
mouse brainstem motor nuclei including the facial motor nucleus, with a lower 
expression of HCN4 also being detected (Santoro, Chen et al. 2000).  
Immunohistochemical studies also indicate a high expr ssion of HCN1 and HCN2 
subunits in the facial motor nucleus with a lower expr ssion of HCN3 and HCN4 
subunits (Notom 2004). 
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3.1.8 Blockers of Ih  
Ih is sensitive to block by caesium (Cs
+) ions, however Cs+ also blocks inwardly 
rectifying K+ channels (Larkman and Kelly 1997).  The novel bradyc rdic agent, ZD 
7288, acts by selectively blocking If in the heart and has also been shown to 
selectively block Ih in the central nervous system (BoSmith, Briggs et al. 1993; 
Harris and Constanti 1995).  ZD 7288 has been utilised to investigate Ih in facial 
motoneurones and has been shown to block the channel t an intracellular site, in a 
voltage-independent manner (Harris and Constanti 1995; Larkman and Kelly 2001).   
3.1.9 Aims  
In addition to confirming the ionic mechanisms underlying the actions of 5-HT and 
NA in neonatal rat FMs the main aim of this chapter was to investigate the 
biophysical and pharmacological properties of the amine-sensitive gKLeak.  The pH-
sensitivity of gKLeak suggested the channel belonged to the TASK family of leak K
+ 
channels.  Although the pharmacology of gKLeak was inconsistent with homomeric 
TASK-1 or TASK-3 channels it did support a heteromeric TASK-1/TASK-3 channel 
identity. 
3.2 Results 
3.2.1 Effect of 5-HT on FMs 
When a FM was voltage-clamped at a potential depolarised to the potassium 
equilibrium potential and close to its resting membrane potential (routinely between 




























Figure 3.3.  5-HT evokes a large inward current. 
Continuous current record obtained from a FM voltage-clamped at –50 mV in 
normal ACSF.   Bath application of 5-HT (10 µM) evokes a large, reversible, inward 
current.  The large vertical deflections represent current responses to voltage 








20 pA at –50 mV, n = 6 under these conditions, example in Figure 3.3).  This is the 
current that underlies the depolarisation of the FM membrane potential.   
The current response to a hyperpolarising voltage step (from –50 to –100 mV) 
demonstrates that there are at least two distinct mechanisms underlying this inward 
current; an enhancement of Ih and a decrease in the instantaneous current (Figure 
3.4).   
3.2.2 5-HT enhances Ih 
Stepping from –50 mV to –100 mV activated the slowly developing 
hyperpolarisation-activated cation current, Ih and this current was significantly 
enhanced by 5-HT (increased by 29 ± 11%, n = 7, P = 0.0006, one sample t test, 
Figure 3.4. Ih amplitude was measured as the difference between the instantaneous 
and steady-state current in response to the voltage step).  The tail currents that arise 
due to the slow deactivation of Ih were also larger in the presence of 5-HT, 
supporting the enhancement of Ih by 5-HT.   
3.2.3 5-HT decreases the instantaneous current 
In addition to enhancing Ih, 5-HT application resulted in a decrease in the 
instantaneous current response to a voltage step command. The availability of 
ZD7288, a selective blocker of Ih, allowed the 5-HT-mediated modulation of the 
instantaneous current to be investigated in isolation of the effects of 5-HT on Ih 
(BoSmith, Briggs et al. 1993; Larkman and Kelly 2001).  The current responses to 
the hyperpolarising voltage steps demonstrate that in the presence of ZD 7288 (10 

































Figure 3.4.  Multiple mechanisms underlie the 5-HT-evoked current. 
A. Hyperpolarizing voltage step command used to monitor changes in 
conductance and Ih. 
B.    Current responses to hyperpolarizing voltage step (A) in control conditions 
(black) and following bath application of 5-HT (10 µM, grey).  5-HT evokes 
an inward current at the holding potential of –50 mV (1).  There is a decrease 
in the instantaneous current (2) and an increase in Ih (3) following application 
of 5-HT.  5-HT also increases the tail current (4), which arises as Ih  
inactivates following removal of the hyperpolarizing voltage step.  The arrow 




















































Figure 3.5.  Actions of 5-HT in the presence of ZD7288, a blocker of Ih. 
A. Continuous current record of a FM voltage-clamped at –50 mV in the presence 
of ZD7288 (10 µM).  Bath application of 5-HT (10 µM) evokes a large inward 
current.  The arrow indicates the zero current level and the large deflections 
represent attenuated current responses to voltage commands. 
B.  Hyperpolarizing voltage step command used to monitor changes in Ih. 
C. Current responses to hyperpolarizing voltage step (B) in control conditions 
(black) and in the presence of 5-HT (10 µM, grey).  In the presence of ZD7288 
(10 µM) Ih is abolished.  Under these conditions 5-HT decreases the current 

















In the presence of ZD7288 (10 µM), 5-HT (10 µM) evoked an inward current when 
bath applied to FMs voltage-clamped at –50 mV (-64 ± 14 pA, n = 6, Figure 3.5A).  
5-HT (10 µM) also decreased the current response to the hyperpolarising step 
compared to control when ZD 7288 (10 µM) was present (Figure 3.5C).  Current-
voltage (I/V) relationships were generated using the current response to a voltage 
ramp (Methods Figure 2.6).  A reduction in the slope of an I/V plot indicates an 
increase in resistance / decrease in conductance.  I  Figure 3.6B the slope of the I/V 
relationship obtained from a FM in the presence of 5-HT (10 µM) was reduced 
compared to control, corresponding to a reduction in conductance from 12.3 nS to 
8.9 nS (in the presence of ZD7288 (10 µM), conductance measurements were 
obtained from the slope of the I/V plot).  In a repr sentative sample of FMs 5-HT (10 
µM) application resulted in a mean decrease in conductance from 8.0 ± 1.2 nS to 5.6 
± 0.9 nS (n = 6, P = 0.018, paired t test).   
The 5-HT-induced current (I5-HT) was obtained by subtraction of the control current 
response to the voltage ramp from the current response btained in the presence of 5-
HT and was plotted against voltage (Figure 3.6B).  The 5-HT-induced current was 
approximately linear over the range measured. In the example shown in Figure 3.6 
the point of intersection of the control I/V plot and the plots obtained in 5-HT is –84 
mV.  The mean point of intersection and hence reversal potential for this action of 5-
HT was –85 ± 9 mV (n = 5), close to the EK as predicted by the Nernst Equation 
(approximately –94 mV, Methods Equation 1).  The difference in the reversal 





































Figure 3.6.  5-HT inhibits a ‘leak’ potassium conductance (gKLeak). 
A. I/V relationships obtained from a FM in the presence (grey) and absence 
(black) of 5-HT (10 µM).   
B. The 5-HT-induced current plot (obtained by subtraction of the control plot 
from the 5-HT plot shown in B).  This current is approximately linear over the 
range measured and intersects with the x-axis at –84 mV, close to the EK (as 


































other ions or a slight underestimation of the junction potential, however, it is clear 
that a K+ conductance plays a significant contribution.  Taken together these findings 
suggest that one of the mechanisms by which 5-HT mediates FM depolarisation is 
through inhibition of a potassium conductance (gK).  The approximate linearity of 
the I5-HT suggests a ‘leak’ gK (gKLeak) (Goldstein, Bockenhauer et al. 2001; Patel and 
Honore 2001; Lesage 2003).  These findings are consiste t with other published 
studies (VanderMaelen and Aghajanian 1980; Vandermalen and Aghajanian 1982; 
Larkman, Penington et al. 1989; Larkman and Kelly 1992).   
3.2.4 NA inhibits a gKLeak  
NA had been shown to inhibit a conductance in adult rat FMs which is similar to the 
5-HT-sensitive gKLeak (Larkman and Kelly 1992). The presence of this NA-sensitive 
conductance in neonatal rat FMs has been further inv stigated   Bath-application of 
NA induced an inward current in neonatal FMs voltage-clamped at -60 mV in 
standard ACSF containing 3 mM K+ and ZD 7288 (10 µM) (Figure 3.7A).  The I/V 
relationships in the presence and absence of NA indicated that the inward current 
was associated with a decrease in membrane conductace (Figure 3.7B).  In a 
representative sample of FMs, NA (10 µM) induced an inward current of -58 ± 7 pA 
associated with a significant decrease in the mean conductance from 9.4 ± 0.8 nS to 
7.3 ± 0.7 nS (n = 19, P = 0.02, paired t test).  The NA-induced current (INA) appeared 
linear over the voltage range -40 to -90 mV (Figure 3.7C), however, some 
rectification was seen outwith these voltages (example in Figures 3.13B).  INA 
reversed at -96 ± 3 mV (n = 19), -70 ± 2 mV, (n = 16) and -61 ± 2 mV (n = 14) when 































































































Figure 3.7. Noradrenaline inhibits a leak K+ conductance in neonatal rat FMs.  
A. Continuous current record of FM voltage-clamped at –50 mV demonstrating 
that bath application of NA (10 µM) evokes an inward current. Vertical 
deflections are attenuated current responses to volage ramp commands and the 
arrow indicates the zero current level. 
B. I/V relationships obtained from the same FM in the presence (grey) and 
absence (black) of NA (10 µM). 
C. The NA-induced current (obtained by subtraction of plots shown in B) is 
approximately linear over the range measured and intersects with the x-axis at  
–94 mV, close to the EK as predicted by the Nernst Equation (-97 mV, Methods 
Equation 1).  
D. Voltage step commands of variable amplitude (left) and superimposed 
expanded current responses to the voltage step commands before (control, 
centre) and during (NA, right) application of NA (10 µM). ACSF contained 7 
mM K+ and the horizontal arrow indicates the zero current level for control and 
–150pA for NA trace.  
E. Subtracted records of INA in response to –30 mV (upper trace) and +20 mV 
(lower trace) voltage steps. Single exponential curves with the time constants 
(τ) indicated (Methods Equation 2) have been superimposed on the activation 
and deactivation phases of the currents. 
 
 
τ = 8.4 ms 
τ = 8.3 ms 







τ = 10.9 ms 
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for the EK obtained from the Nernst equation (Methods Equation 1).  Subtracted 
current records (Figure 3.7D, E) indicated that the NA-sensitive gKLeak displayed 
rapid, voltage-independent, activation and deactivation kinetics.  Subtracted currents 
obtained after stepping from -60 mV to -40 mV displayed activation and deactivation 
time constants of 9 ± 1.6 ms (n = 7) and 6.6 ± 0.3 ms (n = 8), respectively.  Stepping 
to –90 mV from –60 mV revealed activation and deactiv tion time constants of 6.9 ± 
1.1 ms and 8.5 ± 0.7 ms (n = 8). These properties suggest that, in neonatal FMs, NA 
inhibits a gK+ with properties very similar to the 5-HT-sensitive gKLeak. 
3.2.5 NA and 5-HT modulate the same gKLeak in facial motoneurones 
Application of a maximal concentration of NA (10 µM) in the continued presence of 
a maximal concentration of 5-HT (10 µM) failed to induce any further inward 
current (Figure 3.8A) suggesting that the two transmitters act on a shared population 
of leak K+ channels.  5-HT (10 µM) or NA (10 µM) applied alone induced inward 
currents of -45 ± 4 pA (n = 5) and -34 ± 2 pA (n = 3), respectively (Vh = -50 mV, 
[K+]o = 7 mM).  Co-application of 5-HT and NA induced an inward current of -47 ± 
8 pA.  The transmitter-induced current over the range of voltage -30 to -90 mV 
possessed the same properties whether 5-HT or NA were applied together or 
separately (Figure 3.8B).  
3.3 Identity of amine-sensitive gKLeak   
It has been widely suggested that members of the twin-pore (2P) domain K+ channel 
family provide molecular correlates for physiologically identified “leak” K+ 











































Figure 3.8. 5-HT and Noradrenaline inhibit the same leak K+. 
A. Continuous current records of membrane current from a FM voltage clamped at 
–60 mV demonstrating that the NA-induced inward current is occluded by the 
5-HT-induced inward current.  The large deflections represent current 
responses to voltage commands.  
B. Plots of NA- and 5-HT-induced current (from the records shown in A) share 
the same biophysical properties and occlude over the voltage range tested. The 
NA (control) plot was obtained prior to application f 5-HT and the NA (wash) 


























has been investigated  (reviewed by (Goldstein, Bockenhauer et al. 2001), (Patel and 
Honore 2001)). 
3.3.1 External pH modulates a gKLeak  
Identification of mRNA for subunits belonging to the TASK and Kir2 families in the 
rat FMN and the knowledge that channels containing these subunits are sensitive to 
changes in external pH prompted us to investigate the functional expression of pH-
sensitive K+ channels in neonatal rat FMs (Topert, Doring et al. 1998; Talley, Lei et 
al. 2000; Talley, Solorzano et al. 2001).  We evaluated the effects of changing the 
external pH on the resting membrane conductance undr voltage-clamp conditions in 
the presence of ZD-7288 to prevent contamination by pH-sensitive Ih.  Figure 3.9A 
illustrates I/V plots obtained in pH 8, 7 and 6 ACSF in the same FM.  The I/V plots 
indicate that at a holding potential of –60 mV increasing the external [H+] induced an 
inward current associated with a decrease in membrane conductance.  The current 
induced by changing external pH (IpH), obtained by subtracting I/V plots obtained in 
each condition (Figure 3.9B), reversed close to the predicted EK supporting the idea 
that at potentials depolarised to the EK the net inward current reflects the inhibition of 
a resting outward K+ current. IpH appeared linear over the voltage range -40 to -90 
mV however some rectification was seen out with this voltage range.  These 
properties are characteristic of a pH-sensitive gKLeak.   
Results summarised from a population of FMs, voltage-clamped at -60 mV, indicate 
that switching from a standard physiological external pH of 7.4 to pH 6.0 induced an 
inward current of -46 ± 6 pA associated with a decrease in membrane conductance 































































































pH 6 – pH 7 




















Figure 3.9. Altering external pH around the physiological range modulates a 
leak K+ conductance in FMs.  
A. Continuous current recording showing the effects of varying the pH of the 
ACSF on membrane current of a FM voltage clamped at -60 mV. The 
horizontal bars indicate the external pH and duration of application. Vertical 
deflections represent current responses to voltage commands not illustrated in 
this figure. The ACSF contained 3 mM K+ and the horizontal arrow indicates 
the zero current level.  
B. I/V relationships obtained using voltage ramp commands from a FM 
superfused with pH 6, pH 7 and pH 8 ACSF. Conductance decreases with 
increasing H+ concentration.  
C. Subtraction of the plots shown in A indicating that altering external pH 
modulates a leak K+ conductance.  
D. Plots of membrane current (left abscissa) and changes in membrane 
conductance, normalised to the conductance at pH 7.5 (right abscissa), at 
different external pH taken from the FM illustrated in C above. Conductance 
measurements were obtained by linear regression of the I/V relationship 
between –60 and –80 mV. The sensitivity of changes in membrane current and 
conductance to external pH could be described by a four-parameter logistic 
function (Methods, Equation 3). pK values of 7.2 and 7.3 and Hill slopes of 1.2 
and 1 were obtained for current and conductance changes, respectively.  
E. Averaged data (SEM, n = 8) showing the pH sensitivity of changes in 
membrane conductance normalised to the conductance at pH 7. The 
relationship could be described by a modified Hill equation (Methods, Equation 
3) with a pK value of 7.1 ± 0.1 and a Hill slope of 1.5 ± 0.4 (R2 = 0.9874). 
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Under the same conditions, switching from pH 7.4 to pH 8 resulted in an outward 
current (+22 ± 8 pA) and a conductance increase to 9.2 ± 1.5 nS (n = 4, membrane 
conductance at pH 7;4 for the same FMs was 8.3 ± 1.6 nS).  Irrespective of the 
inward or outward nature of the change in membrane current, the reversal potential 
(VpH) was close to the predicted EK (pH 7.4 to pH 6, VpH = -93 ± 1.4 mV; pH 7.4 to 
pH 8, VpH = -89 ± 3 mV).  Altering the external K
+ concentration ([K+]o) to 7 mM 
moved the VpH to -66 ± 1.3 mV (n = 7) in close agreement with the c ange predicted 
by the Nernst equation.   
The pH-sensitivity of gKLeak was investigated further.  Figure 3.9C shows a 
representative chart record of membrane current from a FM voltage clamped at -60 
mV to which ACSF of varying pH was applied.  The time required for the pH-
induced current changes to reach a steady state vari d from 2-5 minutes.  We 
attribute this to the depth of the recorded FM in the slice, the relatively slow 
exchange of ACSF in the recording chamber and the H+ buffering capacity of the 
slice.  The amplitude of IpH and the change in conductance over a range of external 
pH could be described by a modified Hill equation (Methods, Equation 3) (Figure 
3.9D,E).  As illustrated in Figure 3.9D, (for the FM shown in Figure 3.9C) measuring 
either parameter gave closely similar values for pH-sensitivity.  Data taken from 
eight FMs, each of which was exposed to at least four changes in external pH, 
indicated a fit of the pH-evoked conductance with a pK value of 7.1 ± 0.1 and a Hill 
slope of 1.5 ± 0.4 (± SEM, R2 = 0.9874).  The pH-sensitive K+ conductance was 
maximal at pH 8.2 while no further decrease in conductance was seen below pH 6.  
These data indicate that at physiological pH (~ 7.4) the resting pH-sensitive gKLeak is 
approximately 70% of its maximal level.  
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3.3.2 NA and changes in external pH modulate the same gKLeak 
If NA and external pH (and 5-HT) alter FM excitability by modulating the same 
gKLeak the effects of lowering external pH and transmitter application should 
occlude.  The NA-induced inward current was examined in conditions designed to 
inhibit (pH 6.5) and activate (pH 7.7) IpH (Figure 3.10A).  When external pH was 
increased to 7.7, a maximal concentration of NA (10 µM) induced a robust inward 
current of -109 ± 19 pA (n = 5).  Lowering external pH to 6.5 led to a dramatic 
reduction in INA to -34 ± 9 pA in the same FMs.  In the example shown in Figure 
3.10A the response to NA was almost completely occluded when the external pH 
was 6.5.  Figure 3.10B shows that at pH 6.5, INA was occluded over the whole 
voltage range examined while at pH 7.7 the amplitude and the properties of INA were 
almost identical to those of the current induced by switching the external pH from 
7.7 to 6.5.  This supports the idea that both external pH and NA modulate the same 
gKLeak and that both have an equivalent maximal level of inhibition. 
3.4 The effects of TASK channel blockers on the pH- and NA-sensitive 
gKLeak 
3.4.1 Anandamide does not inhibit gKLeak 
The pH-sensitivity of gKLeak suggested that TASK channels might contribute to this 
conductance.  Low micromolar concentrations of the endogenous cannabinoid, 
anandamide, block homomeric human TASK-1 channels (Maingret, Patel et al. 
2001).  Homomeric TASK-3 channels are blocked by higher concentrations of 
anandamide.  Bath-application of anandamide (10 - 2µM) had no effect on FM 
































































Figure 3.10.  Inhibition of the leak K+ conductance by lowering external pH 
occludes the effects of NA. 
A. Plot of membrane current against time for a FM voltage-clamped at –60 mV. 
Solid and dashed horizontal bars indicate the times when the slice was 
superfused with pH 7.7 and pH 6.5 ACSF, respectively. Arrows indicate points 
at which NA (10 µM, 15 sec) was added to the ACSF. Note the almost 
complete occlusion of the NA-induced inward current in pH 6.5 ACSF.  
B. Plots of the current induced by switching from pH 7.7 to pH 6.5 ACSF and the 
NA-induced current in both conditions from the same FM as A. Occlusion of 
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tested in pH 7.4 ACSF (Figure 3.11A, B) or pH 6.0 (Figure 3.11A, C) (n = 4).  
Anandamide also had no effect on the decrease in current induced by either NA (10 
µM) or lowering the external pH from 7.4 to 6 (Figure 3.11D).  INA at a holding 
potential of -50 mV was -53 ± 3 pA in the absence of anandamide compared with -52 
± 3 pA in its presence (n = 3, 3 mM [K+]o). 
3.4.2 Preventing metabolic degradation of anandamide 
It has been reported that anandamide may be metabolic lly degraded in certain in 
vitro conditions and that this can be prevented by arachidonyl trifluoromethyl ketone 
(ATFK) (Barbuti, Ishii et al. 2002).  When applied alone for up to 20 minutes ATFK 
(10 µM) had little effect on the holding membrane current when applied to two FMs.  
The holding current at –50 mV was 96 pA before and 120 pA after ATFK incubation 
for the first FM (Figure 3.12) and 110 pA before and 126 pA after ATFK for the 
second.  The current induced by NA application was also unaffected in the presence 
of ATFK (-74 and –62 pA in the presence and absence of ATFK, respectfully for the 
first FM and –76 and  -98 pA for the second FM).   
Subsequent co-application of anandamide (10 µM) in the continued presence of 
ATFK did not induce a change in the resting membrane current (120 pA for the first 
FM and 126 pA for the second before application of anandamide and 109 pA for the 
first FM and 165 pA for the second FM after application of anandamide).  In the 
continued presence of ATFK, anandamide also had no effect on the current induced 
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Figure 3.11. Anandamide (10 µM) has no effect on the pH-sensitive gKLeak. 
A. Continuous current recording of membrane current against time for a FM 
voltage-clamped at -50 mV.  Horizontal bars indicate the times when the slice 
was superfused with pH 7.4 ACSF, pH 6 ACSF and anandamide (10 µM). 
Vertical deflections are attenuated current responses to ramp voltage 
commands and the arrow indicates the zero current level. Anandamide failed to 
alter membrane current in pH 7.4 ACSF and had no effect on the amplitude or 
time course of the inward current induced by perfusion with pH 6 ACSF.  
B. I/V relationships obtained from same FM as A in thepr sence (grey) and 
absence (black) of anandamide (10 µM) in pH 7.4 ACSF.  Anandamide has no 
effect on the I/V relationship at pH 7.4. 
C. I/V relationships obtained from same FM as A in thepr sence (grey) and 
absence (black) of anandamide (10 µM) in pH 6.0 ACSF.  Anandamide has 
very little effect on the I/V relationship at pH 6.0. 
D. Plot of the current induced by changing the pH from 7.4 to 6.0 (obtained by 
subtraction of plots in B and C) in the presence (gr y) and absence (black) of 
anandamide (10 µM).  Anandamide (10 µM) does not inhibit the current 





















Figure 3.12. ATFK (10 µM) has no effect on the NA-sensitive gKLeak and does 
not alter the efficacy of anandamide. 
Continuous current recording from a FM voltage-clamped at -50 mV.  Bath 
application of ATFK (10 µM) has no effect on the membrane current and co-
application with NA (10 µM) evokes a large inward current, which is similar to the 
control response to NA.  Subsequent application of anandamide (10 µM) with ATFK 
(10 µM) fails to induce an inward current.  Vertical deflections are attenuated current 
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after application of anandamide, respectively (and –98 pA before and –94 pA after 
anandamide application for the second FM). 
3.4.3 Methanandamide does not inhibit gKLeak 
Methanandamide is a metabolically stable analogue of anandamide also shown to 
inhibit TASK-1 channels (Maingret, Patel et al. 2001).  In the example shown in 
Figure 3.13 methanandamide (20 µM) failed to have any effect on the holding 
membrane current (210 pA and 236 pA in the presence and absence of 
methanandamide, respectively).   
Under control conditions NA induced an inward current of -152 pA in the same FM, 
which was also unaffected by methanandamide (-147 pA following incubation with 
methanandamide, Figure 3.13).  In a representative sample of FMs methanandamide 
was found to have little effect on the resting membrane current (126 ± 52 pA before 
and 157 ± 55 pA after methanandamide incubation, n = 3).  In addition, INA was not 
altered in the presence and absence of methanandamide (-104 ± 48 pA and -102 ± 46 
pA in the presence and absence of methanandamide, respectfully, n = 3).  
3.4.4 Ruthenium red does not inhibit gKLeak 
Homomeric TASK-3, but not TASK-1, channels are inhibited by ruthenium red (RR) 
(Czirjak and Enyedi 2003).  Application of RR (10 µM) to FMs had no effect on 
holding current at -50 mV or the inward current evoked by NA (n = 4, Figure 3.14A).  
The NA-induced current in the presence of RR (10 µM) was indistinguishable from 
the control response obtained in the absence of the TASK-3 blocker (Figure 3.14B).  
Thus, inward INA at a holding potential of -50 mV (3 mM [K















































Figure 3.13. Methanandamide (20 µM) has no effect on the NA-sensitive gKLeak. 
A. Continuous current recording of membrane current against time for a FM 
voltage-clamped at -50 mV.  Bath application of NA (10 µM) evokes a large 
inward current.  The NA-induced current is not inhibited following incubation 
with methanandamide (20 µM, 11 minutes).  Vertical deflections are attenuated 
current responses to ramp voltage commands and the arrow indicates the zero 
current level.  
B. Plots of the methanandamide (20 µM)-induced current (IMA) and the NA-
induced current in the absence (INA(Control)) and presence (INA(MA) ) of 
methanandamide. Methanandamide does not inhibit gKLeak or INA.  
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Figure 3.14.  Ruthenium red (10 µM) has no effect on NA-induced inhibition of 
gKLeak. 
A. Current record of a FM voltage-clamped at –50 mV demonstrating inward 
current evoked under control conditions and following incubation with 
ruthenium red (10 µM, 10 minutes).  Large deflections represent current 
responses to voltage commands. 
B. Plots of NA-induced currents in the presence (gry) and absence (black) of 
ruthenium red (10 µM). Note that the currents superimpose indicating a lack of 



























the absence of RR compared with -59 ± 6 pA in its presence (n = 4).  The VNA was 
also unaffected by the presence of RR.  
3.4.5 Zn2+ has no effect on the pH- and NA-sensitive gKLeak 
Homomeric human (h)TASK-1 channels, expressed in cell lines, display little 
sensitivity to Zn2+ (100 µM) while homomeric hTASK-3 channels are substantially 
(~70%) blocked at this concentration (Leonoudakis, Gray et al. 1998; Clarke 2003).   
Bath-application of Zn2+ (100 - 300 µM) did not significantly affect FM membrane 
current (+3 ± 1.7 pA at -60 mV) or membrane slope conductance (5 ± 0.5 to 5.5 ± 
0.5 nS in the presence of Zn2+ over the range -90 to -60 mV, n = 5) in pH 7.4 ACSF.  
In the same FMs, superfusion with pH 6 ACSF induced an inward current of -49 ± 
11 pA and decreased membrane conductance to 3.6 ± 0.7 nS. IpH obtained by 
changing external pH from 6 to 7.7 was unaffected by the presence of Zn2+.  
Consistent with its lack of effect on IpH, Zn
2+ (100 – 300 µM) also failed to alter INA 
(Figure 3.15).  Thus, inward INA at the holding potential (-52 mV, 7 mM [K
+]o) was -
51 ± 20 pA (n = 3) while outward INA at -102 mV was 92 ± 28 pA (n = 3). These 
values compared with -44 ± 13 pA and 88 ± 29 pA at -52 mV and -102 mV, 
respectively, in the presence of Zn2+ (300 µM).  Despite this lack of effect on gKLeak, 
in some FMs Zn2+ did inhibit a small NA-induced enhancement of a Ca2+ 










































Figure 3.15.  Zn2+ (300 µM) does not block the actions of NA on gKLeak. 
Plots of NA-induced currents, from a voltage-clamped FM, in the presence and 
absence of Zn2+ (300 µM).  Zn2+ fails to block the actions of NA on gKLeak but it does 




3.4.6 Bupivacaine partially occludes the pH- and NA-sensitive gKLeak 
The local anaesthetic bupivacaine has been shown to non-selectively block TASK-1 
and TASK-3 channels with IC50’s around 100 µM (Leonoudakis, Gray et al. 1998; 
Kim, Bang et al. 2000).  Bupivacaine (100 µM) induced an inward current in 4 FMs 
tested while in two further motoneurons bupivacaine (100 µM) failed to alter 
membrane current. At a holding potential of -50 mV (3 mM [K+]o) bupivacaine (100 
µM) induced a current of -49 ± 12 pA (n = 4) which reversed at -87 ± 3 mV and 
displayed the linear I/V relationship characteristic of inhibition of gKLeak.  The NA-
induced inward current was partially and reversibly occluded by bupivacaine gKLeak 
(Figure 3.16). Thus, NA (10 µM) induced a current of -137 ± 33 pA and -94 ± 22 pA 
in the absence and presence of bupivacaine respectively, representing occlusion by 




























Figure 3.16.  Bupivacaine (50 µM) partially occludes NA-induced inward 
current in FMs. 
Plots of the current induced by bupivacaine (IBP, 50 µM), NA (INA, 10 µM) and NA 
in the presence of bupivacaine (INA(BP)) demonstrating that bupivacaine (50 µM) 



















3.4.7 Isoflurane enhances gKLeak 
In a recent study of rat TASK channels the volatile anaesthetic isoflurane inhibited 
homomeric TASK-1 current but enhanced current carried by homomeric TASK-3 
and heteromeric TASK-1 / TASK-3 channels (Berg, Talley et al. 2004).  This 
enhancement was seen even when the current was optimally activated by external 
pH.  We investigated the effects of isoflurane on FM gKLeak when the conductance 
was optimally activated by an external solution of pH 8.   
Bath-application of isoflurane (see Section 2.2.2 for solution preparation and 
concentration estimation) increased gKLeak in four out of five facial FMs tested (Vrev 
= –63 ± 2 mV in ACSF containing 7 mM K+, Figure 3.17).  Expressed as a 
percentage of the maximal pH-sensitive current at –100 mV, obtained by exposing 
each FM sequentially to ACSF of pH 8 and pH 6, isoflurane enhanced the pH-
sensitive current by 55 ± 6 % (n = 4).  It is noteworthy that in the remaining FM 
isoflurane reversibly and reproducibly inhibited gKLeak. 
3.5 Validation of pharmacological activity of methanandamide and 
ruthenium red 
The absence of any effects of anandamide, methanandmide and RR on FMs raised 
the possibility that these compounds were not active in the experimental set-up used.  
The ability of methanandamide and RR to inhibit putative TASK channel-mediated 
currents in cultured rat cerebellar granule neurones (CGNs) was tested (Maingret, 
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Figure 3.17.  Isoflurane enhances the pH-sensitive gKLeak in FMs. 
A. I/V relationships from an FM superfused with pH 6, pH 7, pH 8 and pH 8 with 
isoflurane (concentration as indicated in Methods) ACSF.  Isoflurane increases 
gKLeak even when the conductance is maximally activated by pH 8 ACSF. 
B. Subtraction of the plots shown in A indicating greater activation of the pH-
sensitive gKLeak in the presence of isoflurane (pH 6 – pH 8 + Iso) than in its 
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from 7.4 induced a current in CGNs with characterisics of a TASK-mediated leak 
K+ conductance (Figure 3.18, 3.19).   
3.5.1 Methanandamide inhibits TASK-like channels in cultured 
cerebellar granule neurones 
In the example CGN shown in Figure 3.18 (voltage-clamped at -20 mV) lowering the 
pH from 7.4 to 6.0 induced a reversible current of -142 pA.  The current induced by 
lowering pH from 6.0 to 7.4 at -50 mV was -58 pA (Figure 3.18).  In a representative 
sample of CGNs lowering pH from 7.4 to 6.0 induced mean currents of -93 ± 52 pA 
and -46 ± 16 pA at holding potentials of -20 mV and -50 mV, respectively (n = 3). In 
the example in Figure 3.18 bath-application of methanandamide (20 µM) had a small 
effect on CGNs, inducing an inward current of -24 pA at -20 mV and -10 pA at -50 
mV.  This represents an inward current that was 17 % (at -20 mV) of the current 
induced by lowering pH.  Methanandamide induced a mean inward current in a 
representative sample of CGNs that was 21 ± 5 % of the pH 6-induced current (n = 
3).  As can be seen from the I/V plots (Figure 3.18) lowering pH and methanadamide 
induced currents that were approximately linear over th  range measured and had 
reversal potentials close to the predicted EK, similar to the gKLeak in FMs. 
3.5.2 Ruthenium red inhibits TASK-like channels in cultured cerebellar 
granule neurones 
In the example CGN shown in Figure 3.19, lowering pH induced an inward current 
of -149 pA at -20 mV (Figure 3.19).  In the same CGN, RR (10 µM) induced an 



















Figure 3.18.  Methanandamide inhibits gKLeak in CGNs 
A. I/V plots obtained from a cultured CGN in pH 7.4 (black), pH 6.0 (light grey) 
and in the presence of methanandamide (10 µM, dark grey). 
B. Currents induced by methanandamide (10 µM, IMA) and changing from pH 6.0 



















































Figure 3.19.  Ruthenium red inhibits gKLeak in CGNs 
A. I/V plots obtained from cultured CGN in pH 7.4 (black), pH 6.0 (light grey) 
and in the presence of ruthenium red (10 µM, dark grey). 
B. Currents induced by ruthenium red (10 µM, IRR) and changing from pH 6.0 to 
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RR at -50 mV in this CGN were -60 pA and -32 pA, resp ctively.  In a representative 
sample of CGNs RR (10 µM) induced an inward current that was 53 ± 2 % (n = 3) of 
the amplitude of the current induced by lowering pH.  
These findings are consistent with reported effects of methanandamide and RR on 
TASK-1 and TASK-3 channels in cultured CGNs (Maingret, Patel et al. 2001; Han, 
Truell et al. 2002; Lauritzen, Zanzouri et al. 2003; Kang, Han et al. 2004).   
3.6 Discussion 
3.6.1 Excitatory effects of 5-HT and NA 
5-HT and NA were found to have excitatory effects on neonatal rat FMs, consistent 
with previously reported excitatory effect of 5-HT on adult FMs (VanderMaelen and 
Aghajanian 1980; Vandermaelen and Aghajanian 1982; Larkman, Penington et al. 
1989).   
3.6.2 Ionic mechanisms mediating action of 5-HT and NA 
5-HT was found to evoke an inward current in neonatal FMs voltage-clamped at 
potentials depolarised to the predicted EK and the ionic mechanisms underlying this 
inward current were confirmed as an increase in Ih and decrease in a potassium 
conductance (gKLeak).  Additional properties of the 5-HT-sensitive potassium 
conductance were examined in the presence of the Ih blocker, ZD 7288 (BoSmith, 
Briggs et al. 1993).  The current response to a hyperpolarising voltage step 
demonstrates that Ih is abolished in the presence of ZD 7288 and is no lo ger 
enhanced by 5-HT.   
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NA was found to evoke an inward current in neonatal FMs, mediated by an 
inhibition of a gKLeak with similar properties to the 5-HT-sensitive gKLeak.  This is 
consistent with previous studies demonstrating thatNA also promotes adult FM 
excitation through inhibition of a gKLeak alone and not enhancement of Ih (Larkman 
and Kelly 1992).  The inward current evoked by 5-HT occludes the NA-induced 
inward current suggesting these amines modulate the same conductance. 
The I/V relationships obtained in the presence of 5-HT and NA provide evidence that 
these amines modulate a leak potassium conductance (gKLeak).  Firstly the slope of 
the I/V plot in the presence of 5-HT or NA are reduced compared to the slope of the 
control plots indicating that 5-HT and NA decrease conductance through closure of 
ion channels in the membrane.  Secondly the point of intersection of the I/V plots in 
the presence and absence of 5-HT and NA and the point of ntersection with the x-
axis of I5-HT and INA are close to the predicted EK, indicating 5-HT and NA decrease a 
gK.  Thirdly, I5-HT and INA are approximately linear over the voltage range measured 
suggesting that the amine-sensitve gK shows little or no voltage-dependence, a 
characteristic property of gKLeak (Goldstein, Bockenhauer et al. 2001).   
3.6.3 Ih and gKLeak contribute to the resting membrane potential 
Ih and gKLeak contribute to the resting membrane potential in a variety of central 
neurones (reviewed in (Pape 1996; Lesage and Lazdunski 2000)).  The contribution 
of Ih to the membrane potential can be determined by recording current changes 
following application of ZD 7288.  The effect of ZD 7288 application on FM holding 
current was not observed in the present study as slices were incubated with ZD 7288 
prior to recordings being made, therefore the holding current in the absence of ZD 
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7288 was not measured.  Previous studies demonstrate th  when ZD 7288 was 
applied to FMs voltage-clamped close to the resting membrane potential it evoked an 
outward current that reversed at the predicted reversal potential for Ih (although not 
all FMs showed this response to ZD 7288) (Larkman and Kelly 2001).  This supports 
a role for Ih in contributing to the resting membrane potential in FMs.  gKLeak is 
active at typical resting membrane potentials and the decrease in conductance 
observed when 5-HT and NA were applied in the presence of ZD 7288 supports a 
role for gKLeak in setting the resting membrane potential in FMs.  This is supported 
by recent findings that both Ih and a gKLeak contribute to the resting membrane 
potential and control neocortical interneurone excitability (Gibson, Bartley et al. 
2006). 
3.7 Molecular identity of gKLeak in FMs 
3.7.1  5-HT, NA and external pH modulate the same gKLeak 
The results characterise a pH-sensitive conductance d several lines of evidence 
support the idea that pH and NA (and 5-HT) modulate the same gKLeak in neonatal rat 
FMs.  Firstly, NA and lowering external pH below the normal physiological level 
(pH 7.4) inhibited a current that displayed rapid kinetics, a small amount of 
rectification over the potential range -120 to -40 mV and a reversal potential at the 
predicted EK.  Secondly, lowering external pH occluded the actions of NA.  Maximal 
concentrations of NA decreased membrane conductance o a level very close to the 
maximum level of inhibition obtained by lowering ext rnal pH.  Thirdly, raising the 
external pH above pH 7.4 induced an outward current associated with an increase in 
membrane conductance and under these conditions the amplitude of the inward 
current induced by NA was increased.  In addition, the pH- and NA-sensitive gKLeak 
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displayed a common pharmacology to a wide range of K+ channel blockers (Larkman 
and Perkins 2005).  In combination, these results support a common target of 
modulation.  
One possible explanation for the occlusion of the NA-mediated response by low 
external pH is a change in protein structure that disrupts agonist-receptor 
interactions.  Reports suggest α2- but not α1-adrenoceptors display alterations in 
functional responses associated with changes in agoist binding affinity over the pH 
range 6 to 8 (Curro and Greenberg 1983; Nunnari, Repaske et al. 1987; Tateishi and 
Faber 1995).  As the pharmacology of this action of NA indicates that an α1-
adrenoceptor mediates inhibition of gKLeak in FMs (see Chapter 4) it is unlikely that 
occlusion of the NA-mediated modulation of gKLeak by low external pH is due to 
altered agonist-receptor interactions. 
3.7.2 pH-sensitivity of the amine-sensitive gKLeak 
The presence of mRNA for the pH-sensitive K+ channels TASK-1 and TASK-3 in 
the FMN makes these channels potential candidates for gKLeak (Talley, Lei et al. 
2000; Karschin, Wischmeyer et al. 2001).  TASK-1 and TASK-3 channels mediate 
openly rectifying, non-inactivating, whole-cell currents similar to the pH- and NA-
sensitive gKLeak in facial motoneurons (Duprat, Lesage et al. 1997; Leonoudakis, 
Gray et al. 1998; Kim, Bang et al. 2000; Rajan, Wischmeyer et al. 2000; Talley, Lei 
et al. 2000; Vega-Saenz de Miera, Lau et al. 2001).  Activation and inactivation are 
described as “instantaneous”.  For example, TASK-3 channels expressed in Xenopus 
oocytes displayed time constants of around 4 ms, not very dissimilar from the values 
of 8 to 9 ms described here (Rajan, Wischmeyer et al. 2000).  The sensitivity of 
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TASK-1 channels to external pH lies across the physiological range with a pK 
around 7.3 to 7.5(Duprat, Lesage et al. 1997; Talley, L i et al. 2000).  The pK for 
TASK-3 channels is approximately one pH unit lower in the range 6 to 6.7 (Kim, 
Bang et al. 2000; Rajan, Wischmeyer et al. 2000; Vega-Saenz de Miera, Lau et al. 
2001) such that at physiological pH a TASK-3-mediated conductance should be 
maximally activated.  The pH-sensitive gKLeak of FMs has a pK close to 7.1, between 
the published ranges for either homomeric channel.  At pH 7.4 it is activated to 
approximately 70% of its maximal level, suggesting against a homomeric TASK-3 
identity.  The pH-sensitivity of FM gKLeak was determined in physiological external 
[K+] (3 mM) so the pK cannot be attributed to a previously described effect of high 
external [K+] on TASK-1 channels (Lopes, Gallagher et al. 2000; Lopes, Zilberberg 
et al. 2001).  
Interestingly human Kir2.4 is inhibited by external H+ over the range pH 6 to pH 8 
with a pK of 7.1(Karschin, Dissmann et al. 1996; Topert, Doring et al. 1998; Hughes, 
Kumar et al. 2000).  Kir2.4 mRNA, along with mRNA for Kir2.1 and Kir2.2, is 
expressed in some neonatal rat FMs.  As such determining pH-sensitivity alone may 
not be sufficient to distinguish TASK and Kir2 channel types (Karschin and 
Karschin 1997; Topert, Doring et al. 1998).  It has, however, been suggested that rat 
Kir2.4 channels are only slightly pH-sensitive (unpblished observations in (Talley, 
Lei et al. 2000)).  
3.7.3 Pharmacology of the amine- and pH-sensitive gKLeak 
The lack of effect of methanandamide or anandamide, with or without pre-
application of the metabolic inhibitor ATFK, suggests against a TASK-1 identity for 
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FM gKLeak.  However, the insensitivity to anandamide of FM gKLeak should not be 
overstated.  A recent report suggests that unlike human TASK-1 and TASK-3 
channels the rat homologues are not particularly sensitive to low concentrations of 
anandamide and that higher concentrations fail to discriminate the two channel types 
(Berg, Talley et al. 2004). 
The inability of RR to block gKLeak suggests against a TASK-3 identity.  The 
expected effects of these ligands observed in cultured cerebellar granule cells 
indicate that the negative results cannot be attribu ed to factors that might affect the 
activity of these drugs or their delivery to the slices.  Recently, Zn2+ has been used to 
discriminate between human TASK-1 and TASK-3 channels (Clarke 2003).  Human 
TASK-1 is unaffected by Zn2+ (100 µM) whereas the same concentration blocks 
hTASK-3 by greater than 70% (IC50 = ~20 µM).  While the insensitivity of the pH- 
and NA-sensitive gKLeak to Zn
2+ also argues against a TASK-3 channel identity there 
is a suggestion that rat TASK-3 channels are insensitive to Zn2+ (100 µM) 
(Leonoudakis, Gray et al. 1998; Kim, Bang et al. 2000). Recently though the gKLeak 
in rat CG neurones has been shown to be substantially blocked by Zn2+ (100 µM) 
(Clarke, Veale et al. 2004).  
It is of interest that the local anaesthetic bupivacaine inhibited a conductance that 
shared the properties of gKLeak and at least partially occluded the actions of NA in 
some FMs.  Bupivacaine inhibits both TASK-1 and TASK-3 channels with roughly 
equivalent potency (Leonoudakis, Gray et al. 1998; Kim, Bang et al. 2000) and its 
ability to block a pH-sensitive gKLeak in thalamocortical neurones appears sufficient 
to ascribe this a TASK channel-mediated conductance (Meuth, Budde et al. 2003).  
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Nevertheless, bupivacaine also has actions on otherchannels including some voltage-
gated K+ channels (Gonzalez, Longobardo et al. 2001).  Thus, while the current 
blocked by bupivacaine in FMs is consistent with a TASK-like gKLeak, the additional 
block of other K+ channels may also contribute to the overall effect of this drug. 
3.7.4 Possible identities of FM gKLeak: TASK-1 / TASK-3 heterodimers 
Though the results described in this chapter suggest against homomeric TASK-1 or 
TASK-3 channels, evidence indicates TASK-1 and TASK-3 interact to form 
functional heterodimeric channels (Czirjak and Enyedi 2002; Talley and Bayliss 
2002).  Could FM gKLeak be accounted for by heteromeric TASK-1 / TASK-3 
channels?  The pharmacologies of homomeric TASK-1, homomeric TASK-3 and 
heteromeric TASK-1 / TASK-3 currents expressed in various systems and FM gKLeak
 
are compared in Table 3.1.  It has been suggested that heterodimer formation may be 
a favoured process when both TASK-1 and TASK-3 subunits are present, though 
recent studies on cultured cerebellar granule cells indicate both homomeric and 
heteromeric channels can also co-exist in the same cell (Czirjak and Enyedi 2002; 
Kang, Han et al. 2004).  It has also been observed that isoflurane enhances current 
carried by heteromeric TASK-1 / TASK-3 and homomeric TASK-3 channels while 
inhibiting homomeric TASK-1 channels (Berg, Talley et al. 2004). Isoflurane 
enhances FM gKLeak while ruthenium red the TASK-3 blocker has no effect.  
Heteromeric TASK-1 / TASK-3 channels are insensitive to ruthenium red because 
the channel subunits must provide symmetrical interaction sites for potency (Czirjak 





Table 3.1. Comparative pharmacology of TASK channels and rat FM gKLeak. 
Values indicated are % current increase (+) or decrease (-) in the presence of the drug 
indicated, except for the sensitivity of TASK-1 and TASK-3 homomers to Ba2+ for 
which the IC50 is given. Values for Ba
2+ and Cs+ reflect optimal voltage-dependent 
blocker sensitivity. Species is either rat (r) or human (h). Where non-uniform drug 
concentrations are compared the concentrations are given in parentheses in the table. 
Data for TASK-1 / TASK-3 heterodimer refers to concatenated TASK-1 / TASK-3 
construct. Data taken from 1(Berg, Talley et al. 2004) 2(Clarke, Veale et al. 2004) 
3(Czirjak and Enyedi 2002a), 4(Czirjak and Enyedi 2002b), 5(Czirjak, Fischer et al. 
2000), 6(Duprat, Lesage et al. 1997), 6(Kim, Bang et al. 2000), 7(Leonoudakis, Gray 
et al. 1998), 8(Lopes, Zilberberg et al. 2001) and  9(Meadows and Randall 2001). 
 TASK-1 TASK-3 TASK-1 / TASK-3 Rat FM gKLeak 
pK 1 ~ 7.5 (r) ~ 6.8 (r) ~ 7.3 (r) ~ 7.1 
Isoflurane (0.3 mM) 
1 No effect (r) ~ +80% (r) ~ +50% (r) ~ +55% 
Methanandamide  
(10 µM) 1 
~ -85% (r) ~ -64% (r) ~ -55% (r) No Effect 
Ruthenium red 
(5 µM) 3 
No Effect (r) ~ - 85% (r) No Effect (r) 
No Effect                
(10 µM) 
Zn2+ (100 µM) 2, 7, 8 ~ -40% (r) 
No Effect (h) 
No Effect (r) 
~ -70% (h) 
No Data  
~ -20% (h) 
No Effect 
Bupivacaine  
(100 µM) 7, 8 
~ -60% (r) ~ -50% (r) No Data ~ -30% 
Ba2+ 7, 9 IC50 ~ 400 µM 
(r) 
IC50 ~ 300 µM 
(r) 
No Data 
~ -90 %           
(500 µM) 
Cs+ 4, 7, 10  ~ -30%           
(100 µM, r) 
~ -75%                  
(3 mM, r) 
No Effect          
(10 mM, h) 
No Data No Effect  
(300 µM) 
~ -85%                      
(1 mM) 
4-AP 5, 8 ~ -15% (10 
mM, r) 
No Data No Data ~ -60%               
(4 mM) 
TEA 5, 6, 7, 8 ~ -30 %           
(100 mM, r) 
No Effect             
(1 mM, r) 
No Data No Effect         
(30 mM) 
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suggestion that heteromeric TASK-1 / TASK-3 channels could account for FM 
gKLeak The pK for heteromeric channels lies between the values for homomeric 
TASK-1 and TASK-3 channels but is nearer that of TASK-1 (Czirjak and Enyedi 
2002; Talley and Bayliss 2002).  The pK for FM gKLeak is also consistent with a 
heteromeric channel.  The pH-sensitivity of individual FMs did not differ 
significantly from the population average suggesting a single population of pH-
sensitive K+ channels predominates in these cells.  Nevertheless, the observation in 
one FM that isoflurane inhibited gKLeak, consistent with a TASK-1 channel identity 
(Berg, Talley et al. 2004), suggests gKLeak may display some heterogeneity within the 
FM population.  
Further evidence in favour of a heteromeric identity for FM gKLeak is the observation 
that heteromeric channels share the Zn2+ i sensitivity of TASK-1 homomers (Clarke, 
Veale et al. 2004).  The insensitivity of gKLeak to anandamide should be assessed in 
the light of the evidence that rat homomeric TASK-1 and TASK-3 channels 
expressed in HEK 293 cells show lower sensitivity to anandamide and 
methanandamide relative to human channels (Berg, Talley et al. 2004).  In addition, 
these compounds show little selectivity between different rat channels.  Anandamide 
(10 µM) blocks between 60 and 80% of the current flowing through homomeric 
channels and ~50% flowing through heteromeric channels.  This latter observation is 
clearly at odds with the suggestion that a heteromeic channel mediates gKLeak in 
FMs.  However, distinct cellular environments may promote differences between 
endogenous channels and those expressed in cell lines.  The sensitivity of the TASK-
1 / TASK-3 heterodimer to bupivacaine is unknown.  The lack of effect of the 
selective blockers of the homomeric channels precludes any quantification of the 
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relative contributions of channel isoforms within id vidual FMs similar to that 
performed elsewhere (Berg, Talley et al. 2004). 
The gKLeak in FMs displays properties of an amine-sensitive gKLeak described in 
neonatal rat hypoglossal motoneurons (Talley, Lei et al. 2000).  First described as 
TASK-1, hypoglossal motoneuron gKLeak displays pharmacological differences to the 
cloned rat TASK-1 channel and is also enhanced by isoflurane leading to the 
suggestion that it may be a heteromeric channel (Tal ey, Lei et al. 2000; Talley and 
Bayliss 2002; Berg, Talley et al. 2004).  It is of interest that the anandamide 
sensitivity of this gKLeak has not been described (Berg, Talley et al. 2004).  
3.7.5 Could other 2P K+ channels underlie FM gKLeak?   
One study indicates protein for TASK-2 is found in the FMN (Gabriel, Abdallah et 
al. 2002).  TASK-2 gives rise to outwardly rectifying currents with a pK around 7.8 
suggesting activation at physiological pH.  Outward current through TASK-2 
channels is relatively insensitive to Ba2+ nd Cs+ and permeability to Rb+ is less than 
for K+, unlike TASK-1 (Reyes, Duprat et al. 1998; Niemeyer, Cid et al. 2001; Talley 
and Bayliss 2002).  It has previously been determined that the FM gKLeak is inhibited 
by Ba2+ (500 µM) and Cs+ (1 mM) (Larkman and Perkins 2005).  TASK-2 is also 
blocked by bupivacaine (Kindler, Paul et al. 2003).  Nevertheless, alone this 
conductance could not account for the whole range of pH sensitivity or linearity of 
the gKLeak.  The CNS distribution of TASK-4 channels has not been established, 
however, they are activated by alkaline pH, show little activation at pH 7.5 and have 
slow activation kinetics which distinguishes them from gKLeak in FMs (Decher, 
Maier et al. 2001).  TASK-5 channels, either in homomeric or heteromeric (with 
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TASK-1) combinations, have so far eluded functional characterisation nevertheless 
mRNA does not appear to be present in FMs (Ashmole, Goodwin et al. 2001; 
Karschin, Wischmeyer et al. 2001). 
3.7.6 Inwardly rectifying and voltage-gated K+ channels 
The absence of inward rectification in gKLeak might be expected to preclude the 
involvement of Kir2.4 (and other Kir) channels.  Nevertheless, block of the amine-
sensitive gKLeak by Ba
2+ generates an inwardly rectifying I/V relationship (Larkman 
and Perkins 2005).  This could represent either the voltage-dependent block of a 
single conductance or the block of an inwardly rectifying conductance that 
contributes to the overall properties of the gKLeak.  A characteristic of gK ir is that the 
V0.5 shifts with [K
+]o suggesting that the driving force on K
+ determines activation 
rather than voltage alone (Yamaguchi, Nakajima et al. 1990).  Examination of the 
Ba2+-sensitive component of gKLeak in FMs indicated that V0.5 was relatively 
independent of [K+]o suggesting a predominantly voltage-dependent block, distinct 
from the properties of Kir channels (Larkman and Perkins 2005).  Nevertheless, it is 
a possibility that Kir2 heterotetramers in association with accessory β subunits show 
emergent properties distinct from homomeric channels (Schram, Melnyk et al. 2002).  
The NA- and pH-sensitive gKLeak in FMs has also been shown to be blocked by 4-AP 
(4 mM) but not by TEA (30 mM) (Larkman and Perkins 2005).  TASK-1 and TASK-
3 channels are reported to be insensitive to both 4-AP and TEA (Duprat, Lesage et al. 
1997; Leonoudakis, Gray et al. 1998; Czirjak, Fischer et al. 2000; Kim, Bang et al. 
2000; Lopes, Gallagher et al. 2000; Meadows and Randall 2001; Vega-Saenz de 
Miera, Lau et al. 2001).  It has previously been shown that 4-AP blocks fast and slow 
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transient outward K+ currents in FMs though neither appear to contribute to the 
amine-sensitive gKLeak (Larkman and Kelly 1998).  Rapidly activating, slowy 
inactivating, 4-AP-sensitive, voltage-gated K+ conductances have been characterised 
in cardiac muscle (Boyle and Nerbonne 1992). In particular, Kv1.5 has been 
suggested to contribute a sustained current at depolarised membrane potentials 
(reviewed in (Nerbonne 2000)).  Kv1.5 channels are blocked by 4-AP, relatively 
TEA-insensitive, inhibited by acidosis, blocked by upivacaine (EC50 ~10 µM) and 
while being sensitive to Zn2+ the EC50 is close to 800 µM (Clement-Chomienne, Ishii 
et al. 1999; Steidl and Yool 1999; Gonzalez, Longobardo et al. 2001; Kehl, Eduljee 
et al. 2002).  The presence of Kv1.5 protein in FMs is unknown though it is present 
in motoneurons at all levels of the spinal cord (Matus-Leibovitch, Vogel et al. 1996).  
Nevertheless, a pK around 6.2 and a restricted voltage range for sustained current 
between, at best, -60 and 0 mV both suggest that alone these channels may not be 
sufficient to explain the properties of FM gKLeak. 
3.8 Concluding statement 
This chapter confirms the enhancement of Ih by 5-HT and the inhibition of a gKLeak 
by both 5-HT and NA as the ionic mechanisms that mediated the excitatory actions 
of these neurotransmitters in neonatal rat FMs (Larkm n and Kelly 1992; Larkman 
and Kelly 1997; Larkman and Kelly 1998).  This chapter also describes the 
pharmacological and biophysical properties of gKLeak in FMs and provides evidence 
that the channel underlying this conductance is a TASK-1/TASK-3 heterodimeric 
channel.  Confirming the action of 5-HT and NA and determining the molecular 
identity of gKLeak and NA was necessary for the interpretation of functio al 
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significance of the modulatory effect of 5-HT and NA on FM excitability.  This 





5-HT and NA promote neonatal FM excitation by depolarising the postsynaptic 
membrane (see Chapter 3).  The ionic mechanisms that underlie the membrane 
depolarisation have been confirmed as a decrease in gKLeak (5-HT and NA) and an 
enhancement of the hyperpolarisation activated cation current, Ih, (5-HT only) 
(Larkman and Kelly 1992; Larkman and Kelly 1997; Larkman and Kelly 1998).  
However, the receptor subtypes that mediate these actions of 5-HT and NA have not 
yet been conclusively identified. 
4.1.2 5-HT receptors 
Advances in molecular biology techniques has vastly expanded the database on 5-HT 
receptors and there are currently 14 pharmacologically and structurally distinct 
subtypes of 5-HT receptors that are grouped into seven families (5-HT1-7) by their 
signal transduction mechanism and structural similarities (Figure 4.1) (Barnes and 
Sharp 1999; IUPHAR 2000).  The 5-HT3 receptor forms a ligand-gated ion channel 
and all the other 5-HT receptors are seven transmembrane spanning receptors that 
couple to intracellular membrane bound guanosine triphosphate (GTP) binding 
proteins (G proteins) that can activate various intracellular signalling pathways. 
The chapter focuses on the roles of 5-HT2 and 5-HT7 receptors in the excitatory 










































Figure 4.1.  Dendrogram of 5-HT receptors. 
Dendrogram depicting relationship between the known 5-HT receptors.  Modified 
















4.1.3 5-HT2  receptors 
All 5-HT2 receptors are positively coupled to phospholipase C (PLC) through Gq 
proteins.  Phospholipase C activity increases the hydrolysis of phosphatidylinositol 
bisphosphate (PIP2) producing the intracellular messengers inositol triphosphate (IP3) 
and diacylglycerol (DAG) (Alberts, Johnson et al. 200 ).  IP3 is released into the 
cytosol and is free to bind to IP3 receptors on the endoplasmic reticulum membrane 
resulting in the opening of calcium channels formed by the IP3 receptors, releasing 
calcium from these intracellular stores (Alberts, Johnson et al. 2002).  DAG remains 
membrane bound and activates protein kinase C, leading to phosphorylation of target 
proteins.  Evidence supporting this transduction mechanism following activation of 
5-HT2 receptors is reviewed in Boess et al (1994).  Expression of 5-HT2A or 5-HT2C 
receptors in mouse fibroblasts was found to activate PLC and raise intracellular 
[Ca2+] ([Ca2+] i) (Julius, Huang et al. 1990).  When expressed in AV-12 cells both the 
human and rat 5-HT2B receptors were found to couple positively to 
phosphatidylinositol hydrolysis (Kursar, Nelson et al. 1992; Kursar, Nelson et al. 
1994).  It was also found that when the cloned 5-HT2 receptor subtypes were 
expressed in Xenopus laevis oocytes, application of 5-HT resulted in an opening of 
Ca2+-sensitive Cl- channels, indicating an increase in [Ca2+] i (reviewed in (Boess and 
Martin 1994)).  
4.1.4 5-HT2 receptors in the facial nucleus 
Autoradiographical studies using the 5-HT2A receptor antagonist, [
3H]-MDL-100907, 
identified 5-HT2A binding sites in some of the brainstem nuclei including the 
trigeminal and facial motor nuclei (Lopez-Gimenez, Mengod et al. 1997).  This 
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presence of 5-HT2A receptors in facial motoneurones is supported by both 
immunohistochemical and in situ hybridisation studies (Pompeiano, Palacios et al. 
1994; Cornea-Hébert 1999; Fonseca, Ni et al. 2001; Volgin, Fay et al. 2003).  
However, not all immunohistochemical studies detectd 5-HT2A receptors in the 
facial motor nucleus (Morilak, Garlow et al. 1993). 
5-HT2B receptors in the rat have been identified in peripheral tissue, particularly in 
the stomach fundus (Kursar, Nelson et al. 1992).  Although mRNA for the 5-HT2B 
receptor has been detected in the human brain, several early studies failed to detect 5-
HT2B receptors in the rat brain (Kursar, Nelson et al. 1994; Pompeiano, Palacios et 
al. 1994).  Subsequently 5-HT2B receptor protein has been detected in the frontal 
cortex, cerebellum, hypothalamus, medial amygdala and spinal cord of the rat but its 
presence in the facial nucleus has not been reported (Duxon, Flanigan et al. 1997).   
5-HT2C mRNA was has been detected in regions of the brainstem and spinal cord 
including cranial motor nuclei such as the facial motor nuclei, however, the protein 
distribution of this receptor in the brainstem has not been reported (Pompeiano, 
Palacios et al. 1994).   
4.1.6 Do 5-HT2 receptor mediate inhibition of FM gKLeak? 
 The excitatory responses to 5-HT2A and 5-HT2C receptor activation in the rat 
perform cortex, nucleus accumbens and cortical pyramid l neurones are all mediated 
by an inhibition of K+ conductances raising the possibility that these rec ptors may 
be involved in the inhibition of gKLeak in FMs (North and Uchimura 1989; Araneda 
and Andrade 1991; Sheldon 1991; Aghajanian and Marek 1997).  In addition, non-
selective 5-HT2 receptor activation has been shown to have excitatory effects on rat 
 110 
hypoglossal motoneurones and facial motoneurones (Ra mussen and Aghajanian 
1990; Bouryi and Lewis 2003).  The development of subtype selective antagonists 
including the 5-HT2A-selective antagonist, R-96544, has enabled this issue to be 
addressed (Ogawa, Sugidachi et al. 2002).   
4.1.7 Increase in intracellular cAMP mediates enhancement of Ih by 5-HT 
It has previously been determined that the enhancement of Ih by 5-HT in FMs is 
mediated by an increase in intracellular cyclic AMP (cAMP) (Larkman and Kelly 
1997).  The cAMP binds to an intracellular region of the channel shifting its 
activation range to more depolarised potentials (Larkm n and Kelly 1992; Larkman, 
Kelly et al. 1995).   
5-HT receptor subtypes that couple positively to adenylate cyclase (via Gs proteins) 
to increase intracellular cAMP levels belong to the 5-HT4, 5-HT6 and 5-HT7 receptor 
subfamilies (Barnes and Sharp 1999; IUPHAR 2000; Alberts, Johnson et al. 2002).  
However, previous pharmacological investigations using the 5-HT4 receptor-
selective antagonist, GR-113808A, and the 5-HT6 and 5-HT7 antagonist, clozapine, 
failed to implicate these receptors in the enhancement of Ih in FMs (Larkman and 
Kelly 1997).  The role of the 5-HT7 receptor subtype has been re-examined in this 
chapter due to the emergence of the high affinity 5-HT7 receptor selective antagonist, 
SB269970 (Hagan, Price et al. 2000; Lovell, Bromidge et al. 2000). 
4.1.8 5-HT7 receptors in FMs 
Although, 5-HT7 receptor mRNA and protein has been detected in the cortex, 
hippocampus, thalamus, hypothalamus and tenia tecta, the expression of 5-HT7 
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receptors in the brainstem nuclei has not yet been r ported.(Neumaier, Sexton et al. 
2001). 
4.1.9 Adrenoceptors mediating inhibition of gKLeak in FMs 
The receptors that are activated by noradrenaline (adrenoceptors) are the α1-, α2- and 
β-adrenoceptors (Docherty 1998).  The α1-adrenoceptors are Gq protein coupled 
receptors that activate the PLC pathway (see 5-HT2 receptor section) and mediate the 
excitatory effects of NA, whereas the α2-adrenoceptors inhibit cAMP formation 
(Docherty 1998).  The β-adrenoceptors are coupled to adenylate cyclase activity 
(IUPHAR 2000). 
α1-adrenoceptor mRNA has been detected in the facial motor nucleus, suggesting this 
receptor subtype mediates the inhibition of gKLeak by NA in FMs (VanderMaelen and 
Aghajanian 1980; Larkman and Kelly 1992; Pieribone, Nicholas et al. 1994).  This 
issue has been addressed using the α1-adrenoceptor selective agonist, phenylephrine, 
and antagonist, prazosin (IUPHAR 2000). 
4.1.10 Aims 
The ionic mechanisms that underlie the membrane depolarisation by 5-HT have been 
confirmed as an enhancement of the hyperpolarisation activated cation current, Ih, 
and decrease in a potassium conductance (see Chapter 3) (Larkman and Kelly 1992; 
Larkman and Kelly 1997; Larkman and Kelly 1998).  In addition, NA promotes FM 
membrane excitation by inhibiting a potassium conductance but does not enhance Ih 
(Larkman and Kelly 1992).   
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In this chapter pharmacological approaches have been utilised to identify the receptor 
subtypes underlying 5-HT- and NA-mediated depolarisation of FMs.  The findings 
suggest that inhibition of gKLeak is mediated by activation of 5-HT2A and α1-
adrenoceptor activation and the enhancement of Ih is mediated by 5-HT7 receptor 
activation.  The mechanism by which receptor activation leads to inhibition of gK leak 
is also addressed in this chapter. The results suggest a role for PIP2 hydrolysis in NA-
induced channel closure but the evidence is less conclusive for a similar involvement 
in the actions of 5-HT on these channels. 
4.2 Results  
4.2.1 5-HT Receptor subtype mediating inhibition of gKLeak 
Preliminary studies indicated that non-selective 5-HT2 antagonists block the action of 
5-HT on gKLeak and the presence of 5-HT2A and 5-HT2C receptors in the rat FMN 
prompted an investigation into whether this receptor-subtype mediates this action of 
5-HT (Pompeiano, Palacios et al. 1994; Wright, Seroogy et al. 1995).   
In the example shown in Figure 4.2, 5-HT (10 µM) evoked an inward current of –252 
pA when applied to a FM voltage-clamped at –50 mV (in the presence of ZD7288, 
10 µM).  This inward current was associated with a reduction in membrane 
conductance from 9.9 nS to 5.0 nS.  The mean inward current at the holding potential 
(-50 mV) and reduction in membrane conductance evokd by 5-HT was –123 ± 65 
pA and from 8.2 ± 0.9 nS to 5.2 ± 0.4 nS (P = 0.017, paired t test), respectively (n = 
3).  The 5-HT2A receptor antagonist, R96544 (0.3 µM), was applied for a minimum 
of 10 minutes and had no effect on membrane current (77 ± 84 pA before, and 105 ± 

































Figure 4.2.  The 5-HT2A receptor antagonist (R96544, 0.3 µM) partially blocks 
inhibition of gKLeak by 5-HT. 
A. Continuous current record of facial motoneuron voltage-clamped at –50 mV in 
the presence of ZD7288 (10 µM).  Bath application of 5-HT (10 µM) evokes a 
large inward current (1).  Following incubation with he 5-HT2A receptor 
antagonist, R96544 (0.3 µM, 10 minutes), bath application of 5-HT (10 µM) in 
the continued presence of the antagonist evokes a smaller inward current.  The 
arrow indicates the zero current level. 
B. I/V relationships obtained from a facial motoneuron in the presence (light 
grey) and absence (black) of 5-HT (10 µM).  5-HT only has a small effect on 
the I/V relationship when applied in the presence of R96544 (0.3 µM, dark 
grey). 
C. Plot of the 5-HT-induced current (obtained by subtraction of plots shown in B) 
indicate that R96544 (0.3 µM) reduces the 5-HT-induced current (grey) 








































was then co-applied with the antagonist.  In the example in Figure 4.2, incubation 
with R96544 (0.3 µM) reduced the inward current evoked by 5-HT to –56pA (22 % 
of control response) and reduced the change in conductance (12.8 nS to 10.6 nS in 
presence of 5-HT).  Incubation with R96544 (0.3 µM) caused a reduction in the mean 
inward current evoked by 5-HT at the holding potential to –30 ± 18 pA (n = 3, Figure 
4.2A), representing a significant reduction to 28 ± 14 % of control (n = 3, P = 0.04, 
one sample t test, Figure 4.4).  In the presence of R96544 (0.3µM), the 5-HT-
mediated inhibition of gKLeak is reduced over the entire voltage range and 5-HT no 
longer significantly reduces the mean FM membrane conductance (10.6 ± 1.2 nS to 
9.2 ± 0.8 nS, P = 0.07, paired t test, Figure 4.2B, C).  Conductance measurements 
were calculated from the slope of the I/V plot.  The time limitations of voltage-clamp 
recordings from FMs did not allow for the reversibility of this antagonist to be 
investigated. 
A similar experiment was carried out on separate group of FMs where the 
concentration of R96544 was increased to 1 µM.  R96544 (1 µM) had no effect on 
membrane current at the holding potential (-50 mV, 147 ± 60 pA before and 182 ± 
65 pA after incubation with R96544, n = 3).  Figure 4.3A demonstrates the current 
evoked by 5-HT (10 µM) following incubation with R96544 (1 µM) is reduced 
compared to control (-18 pA in the presence of R96544 (1 µM) compared to –85 pA 
under control conditions).  The mean 5-HT induced current (measured at –50 mV) 
was reduced from –50 ± 18 pA to –8 ± 5 pA in the prsence of R96544 (1 µM).  This 
represents a significant reduction in inward current evoked by 5-HT (10 µM) to 15 ± 
5% of control (P = 0.003, one sample t test, n = 3, Figure 4.4).  R96544 (1 µM) 



































Figure 4.3.  The 5-HT2A receptor antagonist (R96544, 1 µM) blocks inhibition of 
gKLeak by 5-HT. 
A. Continuous current record of FM voltage-clamped at –50 mV in the presence 
of ZD7288 (10 µM).  Bath application of 5-HT (10 µM) evokes a large inward 
current (1).  Following incubation with the 5-HT2A receptor antagonist, 
R96544 (1 µM, 10 minutes), bath application of 5-HT (10 µM) in the 
continued presence of the antagonist evokes an inward current that is reduced 
compared to control (2).  The arrow indicates the +150 pA level. 
B. I/V relationships obtained from a facial motoneuron in the presence (dark 
grey) and absence (black) of 5-HT (10 µM).  5-HT has no effect on the I/V 
relationship when applied in the presence of R96544 (1 µM, light grey). 
C. Plots of the 5-HT-induced current (obtained by subtraction of plots shown in 
B) indicate that R96544 (0.3 µM) abolishes the 5-HT-induced current (grey) 
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Figure 4.4.  Summary of effects of R96544 on 5-HT-induced current.   
The 5-HT2A receptor antagonist, R96544, reduces the 5-HT-induce  current 
compared to control.  The 5-HT-induced current was measured at –50 mV and is 
expressed as the mean percentage of the control 5-HT-induced current and error bars 
represent the SEM (n = 3 for each antagonist concentration).  0.3 µM of the 
antagonist significantly reduced the 5-HT-induced current (* P= 0.04). Increasing the 
concentration of the antagonist to 1 µM results in a greater reduction in the 5-HT-













































4.4B, C).  In the example shown in Figure 4.3, the conductance change induced by 5-
HT (10 µM) under control conditions was from 12.3 nS to 8.9nS.  In the same FM 
and in the presence of R96544 (1 µM), 5-HT no longer altered membrane 
conductance (11.6 nS and 11.7 nS in the presence and absence of 5-HT).  Under 
control conditions 5-HT application resulted in a mean reduction in conductance 
from 7.8 ± 2.5 nS to 6.0 ± 2.0 nS (n =3) and this was inhibited by R96544 (1 µM) 
(7.7 ± 2.4 nS to 7.5 ± 2.3 nS in the presence of 5-HT for the same FMs).  These data 
indicate 5-HT2A receptor activation mediates the inhibition of gKLeak by 5-HT in 
FMs. 
4.2.2 Mechanism of enhancement of Ih by 5-HT 
As previously established 5-HT enhances Ih by shifting the steady-state activation 
curve to more depolarised potentials and increasing the rate of activation (Larkman 
and Kelly 1992).  These effects of 5-HT have been co firmed here (Figure 4.5).  In 
Figure 4.5B the current responses in the presence of 5-HT were shifted so the peak of 
the instantaneous current was the same as the control, thereby clearly illustrating the 
enhancement of Ih over the activation range ( nabling the effect on Ih to be detected 
visually).  In the example shown in Figure 4.5 the enhancement of the amplitude and 
rate of activation of Ih by 5-HT is apparent between –90 mV and –120 mV.   This is 
consistent with the previous findings that intracellular cAMP shift the activation 
range of Ih to more depolarised potentials (Larkman and Kelly 1997).   
4.2.3 Optimising conditions for investigating Ih modulation 
Prior to establishing the identity of the receptor that mediates the inhibition of gKLeak, 




































Figure 4.5.  5-HT shifts the threshold for activation of hyperpolarisation-
activated cation current, Ih. 
A. Voltage command (10 mV steps) used to monitor changes in Ih. 
B.    Current responses to hyperpolarizing voltage steps (A) in control conditions 
(black) and following bath application of 5-HT (10 µM, grey).  The 5-HT 
responses were shifted so the peak of the instantaneous current was the same as 
the control value, this enables the effect on Ih to be observed   The arrow 













approach to studying the 5-HT actions on Ih is to optimise Ih and minimise 
contribution of gKLeak to the overall 5-HT response.  The external potassium 
concentration was increased from 3 mM to 12 mM, which shifted the EK to 
approximately –59 mV (as predicted by the Nernst Equation, Methods Equation 1).  
Under these conditions in a FM voltage-clamped around –59 mV inhibition of gKLeak 
would not evoke any significant net current change and in cells voltage-clamped 
below -59 mV inhibition of gKLeak would be observed as an outward current.  H-
channels are mixed cation channels with a higher sel ctivity for K+ over Na+ and the 
increased driving force that arises by increasing the external K+ concentration results 
in a larger Ih being measured. When 5-HT was applied to a FM voltage-clamped at –
60 mV in 12 mM K+ ACSF (Methods Solution 2.4) an inward current was ob erved 
(-47 ± 8 pA, n =10, Figure 4.6A).  Previous studies have shown this inward current 
to be abolished by ZD-7288 (Larkman & Kelly, 1998).  Under these conditions Ih
was significantly enhanced by 5-HT application (increased by 31 ± 6 pA, n = 8, P < 
0.0001, one sample t test, Figure 4.6B). 
4.2.4 5-HT receptor subtype mediating enhancement of Ih 
It has previously been determined that the mechanism for the enhancement of Ih by 
5-HT involves a phosphorylation-independent action of cAMP on the channel, 
however, the 5-HT receptor subtype mediating this effect has not previously been 
identified (Larkman, Kelly et al. 1995; Larkman and Kelly 1997).  cAMP is 
produced by adenylate cyclase and members of 5-HT4, 6 and 7 receptor families are 
known to couple to G-proteins that promote adenylate cyclase activity.  Prior 





































Figure 4.6.  In 12 mM [K+]o 5-HT enhances Ih. 
A. Continuous current record of a facial motoneuron v ltage-clamped at – 60mV 
in 12 mM K+ ACSF.  5-HT evokes an inward current and the large deflections 
represent current responses to voltage commands.  The arrow indicates the –
200 pA level. 
B. Voltage command used to monitor changes in Ih. 
C. Current responses to hyperpolarizing voltage steps (B) in control conditions 
(black) and following bath application of 5-HT (10 µM, grey).  The arrow 
















antagonist, clozapine, did not block the enhancement of Ih by 5-HT (Larkman and 
Kelly 1997).  However, the development of the selectiv  5-HT7 receptor antagonist, 
SB269970, has allowed the contribution of this receptor to the enhancement of Ih by 
5-HT to be further investigated (Hagan, Price et al. 2000; Lovell, Bromidge et al. 
2000).   
Figure 4.7A demonstrates that bath-application 5-HT (10 µM) to a FM voltage-
clamped at –60 mV evokes a control inward current of –68 pA.  This inward current 
was replicated following a second application of 5-HT (Figure 4.7A).  The mean 5-
HT-evoked inward current under these conditions was–60 ± 4 pA (n = 4).  The 5-
HT7 receptor antagonist, SB269970 (10 µM), was applied for a minimum of 10 
minutes prior to co-application of 5-HT with the ant gonist and had no effect on the 
membrane current at the holding potential (-140 ± 50 pA under control conditions 
and -124 ± 46 pA following incubation with SB269970, P = 0.07, paired t test, n = 
4).  In the example in shown in Figure 4.7B, in thepr sence of SB269970 (10 µM) 
the inward current evoked by 5-HT was reduced from –68 pA to -8 pA.  The mean 
inward current evoked by 5-HT in the presence of SB269970 (10 µM) was 14 ± 3 
pA, representing a significant reduction compared to control (P = 0.01, paired t test, 
n = 4).  The small outward current observed is due to the inhibition of gKLeak by 5-
HT (Figure 4.7B).  In the same FM as Figure 4.7, the current response to a 
hyperpolarising voltage step demonstrates that 5-HT (10 µM) enhances steady-state 
Ih by 162 pA (21 %, Figure 4.8B).  The mean enhancement of Ih by 5-HT was 101 ± 
21 pA, representing an increase of 22 ± 1 % (n = 4).  Following prior incubation with 
SB269970 (10 µM) the enhancement of Ih by 5-HT, in the example shown in Figure 
































Figure 4.7.  SB269970 (10 µM) reduces the 5-HT-evoked inward. 
A. Continuous current record from a facial motoneuron v ltage-clamped at –60 
mV in 12 mM K+ ACSF.  5-HT (10 µM) evokes a large, reversible inward 
current, which is reproducible.  The large deflections on the current trace 
represent current responses to voltage commands on a c mpressed time scale 
and the arrow indicates the –200 pA level. 
B. Continuous current record from the same facial motoneuron voltage-clamped 
at –60 mV in the presence of the 5-HT7 receptor antagonist, SB269970 (10 
µM), in 12 mM K+ ASCF, following incubation with the antagonist for 10 
mins.  The inward current evoked by 5-HT (10 µM) is reduced compared to 
control.  Note the outward currents that arise due to inhibition of gKLeak by 5-
HT (highlighted by the dashed circles). The arrow indicates the –200 pA level. 
 











































Figure 4.8.  SB269970 (10 µM) reduces the enhancement of Ih by 5-HT. 
A. Hyperpolarizing current command used to monitor changes in Ih. 
B. Current responses to hyperpolarizing voltage (A) from a facial motoneuron in 
12 mM K+ ACSF in the presence (grey) and absence (black) of 5-HT (10 µM).  
The arrow indicates the –200 pA level.   
C. Current responses to hyperpolarizing voltage (A) from a facial motoneuron in 
12 mM K+ ACSF in the presence (grey) and absence (black) of 5-HT (10 µM), 
following incubation with the 5-HT7 receptor antagonist, SB269970 (10 µM) 
for 10 minutes.  The enhancement of Ih by 5-HT is reduced compared to 
















5-HT in the presence of SB269970 (10 µM) was 59 ± 14 pA, representing an 
increase of 15 ± 2 % (n = 4).  Thus the enhancement of Ih in the presence of 
SB269970 (10 µM) was significantly reduced to 58 ± 5 % of control (P = 0.004, one 
sample t test, n = 4).   
The high antagonist concentration used in the above exp riment raised the possibility 
that other receptor subtypes were being affected by the antagonist, thus the 
experiment was repeated using a lower concentration.  5-HT (10 µM) was bath-
applied to a FM voltage-clamped at –60 mV and the current response to a 
hyperpolarising voltage step demonstrates that, in this example, 5-HT enhances Ih by 
approximately 129 pA (Figure 4.9B).  Bath application of SB269970 (0.3 µM) for a 
minimum of 10 minutes to the recorded FM had no effect on the membrane current (-
237 ± 132 pA under control conditions and -254 ± 141 pA in SB269970, P = 0.22, 
paired t test, n = 3).  Figure 4.9C demonstrates that when 5-HT (10 µM) was co-
applied with the antagonist the enhancement of Ih by 5-HT was reduced to 2 pA.  The 
mean enhancement of Ih by 5-HT was reduced to 29 ± 14% of control in the presence 
of SB269970 (0.3 µM) (n = 3, P = 0.04, one sample t test, Figure 4.9C).   
The enhancement of Ih by 5-HT was significantly reduced by both 0.3 µM and 10 
µM of SB269970 and the effects of these two antagonist concentrations were not 
significantly different from each other (P = 0.1, unpaired t test).  These data indicate 




































Figure 4.9.  SB269970 (0.3 µM) reduces the enhancement of Ih by 5-HT. 
A. Hyperpolarizing current command used to monitor changes in Ih. 
B. Current responses to hyperpolarizing voltage (A) from a facial motoneuron in 
12 mM K+ ACSF in the presence (grey) and absence (black) of 5-HT (10 µM).  
The arrow indicates the -500 pA level.   
C. Current responses to hyperpolarizing voltage (A) from the same facial 
motoneuron in 12 mM K+ ACSF in the presence (grey) and absence (black) of 
5-HT (10 µM), following incubation with the 5-HT7 receptor antagonist, 
SB269970 (0.3 µM) for 10 minutes.  The enhancement of Ih by 5-HT is 
reduced compared to control (B).  The arrow indicates the –500 pA level.   















4.2.5 α1-adrenoceptors mediate inhibition of gKleak in FMs. 
NA also promotes FM excitability by inhibiting KLeak in FMs (Chapter 3) and the 
adrenoceptor subtype mediating this action of NA has been investigated.  The α-
adrenoceptor agonist, phenylephrine (PE), mimicked the ability of NA to inhibit 
gKLeak with an EC50 of ~1 µM (n = 12, Figure 4.10). The β-adrenergic receptor 
agonist isoproterenol (5 - 100 µM) had no effect on gKLeak (n = 3).  NA- and PE-
induced inhibition of gKLeak could be abolished by bath-application of the α1-
adrenergic receptor antagonists, prazosin (0.5 – 1 µM, n = 5) (Figure 4.10A, B).  
Modulation of gKLeak by NA and PE was not blocked by the β-adrenergic receptor 
antagonist propranolol (10 µM; n = 3, Figure 4.10D).   
Chapter 3 described the identification of gKLeak based on its pH-sensitivity and it is 
known that lowering external pH has been shown to alter agonist receptor 
interactions for some adrenoceptors.  It was therefore important to confirm the 
identity of the adrenoceptor mediating these actions n FMs as the α1-adrenoceptor as 
this subtype is not sensitive to changes in external pH (Curro and Greenberg 1983; 
Nunnari, Repaske et al. 1987; Tateishi and Faber 1995).     
4.3 Mechanism for inhibition of gKLeak 
The receptors that mediate the inhibition of gKLeak (5-HT2A and α1-adrenoceptors) are 
both coupled to Gq proteins.  The Gq pathway stimulates phospholipase-C activity 
which in turn increases the hydrolysis of phosphatidylinositol biphosphate (PIP2) in 
the membrane (Alberts, Johnson et al. 2002).  This results in the generation of the 


































Figure 4.10. Noradrenaline inhibits gKLeak through activation of α1 
adrenoceptors.  
A. Continuous current records from an FM voltage-clamped at -60 mV showing 
that the inward currents evoked by bath-application of phenylephrine (PE, 30 
µM) and NA (5 µM) were inhibited by the α1 receptor antagonist, prazosin (0.5 
µM). The response to 5-HT (10 µM) was unaffected by this antagonist.  
B. The NA- and PE-induced currents, obtained by subtraction of current responses 
to voltage ramps, share the same biophysical properties and are blocked over 
the whole voltage range by prazosin.   
C. Dose response curve for PE. Response amplitude was normalised to the 
response to 5-HT (10 µM). Data points represent mean ± SEM for 5 different 
FMs. The solid line represents a fit of the data to (Methods Equation 3) with an 
EC50 of 1 µM and a Hill slope of 0.71.  
D. Continuous current records from an FM voltage-clamped at -60 mV showing a 
lack of effect of the β-adrenergic receptor antagonist, propranolol (10 µM), on 
the currents induced by NA (5 µM).  
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(Alberts, Johnson et al. 2002).  However, initial studies have determined that the 
downstream effects of these molecules (increased [Ca2+] i and PKC activation, 
respectively) are not involved in the inhibition of gKLeak (Larkman and Kelly 1998; 
Larkman, Perkins et al 2003).  More recently it has been determined that the 
excitatory effects of activation of 5-HT2 receptors can occur without the involvement 
of DAG or IP3 signalling (Czirjak, Petheo et al. 2001; Lopes, Rohacs et al. 2005).  
Instead it appears that PIP2 depletion from the membrane underlies an agonist-
induced inhibition of K2P and M channels (Czirjak, Petheo et al. 2001; Lopes, Rohacs 
et al. 2005).  This mechanism for inhibition of gKLeak in FMs has been further 
investigated. 
4.3.1 PLC-β1 is present in the facial nucleus 
Figure 4.11 shows a representative sample section (48 µm thick) from a wild type 
mouse (8 days old) stained with an antibody to PLC-β1 (1 in 2000 dilution).  The 
facial nucleus displays low, but distinct, levels of immunoreactivity for PLC-β1 
indicating that this enzyme is present in FMs.  Although the presence of PLC-β1 in 
the FMN supports a role of this enzyme in the agonist-i duced inhibition of gKLeak 
other Gq coupled-receptors may be present in FMs which may also require PLC-β 
activity. 
The functional contribution of PLC-β1 to the 5-HT- and NA-induced inhibition of 
gKLeak was assessed using mice in which PLC-β1 had been knocked out.  Table 4.1 
summarises the data from 3 PLC-β1-/- mice and 6 littermate controls.  Neither the 
amplitude nor density of the current induced by 5-HT were significantly different in 






























Figure 4.11. PLC-β is present in the facial nucleus. 
A. Representative section from a P8 wildtype mouse demonstrates 
immunoreactivity for PLC-β1 in the facial nucleus (arrows).  The scale bar 
represents 1.5 mm. 
B. Higher magnification of section highlighted by the box in A.  The presence of 







Control / PLC-β1-/+ 
(N = 6) 
PLC-β1-/- 
(N = 3) 
I5-HT Amplitude (pA) -54.5 ± 11.6 (n = 10) -60.7 ± 13.5 (n = 6) 
I5-HT Density (pA/pF) -1.96 ± 0.44 (n = 10) -1.87 ± 0.57 (n = 6) 
INA Amplitude (pA) -44.3 ± 9.7 (n = 7) -9.8 ± 5.1 (n = 6)
* 






Table 4.1.  PLC-β1-/- mice show significantly reduced NA-induced current. 
Current amplitude was measured at a holding potential of -58 mV.  Statistical 
significance was assessed by Student’s t test (*P < 0.01, ** P < 0.001, N = number of 
animals, n = number of recordings). 
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the current induced by NA were significantly lower in the PLC-β1-/- mice compared 
to their littermate controls (Table 4.1).  I5-HT might not be reduced in the PLC-β1
-/-
 
mice for several reasons.  Firstly, our sample sizemay be too small, secondly 5-HT2 
receptors may couple to a different isoform of PLC-β or thirdly PLC-β might not be 
involved.   
The contribution of other isoforms was investigated using the non-specific PLC-β 
inhibitor, U73122 (Bleasdale, Bundy et al. 1989).  The mean control 5-HT-induced 
current at -50 mV was -103 ± 38 pA.  Following incubation in ACSF containing 
U73122 (10 µM) the 5-HT-induced current was -97 ± 30 pA (n = 3).  The lack of 
effect of the inhibitor suggested that PLC activity is not required for this action of 5-
HT.  However, one possibility is that the incubation time in these acute application 
experiments is not long enough to allow U73122 to enter the FMs at a high enough 
concentration to inhibit PLC-β isoforms.  In an attempt to address this an alternaive 
experimental approach was taken and U73122 was included in the internal solution.  
Responses to 5-HT obtained from FMs when U73122 was included in the pipette 
were compared with control responses to 5-HT obtained from FMs in the same slices 
using patch pipettes that did not contain the inhibitor.  A control 5-HT-induced 
current of -26 ± 5 pA (at -50 mV) was obtained from three applications of 5-HT.  In 
another FM from the same slice in which U73122 (5 µM) was included in the 
internal solution, the 5-HT-induced current were +21 and +13 pA (2 applications of 
5-HT).  From this limited data the indications are that an isoform of PLC may be 
required for the 5-HT-induced inhibition of gKLeak.  However, more extensive studies 
will be needed to confirm these initial observations.  
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4.4 Discussion 
4.4.1 5-HT2 receptor activation inhibits gKLeak 
Activation of 5-HT2 receptors mediates the excitatory action of 5-HT by decreasing 
potassium conductances in several types of neurons including rat nucleus accumbens 
neurons and pyramidal neurons in the piriform cortex (North and Uchimura 1989; 
Sheldon 1991).  5-HT2A receptor protein and mRNA for both the 5-HT2A and 5-HT2C 
receptors have been detected in the FMN (Pompeiano, Palacios et al. 1994; Cornea-
Hébert 1999; Fonseca, Ni et al. 2001; Volgin, Fay et al. 2003).  The 5-HT2A/2C 
selective agonist, 1-[2,5-demethoxy-4-methylphenyl]-2-aminopropane (DOM), has 
previously been shown to have excitatory effects on FMs (Rasmussen and 
Aghajanian 1990).  These findings suggested that 5-HT2A or 5-HT2C receptor 
activation could mediate the inhibition of gKLeak and this was investigated further.   
Application of the 5-HT2A receptor antagonist, R96544 (0.3 µM or 1 µM) had no 
effect on FM membrane current but did significantly block the 5-HT-mediated 
inhibition of gKLeak.   
4.4.2 Selectivity of R96544 
R96544 has 100-fold lower affinity for 5-HT1A, 5-HT1B, 5-HT1D, 5-ht5A, 5-HT6 and 
5-HT7 receptors and was found to be ineffective at modulating 5-HT3- or 5-HT2B-
mediated actions of 5-HT (Ogawa, Sugidachi et al. 2002).  However, R96544 does 
display relatively high affinity for 5-HT2C receptors (although 4-fold less than 5-
HT2A receptors), therefore the action of this antagonist i  FMs does not rule out the 
involvement of 5-HT2C receptors in the 5-HT-mediated modulation of gKLeak 
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(Ogawa, Sugidachi et al. 2002).  A similar set of experiments performed using RS-
101221, which has 100-fold selectivity for 5-HT2C receptors over 5-HT2A receptors 
would conclusively determine the contribution of 5-HT2A and/or 5-HT2C receptors to 
the 5-HT-mediated excitation of FMs (Bonhaus, Weinhardt et al. 1997). 
4.4.3 Developmental changes in 5-HT2 receptor expression 
It is worthwhile noting that the experiments with R96544 were performed on 
neonatal rats aged between postnatal days 4 and 16 and one study has documented 
the postnatal development of 5-HT2 receptors in hypoglossal motoneurones (Volgin, 
Fay et al. 2003).  In hypoglossal motoneurones the expression of 5-HT2A mRNA was 
higher compared to 5-HT2C mRNA expression in rats aged 3-14 days old (Volgin, 
Fay et al. 2003).  The percentage of motoneurones expressing 5-HT2C mRNA 
increased with age, however, expression of 5-HT2C mRNA alone was never observed 
(Volgin, Fay et al. 2003).  This study also describes the increase in 5-HT2A 
immunoreactivity in the FMN postnatal days 5 and 19 (Volgin, Fay et al. 2003).  If a 
similar change in 5-HT2C receptor expression occurs in the FMN this could 
significantly affect any further studies into the role of 5-HT2A and 5-HT2C receptors 
in this nucleus and should, therefore, be investigated further by 
immunohistochemical analysis of receptor expression between postnatal days 4 and 
16. 
4.4.4 5-HT7 receptor activation enhances Ih 
 5-HT enhances Ih through a direct action of cAMP on the channel and previous 
investigations failed to identify the receptor subtype mediating this effect of 5-HT 
(Larkman and Kelly 1997).  5-HT4, 5-HT6 and 5-HT7 receptors are all coupled 
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positively to adenylate cyclase and enhance cAMP production, therefore, 
representing potential candidates for the receptor mediating the enhancement of Ih in 
FMs.  The 5-HT4 receptor antagonist, GR-113808A, and the 5-HT6/7 receptor 
antagonist, clozapine, had no effect on the enhancement of Ih by 5-HT (Larkman and 
Kelly 1997).  5-HT7 receptors have been implicated in the 5-HT-mediate 
enhancement of Ih in CA1 hippocampal neurons, in the anterodorsal thlamus and in 
dorsal root ganglion neurons (Cardenas, Del Mar et al. 1999; Chapin and Andrade 
2001; Bickmeyer, Heine et al. 2002).  The potential role of this receptor subtype was 
further investigated in FMs using the highly selective 5-HT7 receptor antagonist, SB 
269970, (100-fold higher affinity for 5-HT7 over other 5-HT receptors) (Lovell, 
Bromidge et al. 2000).   SB 269970 significantly decreased the enhancement of Ih by 
5-HT indicating 5-HT7 receptors mediate this action of 5-HT.  The 5-HT7 receptors 
are the most recently identified members of the 5-HT receptor family and their action 
in FMs provides evidence for novel functional role in the modulation of motor 
activity. 
4.4.5 α1-adrenoceptors mediate NA-induced inhibition of gKLeak 
The pharmacology of the NA-induced inhibition of gKLeak was investigated in FMs 
and suggested a α1-adrenoceptor subtype.  This is consistent with the signal 
transduction mechanism of α1-adrenoceptors (increased PLC-β activity via Gq 
protein activity) being the same as that of 5-HT2 receptors which were found to 
mediate the 5-HT induced inhibition of gKLeak (Alberts, Johnson et al. 2002).   
This finding also suggests that occlusion of the NA-mediated modulation of gKLeak 
by low external pH (Chapter 3) is not due to altered agonist-receptor interactions as 
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α2- but not α1-adrenoceptors show altered functional responses associ ted with 
changes in agonist binding affinity over the pH range 6 to 8 (Curro and Greenberg 
1983; Nunnari, Repaske et al. 1987; Tateishi and Faber 1995). 
4.4.6 Agonist and antagonist concentrations used in slices 
The concentrations of the agonists and antagonists used in these experiments are 
much higher than the EC50 or IC50 values reported in the literature for in vitro assays.  
This is common for slice electrophysiology as the dense extracellular matrix in slices 
can reduce access of the drug to the cell that is being studied.  In addition, uptake or 
metabolism of some compounds may also occur, reducing the actual concentration 
around the recorded cell.  For example, the reported affinities for 5-HT at 5-HT2 and 
5-HT7 receptors are 1 – 17 nM (Ki or Kd values) whereas 10 µM 5-HT is required to 
routinely produce a maximal response in FMs (Peroutka and Snyder 1979; Ruat, 
Traiffort et al. 1993).  R96544 has a reported IC50 of 2.2 nM, however, 0.3 µM 
R96544 only partially blocked the 5-HT-induced inhibition of gKLeak and 10 µM  
fully blocked this response to 5-HT (Ogawa, Sugidachi et al. 2002).  These 
concentrations are unlikely to effect most other 5-HT receptor subtypes due to the 
high selectivity of this compound for the 5-HT2A receptor (Ogawa, Sugidachi et al. 
2002).  However, these concentrations may also block 5-HT2C receptors and the 
contribution of this subtype should be further investigated (see section 4.4.2).  The 
reported Kd values for SB269970 binding to 5-HT7 receptor-expressing HEK293 
cells and guinea pig cortex membranes are 1.25 ± 0.3 nM and 1.7 ± 0.3 nM, 
respectively (Thomas, Atkinson, et al. 2000).  In this study 0.3 – 10 µM SB269970 
was used, however, due to the high selectivity of this antagonist for 5-HT7 receptors 
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over the other subtypes it is unlikely that even at these concentrations other 5-HT 
receptors were blocked (Lovell, Bromidge et al. 2000). 
4.4.7 Mechanism for receptor activation leading to inhibition of gKLeak 
Inhibition of FM gKLeak by 5-HT involves activation of 5-HT2 receptors and α1 
adrenoceptors mediate the similar actions of NA.  Both receptor subtypes couple 
through Gq proteins to phospholipase C (PLC)-mediated hydrolysis of phosphatidyl-
4,5-inositol-bisphosphate (PIP2).  The detection of PLC-β1 in the FMN by 
immunohistochemistry raises the possibility that modulation of gKLeak by these 
neurotransmitters may involve activation of this enzyme.  This is supported by the 
finding that in PLC-β1-/- mice the NA-induced current is significantly altered.  
However, previous studies have demonstrated that altering the downstream pathways 
of PLC (increased [Ca2+] I and PKC signaling) did not affect gKLeak (Larkman 2003). 
Gq-coupled muscarinic M1 and group 1 metabotropic glutamate receptors, but not Gi-
coupled muscarinic M2 receptors, inhibit co-expressed human TASK-1 and TASK-3 
channels through a PIP2 hydrolysis-dependent pathway (Czirjak, Petheo et al. 2001; 
Chemin, Girard et al. 2003).  The PLC inhibitor, U73122, did reduce the inhibition of 
TASK-1 following M1 receptor activation, however, the downstream signals of 
phospholipase C (Ca2+ and DAG) did not appear to be involved (Czirjak, Petheo et 
al. 2001).  Externally applied U73122 did not effect the 5-HT-mediated reduction in 
gKLeak and although inclusion of U73122 in the internal so ution did appear to 
prevent the inhibition of gKLeak this experiment did lack a direct control response to 
5-HT. 
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PIP2 has been shown to directly activate several K2P channels and it is proposed that 
PIP2 depletion from the membrane underlies the agonist-i duced inhibition of these 
channels (Lopes, Rohacs et al. 2005).  Modulation of the activity of membrane ion 
channels is emerging as a common role for PIP2.  KCNQ2/3 channels (which 
underlie the M current) can be activated by PIP2 application and recovery from 
agonist-induced inhibition of the channel is dependent on PIP2 synthesis (Suh and 
Hille 2002; Zhang, Craciun et al. 2003).  Additionally, G protein-gated inwardly 
rectifying K+ channels, inwardly rectifying background K+ channels, human ether-a-
go-go–related gene (HERG) K+ channels and N-type Ca2+ channels have all been 
shown to be regulated by PIP2 (Huang, Feng et al. 1998; Bian, Cui et al. 2001; 
Gamper, Reznikov et al. 2004; Cho, Lee et al. 2005). 
Although the PLC-mediated hydrolysis of PIP2 has been shown to modulate the 
activity of several ion channels, one study suggests that inhibition of TASK-1 and 
TASK-3 channels is through a direct action of the Gα subunit and is independent of 
PLC and PIP2 (Chen, Talley et al. 2006).   
 4.5 Concluding statement 
This chapter has investigated the receptor subtypes which mediate the excitatory 
actions of 5-HT and NA in neonatal FMs.  The inhibition of gKLeak by 5-HT and NA 
was mediated by activation of 5-HT2A receptors (and possibly 5-HT2C receptors) and 
α1-adrenoceptors, respectively.  The enhancement of Ih was found to be a result of 
activation of 5-HT7 receptors providing a novel functional role for this receptor 
subtype. 
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In addition, the mechanism by which 5-HT2 receptor and α1-adrenoceptor activation 
leads to inhibition of gKLeak was investigated.  The detection of PLC-β1 in the FMN 
and the finding that PLC-β1-/- mice show reduced NA-induced current supports a role 
for this enzyme in the inhibition of gKLeak.  However, the mechanism by which this 
occurs does not appear to be via the conventional signaling pathways of this enzyme.  
One possibility is that PIP2 in the membrane support the channel in its open state and 










5.1.1 Excitatory synaptic transmission  
Glutamate is the principal excitatory neurotransmitter within the mammalian CNS 
and preliminary studies indicate glutamate has excitatory actions on FMs 
(VanderMaelen and Aghajanian 1980).  Fast synaptic responses to glutamate are 
mediated by three subtypes of ionotropic receptors characterized by the selective 
agonists that activate them: N-methyl-D-aspartate (NMDA), α-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid (AMPA) and kainate (Figure 5.1).   
5.1.2 Glutamate receptors 
Glutamate receptors form ion channels that are permeable to Na+ and K+.  
Additionally, NMDA and some AMPA receptors (those lacking the GluR2 subunit) 
are permeable to Ca2+ (Dingledine, Borges et al. 1999).  The net effect of the 
movement Na+, Ca2+ and K+ ions through the channels mediates a depolarisation of 
the postsynaptic membrane, if a sufficient depolarization occurs at the cell soma an 
action potential will be triggered in the postsynaptic neurone.  Ca2+ influx into the 
postsynaptic terminal also triggers biochemical effects that can be important for 
synaptic plasticity (reviewed in (Soderling, Tan et al. 1994; Dingledine, Borges et al. 

























Figure 5.1.  Classification of ionotropic glutamate receptors. 
Ionotrophic glutamate receptors are classified according to the selective agonists 
which activate them.   





















NMDA and non-NMDA glutamate receptors co-localize at many central synapses 
and are activated by glutamate with differing time courses (O'Brien, Isaacson et al. 
1997; Ozawa, Kamiya et al. 1998).  AMPA glutamate receptors have fast kinetics, 
their permeability to Ca2+ is dependent on subunit composition and they are not 
blocked by extracellular Mg2+.  Conversely NMDA receptors have intrinsically slow 
kinetics, are highly permeable to Ca2+ nd show a voltage-dependent block by Mg2+ 
(Mayer, Westbrook et al. 1984).  Removal of the Mg2+ block of NMDA receptors 
(and their subsequent activation by glutamate) occurs following the depolarization of 
the membrane which occurs when non-NMDA glutamate receptors are activated 
(Mayer, Westbrook et al. 1984).  
Originally, glutamate receptors were thought to exist as pentamers, however, 
evidence now exists supporting a tetrameric structue from studies on NMDA and 
GluR2 receptors (Schorge and Colquhoun 2003; Tichelaar, Safferling et al. 2004).  
Functional NMDA glutamate receptor requires both the NR1 and an NR2 subunit.  
This is due to the glutamate binding site being located on the NR2 subunit and the 
binding site for the obligatory co-agonist, glycine, on the NR1 subunit (Kleckner and 
Dingledine 1988; Dingledine, Borges et al. 1999). 
5.1.3 Glutamate receptors in the FMN 
Glutamate receptors are widely expressed throughout the mammalian CNS and 
immunohistochemistry and in situ hybridisation studies have identified AMPA, 
NMDA and kainate receptor subunits in the FMN.  Allfour of the known AMPA 
receptor subunits are present in the FMN, with GluR2, 3 and 4 showing higher 
expression than the GluR1 subunit (Martin, Blackstone et al. 1993; Sato, Kiyama et 
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al. 1993).  The expression patterns of kainate receptors subunits (GluR 5-7, KA1-2) 
has been less well examined and only moderate staining with GluR6/7 and KA2 
specific antibodies has been reported in the FMN (Petralia, Wang et al. 1994).   
All NMDA receptors are believed to contain at least one NR1 subunit, this subunit 
contains the binding site for the obligatory co-agonist, glycine.  NR1 is highly 
expressed in most central neurones, including FMs (Petralia, Yokotani et al. 1994).  
The glutamate-binding site for NMDA receptors is located on the NR2 subunit, of 
which there are four known subtypes (NR2A-D).  Immunohistochemistry using an 
antibody that recognizes both NR2A and NR2B subunits shows positive staining in 
the FMN, however, it has been well reported that NMDA receptor subunit 
composition changes during development (Petralia, Wng et al. 1994).  Members of 
a third class of NMDA receptor (NR3A-B) have also been cloned although the role 
of this subunit is not fully understood.  NR3 subunits are insensitive to glutamate and 
can be expressed with NR1 subunits to form excitatory glycine receptors that are 
relatively Ca2+-impermeable and insensitive to block by extracellular Mg2+ 
(Chatterton, Awobuluyi et al. 2002). When co-expressed with NR1 and NR2 
subunits, members of the NR3 class reduce the glutamate-induced current in a 
dominant-negative manner (Nishi, Hinds et al. 2001; Chatterton, Awobuluyi et al. 
2002).  Interestingly, NR3 subunits are found predominantly in motoneurones 




The aim of this chapter was to characterise excitatory synaptic transmission in 
neonatal rat facial motor neurones.  The interpretation of any effects of 5-HT on 
synaptic integration would be simplified if single synapses were being activated so 
minimal stimulation protocols were used to attempt to stimulate single synapses.  
Minimal stimulation intensities were applied close to the FM dendrites and evoke 
excitatory postsynaptic currents (EPSCs) and potentials (EPSPs) that fluctuated in 
amplitude.  Whether these fluctuations in amplitude represented quantal release from 
a single synapse or stimulation of more than one synapse was further investigated 
using paired pulse analysis. 
The identity of the postsynaptic receptors which mediat  EPSCs in FMs was also 
investigated to provide further insight into synaptic ransmission in the facial 
nucleus.  A pharmacological approach was used to identify a non-NMDA and 
NMDA glutamate receptor component to EPSCs in FMs and the subunit composition 
of these receptors. 
5.2 Results   
5.2.1 Evoked EPSCs in facial motoneurones 
EPSCs were evoked by positioning a stimulating electrode close to the dendrites of 
the FM and applying minimal stimulation (see Methods).  In a representative FM, 
voltage-clamped at –70 mV, stimulating close to the dendrites evokes a fast EPSC 






























Figure 5.2.  Stimulating close to the dendrites of a FM evokes EPSCs. 
A. Mean of 21 events (including failures) recorded from a FM voltage-clamped at 
–70 mV.  The arrow indicates the zero current level and the large deflection 
before the EPSC represents the stimulus artifact. 
B. Representative traces from the same FM as A, demonstrating that a constant 
stimulus intensity occasionally fails to generate a r sponse (failure) and evokes 
EPSCs that fluctuate in amplitude.  The horizontal arrow indicates the zero 










Figure 5.2B shows example individual traces from the same FM indicating that 
EPSCs showed discrete amplitude fluctuations and that stimulation occasionally 
failed to generate an EPSC (a criteria for minimal stimulation).  The individual 
example EPSCs shown in Figure 5.2B had peak amplitudes of 56, 113, 169 and 219 
pA.  EPSCs evoked using minimal stimulation intensitie , at a holding potential of –
70 mV, had mean amplitude of –80 ± 3 pA and rise and decay time constants of 1.8 
± 0.6 and 11.1 ± 3.0 ms, respectively (n = 15, Table 5.1).  
The fluctuations in EPSC amplitude could occur as aresult of release of one or more 
vesicles from a single synapse or activation of multiple synapses.  As the stimulation 
intensity was increased the rate of failure to evok an EPSC decreased and eventually 
more synapses were recruited and the mean EPSC amplitude significantly increased.   
5.2.2 Evoked EPSPs in facial motoneurones 
After an EPSC was evoked as described above, the recording mode was switched to 
current-clamp and an excitatory postsynaptic potential (EPSP) recorded.  Figure 
5.3A shows an example of a mean EPSP, 2.2 mV in amplitude, recorded from a FM 
at its resting membrane potential (-72.5 mV, mean of 34 events including failures).  
Individual traces from the same FM demonstrate that EPSPs showed discrete 
amplitude fluctuations and that stimulation occasionally failed to generate an EPSP 
(Figure 5.2B).  The example EPSPs shown in Figure 5.3B are 0.9, 1.8 and 2.7 mV in 
amplitude.  Figure 5.3B also demonstrates that when t  same FM was voltage-
clamped at –70 mV, an identical stimulation evoked EPSCs that demonstrated 





EPSC  EPSP  
  Amplitude -80 ± 3 pA 1.8 ± 1.3 mV 
  Rise time constant 1.8 ± 0.6 ms 2.5 ± 1.3 ms 







Table 5.1.  Properties of averaged synaptic events from FMs. 
EPSCs were evoked in FMs voltage-clamped at –70 mV (n = 15) using minimal 
stimulus intensities.  EPSPs were measured at the resting membrane potential (-67 ± 
3 mV)  and evoked using minimal stimulus intensitie that generated EPSCs, in the 

































Figure 5.3.  Stimulating close to the dendrites of a FM evokes EPSPs. 
A. Mean of 34 events (including failures) recorded from a current-clamped FM at 
the resting membrane potential (-72.5 mV, as indicated by arrow).  The large 
deflection before the EPSP represents the stimulus artifact. 
B. Representative traces from the same FM as A, demonstrating that a constant 
stimulus intensity occasionally failed to generate  response (as indicated) and 
evoked EPSPs that fluctuate in amplitude.  When the same motoneuron was 
voltage-clamped at –70 mV, an identical stimulation evoked EPSCs with 
fluctuations in amplitude that corresponded with the EPSPs.  The horizontal 
arrows indicate the –72 mV and the –100 pA levels.  Stimulation was applied 
















to that of the EPSPs (approximately 98, 195 and 285 pA).  EPSPs evoked at the 
resting membrane potential (-68 ± 3 mV), using minial stimulation intensities that 
evoked EPSCs with a mean amplitude of  –26 ± 10 pA, had mean amplitude of 1.8 ± 
1.3 mV and rise and decay time constants of 2.5 ± 1.3 and 31.7 ± 10.0 ms, 
respectively (n = 3, Table 5.1).   
5.2.3 Current-voltage relationship of EPSC amplitude 
Current-voltage (I/V) relationships of EPSC amplitude can indicate the ions which 
pass through the open receptor channel and also provide insight into receptor subunit 
composition.  The I/V plot shown in Figure 5.4A was generated from an average of a 
minimum of 10 EPSCs from 4-7 FMs for each potential (any failures were omitted 
from the average).  EPSCs from a representative FM demonstrate that the amplitude 
of individual EPSCs change proportionally with voltage (Figure 5.4B). This I/V 
relationship had a reversal potential of –17 ± 4 mV(n = 4-7) and was found to be 
outwardly rectifying (ratio of 2.6, see Methods).  This outward rectification occurs as 
a result of an NMDA glutamate receptor component (see ection 5.3) being revealed 
at potentials where the receptor block by Mg2+ is removed (Nowak, Bregestovski et 
al. 1984).  The failure rate did not appear to change when the holding potential was 
altered suggesting that the probability of vesicle release was not dependent on the 






































Figure 5.4.  Current-voltage relationship of mean EPSC amplitude in FMs. 
A. I/V relationship generated from the mean EPSC amplitude (without failures) at 
each potential (n = 4-7 facial motoneurones, with an average of a minimum of 
10 EPSCs at each potential in each cell) 
B. Example traces from a representative facial motoneurones demonstrating that 
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5.2.4 Paired pulse facilitation  
Vesicular release of neurotransmitter is dependent on Ca2+ influx into the presynaptic 
terminal.  When two identical stimulation pulses are applied close together the 
residual Ca2+ in the presynaptic terminal after the first pulse can increase the 
probability of release following the second pulse, resulting in the second of a pair of 
mean EPSCs being larger in amplitude than the first (reviewed in (Zucker 1989)).  
Minimal stimulation intensities were used to target a minimum number of synapses 
and occasionally only single synapses were stimulated. Analysis of the paired pulse 
ratio of two EPSCs evoked close together was used to assess whether single synapses 
could be stimulated in FMs   
Figure 5.5 shows the mean EPSCs evoked by paired stimuli (50 ms apart) in a FM 
voltage-clamped at –70 mV (including failures).  The amplitude of the first mean 
EPSC in this FM was –25 pA and the amplitude of the second EPSC was –39 pA 
(including failures, Figure 5.5A).  This represents a paired pulse ratio of 1.6 (mean 
amplitude of EPSC 2/mean amplitude of EPSC 1).  When t  EPSCs from this FM 
were averaged excluding the failures, the first EPSC was –37 pA in amplitude and 
the second EPSC was –36 pA (Figure 5.5B).  The lack of paired pulse facilitation 
when failures were excluded indicates that the EPSCs in this FM were generated by 
activation of a single synapse (Stevens and Wang 1995).  The EPSCs at this putative 
single synapse show amplitude fluctuations providing evidence supporting quantal 








































Figure 5.5.  Paired pulse facilitation at single synapses. 
A. Mean EPSCs (including failures) evoked by paired stimuli (50 ms apart) in a 
FM voltage-clamped at –70 mV.  Note that EPSC 2 is larger than EPSC 1.  
The arrow indicates the –160 pA level. 
B. Mean EPSCs from the same FM as A with failures excluded.  Note that now 
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Figure 5.6.  Paired pulse facilitation at multiple synapses. 
A. Mean EPSCs (including failures) evoked by paired stimuli (50 ms apart) in a 
FM voltage-clamped at –70 mV.  Note that EPSC 2 is larger than EPSC 1.  
The arrow indicates the –160 pA level. 
B.      Mean EPSCs from the same FM as A with failures excluded.  Note that      
          EPSC 2 is still much larger than EPSC 1.  The arrow indicates the –160 pA    
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Figure 5.6A demonstrates paired pulse facilitation in another FM voltage-clamped at 
-70 mV.  When failures were included the first EPSC was –27 pA in amplitude and 
the second was -73 pA representing a paired pulse ratio of 2.7.  When failures were 
excluded from the mean EPSC in this FM the amplitude of the first EPSC was -40 
pA and the amplitude of the second was -83 pA (Figure 5.6B).  The paired pulse 
ratio for this FM was now 2.1.  When mean EPSCs still how paired pulse 
facilitation when failures are excluded (as in this example) it is an indication that the 
EPSCs are generated by activation of multiple synapses (Stevens and Wang 1995). 
An alternative method for assessing the number of synapses activated was also 
applied to EPSCs evoked in FMs.  Cumulative amplitude histograms can be 
generated by plotting the number of EPSCs in each amplitude bin against amplitude.  
Clear peaks in these histograms are indicative of quantal amplitudes, however, the 
accuracy of this analysis method is dependent on having a large sample size.  As 
EPSCs were only evoked every 20 seconds in all recordings insufficient numbers of 
EPSCs were evoked during the recording period to enabl  accurate histograms to be 
generated. Figure 5.7 is a typical example of a cumulative probability histogram of 
EPSC amplitude from a representative FM.  Arrows indicate potential peaks in the 









Figure 5.7.  Probability histogram of evoked EPSC amplitude. 
In this example FM the distribution of individual equally spaced EPSC amplitudes 
suggests there are three peak amplitudes (indicated by arrows). This could potentially 
be interpreted as a result of activation of up to three synapses or quantal release from 



































Figure 5.8.  Effect of NBQX, AP-5 and removing external Mg 2+ on EPSC 
amplitude in FMs. 
A. Representative mean EPSCs obtained from a FM voltage-clamped at -70 mV 
demonstrating that the mean EPSC amplitude is reduced in the presence of 
NBQX (20 µM, grey) compared to control (black). 
B. Representative mean EPSCs obtained from the sameFM voltage-clamped at -
70 mV demonstrating that in the presence of NBQX (20 µM), removal of 
external Mg2+ reveals an EPSC.  The amplitude of this EPSC is reduc d in the 






NBQX (20 µM) 
B. AP-5 (50 µM) 
Mg2+ free  
NBQX (20 µM) 
Mg2+ free  
NBQX (20 µM) 
 157 
5.3 Receptors mediating excitatory synaptic transmission  
5.3.1 Glutamatergic receptor contribution to EPSCs 
The nature of the neurotransmitter and receptors involved in generating EPSCs in 
FMs was investigated using pharmacological and physiological techniques.  Figure 
5.8A demonstrates that the mean EPSC amplitude froma representative FM was 
reduced following application of the AMPA/kainate glutamate receptor antagonist, 
NBQX (20 µM) (Sheardown, Nielsen et al. 1990).  In this example, NBQX (20 µM), 
reduced the mean EPSC amplitude from -122 pA to -17 pA (response to a minimum 
of 10 stimuli was recorded under each condition).  NBQX inhibited the EPSC 
amplitude in every FM tested and amplitude of the mean EPSC from 12 FMs was 
reduced from –80 ± 8 pA to -12 ± 2 pA in the presence of NBQX (20 µM, n = 12, P 
< 0.0001, paired t test, Figure 5.9).  This represents a significant reduction in EPSC 
amplitude to 16 ± 3 % of control (n = 12, P < 0.0001, one sample t test).   
NMDA glutamate receptors are blocked by Mg2+ at hyperpolarised potentials so in 
order to determine whether they contribute to EPSCs in FMs the Mg2+ block had to 
be removed (Nowak, Bregestovski et al. 1984).  After observing a reduction in EPSC 
amplitude by NBQX (20 µM), the external solution was switched to Mg2+-free ACSF 
(also containing NBQX, 20 µM).  As the Mg2+ concentration in the bath solution was 
lowered an EPSC was revealed.  In the example shown in Figure 5.8B, the low 
concentration of external Mg2+ allowed an EPSC with a mean amplitude of -54 pA 
(average of 17 traces including failures) to be reco ded.  The mean EPSC amplitude 
from a representative sample of FMs under these conditi s was significantly 



































Figure 5.9.  Summary of effect of NBQX, AP-5 and removing external Mg2+ on 
EPSC amplitude. 
NBQX (20 µM) significantly reduces the mean EPSC amplitude compared to control 
(n = 12, *** P < 0.001).  Removal of external Mg2+ reveals an EPSC which is 
significantly reduced in the presence of AP-5 (50 µM, n = 6, P = 0.03).  A minimum 
of 10 EPSCs were obtained from each FM under each condition and statistical 
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The mean rise and decay times of this EPSC were 3.0 ± 1.7 and 17.9 ± 13.9 ms, 
respectively (n = 6).  This increase in the rise time of the EPSC (compared to 1.6 ± 
0.8 ms for the control EPSC) was consistent with a contribution of NMDA receptors 
(Mayer, Westbrook et al. 1984).  In order to confirm that these EPSCs were mediated 
by NMDA glutamate receptor activation their sensitivity to the NMDA glutamate 
receptor antagonist, AP-5, was tested (Olverman, Jones et al. 1984).  As 
demonstrated in Figure 5.8B, bath-application of AP-5 (50 µM) reduced the mean 
EPSC in this FM to –25 pA. The mean EPSC amplitude from the sample FMs was 
significantly reduced to –20 ± 5 pA (n = 4, P = 0.03, paired t test, Figure 5.9).  Thus 
in the presence of NBQX and low external Mg2+, application of AP-5 (50 µM) 
significantly reduced the mean EPSC amplitude to 39 ± 9 % of control (n = 4, P = 
0.0067, one sample t test).   
An alternative method used for removing the voltage-dependent Mg2+ block of 
NMDA glutamate receptors was to voltage-clamp the FM at a depolarised potential.  
Figure 5.10A shows the block of non-NMDA glutamate receptor-mediated EPSCs by 
NBQX (20 µM) at –70 mV, as described earlier.  In the continued presence of 
NBQX (20 µM), the FM was depolarised to +20 mV. This removes the voltage-
dependent Mg2+ block of NMDA receptors and reveals EPSCs which were observed 
as outward currents.  Figure 5.10B shows the mean EPSC from a representative FM 
under these conditions and the amplitude of this EPSC is +112 pA.  Individual 
EPSCs from this FM are shown in Figure 5.10C.  The mean EPSC amplitude at +20 
































Figure 5.10.  Effect of depolarizing FM on EPSC amplitude in the presence of 
NBQX. 
A. Representative mean EPSCs obtained from a FM voltage-clamped at -70 mV in 
the presence (grey) and absence of NBQX (20 µM, black) demonstrating that 
AMPA/kainate glutamate receptor-mediated responses ar  blocked.  The arrow 
represents the -150 pA level.   
B. Mean EPSC obtained from the same FM voltage-clamped at +20 mV, 
demonstrating that in the continued presence of NBQX (20 µM) removal of the 
voltage-dependent Mg2+ block reveals an EPSC.  The arrow represents the 700 
pA level.   
C.  Representative EPSCs obtained from the same FM voltage-clamped at +20 
mV, demonstrating that in the continued presence of NBQX (20 µM) removal 
of the voltage-dependent Mg2+ block reveals EPSCs that fluctuate in amplitude.  













In the example shown in Figure 5.10 the non-NMDA comp nent is not entirely 
blocked by NBQX, therefore the EPSC at +20mV may be partially mediated by non-
NMDA receptor activation. 
5.3.2 Identification of glutamate receptor subunits 
Having identified an AMPA/kainate and NMDA glutamate receptor contribution to 
EPSCs in FMs, the receptor subtypes involved were further investigated.  The lack of 
subtype selective AMPA or kainate glutamate receptor antagonists prevented the use 
of a pharmacological approach to determine which subtypes contribute to EPSCs in 
FMs, however, it has been established that the I/V relationship of GluR2-lacking 
AMPA receptors show a high degree of inward rectification (Sato, Kiyama et al. 
1993).  Figure 5.11A shows a control EPSC recorded from a FM voltage-clamped at 
+40 mV.  In this example, bath application of AP-5 (100 µM) reduced the EPSC 
amplitude from +234 pA to +97 pA, representing a reduction by 59 %.  The mean 
EPSC amplitude recorded at +40 mV was +142 ± 38 pA and this was reduced to +73 
± 25 pA following application of AP-5 (100 µM, n = 4).  Having blocked NMDA 
glutamate receptors with AP-5 (100 µM), I/V relationships of EPSC amplitude were 
generated from a minimum of 10 EPSCs (with failures omitted) for each potential (n 
= 4, Figure 5.11B).  This I/V relationship had a reversal potential of –17 ± 4 mV (n = 
4-7) and was found to show outward rectification (ratio of 2.0, see Methods) 




































Figure 5.11.  Current-voltage relationship of mean EPSC amplitude in FMs in 
the presence of AP-5. 
A. Traces from a representative FM demonstrating that t e amplitude of the mean 
EPSC at +40 mV is reduced in the presence of AP-5 (100µM, grey) compared 
to control (black). 
B. I/V relationship in the presence of AP-5 (100 µM) generated from the mean 
EPSC amplitude (without failures) at each potential (n = 4 FMs, with an 




















Ifenprodil is an NMDA glutamate receptor antagonist that has approximately 400-
fold higher affinity for NR1A/NR2B than NR1A/NR2A receptors in Xenopus 
oocytes (Williams 1993).  Ifenprodil was used to assess the contribution of 
NR1A/NR2B receptors to EPSCs in FMs.  Figure 5.12A shows a control mean EPSC 
recorded from a FM voltage-clamped at –70 mV and the mean EPSC in the presence 
of NBQX (20 µM).  In the example shown NBQX (20 µM) causes a reduction in 
EPSC amplitude from –58 pA to –28 pA, a reduction of 52 %.  The mean control 
EPSC amplitude from 5 representative FMs at –70 mV was –48 ± 6 pA and this was 
reduced to –12 ± 6 pA in the presence of NBQX (20 µM, P = 0.0014, n = 5, paired t 
test).  This represents a significant reduction by 76 ± 10 % (P = 0.0015, n = 5, one 
sample t test).   
Having blocked AMPA/kainate glutamate receptors with NBQX (20 µM), Mg2+-free 
ACSF was applied to remove the Mg2+ block of NMDA glutamate receptors.  In the 
FM shown in Figure 5.12B, removal of external Mg2+ revealed an EPSC with an 
amplitude of –47 pA which was reduced to –19 pA in the presence of ifenprodil (10 
µM).  The mean EPSC amplitude recorded in Mg2+-free external solution, in the 
presence of NBQX (20 µM) at –70 mV was significantly increased to –30 ± 5pA  (P 
= 0.0057, n =5, paired t test).  This was reduced to –12 ± 3 pA in the presence of 
ifenprodil (10 µM), representing a significant reduction in EPSC amplitude by 57 ± 8 
% (P = 0.0022, n = 5, one sample t test).  These data indicate that NR1A/NR2B 




































Figure 5.12.  Effect of ifenprodil on EPSC amplitude in FMs in Mg2+-free ACSF 
and in the presence of NBQX. 
A. Representative mean EPSCs obtained from a FM voltage-clamped at -70 mV 
demonstrating that the mean EPSC amplitude is reduced in the presence of 
NBQX (20 µM, grey) compared to control (black).  The arrow indicates the –
120 pA level. 
B. Representative mean EPSCs obtained from the sameFM voltage-clamped at -
70 mV demonstrating that in the presence of NBQX (20 µM), removal of 
external Mg2+ reveals an EPSC.  The amplitude of this EPSC is reduc d in the 
presence of ifenprodil (10 µM, grey) compared to control (black). The arrow 
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5.4 Discussion 
5.4.1  Excitatory synaptic transmission in the facial nucleus 
Stimulation close to the dendrites of a FM voltage-clamped at -70 mV evoked inward 
currents with fast kinetics consistent with activation of postsynaptic glutamatergic 
receptors and previous findings that glutamate has excitatory actions on FMs 
(VanderMaelen and Aghajanian 1980).   It was also possible to evoke EPSPs when 
the FM was held in the current-clamp configuration, however, the subsequent 
characterisation of these synapses was performed in the voltage-clamp configuration. 
5.4.2 Number of release sites activated 
Stimulation evoked EPSCs that showed amplitude fluctuations and whether these 
fluctuations occurred as a result of quantal release t one synapse or activation of 
multiple synapses was investigated further.  EPSCs in FMs were evoked by a 
stimulation paradigm based on minimal stimulation (Raastad, Storm et al. 1992).  
The original criteria for minimal stimulation was that release failed at a rate of 
approximately 50 % and that the EPSC amplitude remained constant at a range of 
stimulus intensities (until it was increased over the threshold for minimal 
stimulation), however, this has been modified so that e stimulus intensity applied 
results in the lowest possible failure rate without a subsequent increase in mean 
EPSC amplitude above that observed with a 50 % failure rate (Raastad, Storm et al. 
1992; Lawrence, Grinspan et al. 2004).  In FMs the stimulus intensity was 
determined by first identifying a functional synapse with a relatively high stimulus, 
the stimulus was then turned to its lowest setting a d gradually increased until an 
 166 
EPSC was observed.  The stimulus intensity was then increased until the failure rate 
was at its minimum (approximately 25 %) without observing an increase in the mean 
EPSC amplitude (Lawrence, Grinspan et al. 2004).  At these intensities EPSCs were 
evoked with discrete amplitude reminiscent of quantal release at the neuromuscular 
junction and some central synapses (for reviews see (Kuno 1971; Tremblay, Laurie 
et al. 1983)).  Traditionally, cumulative probability histograms of EPSC amplitude 
would be generated to analyse whether quantal releas  from a single release site (or 
several identical sites) is occurring or whether release is from several sites with 
different quantal contents.  However, in the experim nts described here the 
stimulation was only applied once every 20 seconds to ensure no synaptic plasticity 
occurred and the cumulative probability histograms generated from the number of 
events recorded could not be used to reliably predict the number of release sites.   
Paired pulse analysis can be a useful tool in determining whether minimal 
stimulation is only activating one synapse if the assumption is made that each 
synapse has only a single release site (Stevens and W g 1995).  At a single synapse 
paired pulse facilitation of mean EPSCs occurs as aresult of release probability of 
the second stimulation being greater than the first (thought to be due to the residual 
Ca2+ in the terminal).  As the same amount of neurotransmitter is release following 
both these stimuli the lower mean amplitude of the first EPSC is only due to the 
higher failure rate.  Thus, at a single synapse, removal of failures results in the first 
and second mean EPSCs being of equal amplitude (Stevens and Wang 1995).  If 
multiple synapses are being stimulated then the amplitude of the second pulse (even 
in the absence of failures) will be greater than the first.  This occurs as a result of the 
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probability of release following the second pulse being high (due to the residual 
Ca2+) in a larger proportion of the synapses (Stevens and Wang 1995). 
In the FMs tested, some demonstrated the paired pulse properties of single synapses 
whereas in others more than one synapse was clearly being stimulated.  Identical 
stimulation paradigms were used in all FMs suggesting that where multiple synapse 
involvement was demonstrated it is likely that only a few synapses would be 
activated. 
The EPSCs recorded at the single synapses identified by paired pulse analysis 
showed amplitude fluctations providing evidence supporting the release of multiple 
quanta at a single central synapse (Sastry and Bhagavatula 1996; Auger and Marty 
2000; Stevens 2003). 
5.4.3  AMPA/kainate receptors contribute to EPSCs 
Control EPSCs were sensitive to block by NBQX indicating a role for non-NMDA 
glutamate receptors in fast excitatory synaptic transmission in FMs.  Several non-
NMDA antagonists have affinity for both kainate and AMPA glutamate receptors 
and cannot be used to distinguish between the two types of receptors.  NBQX is 
more potent at AMPA receptors (IC50 = 0.15 µM assessed by rat cortical membrane 
radioligand binding assays) than at kainate receptors (IC50 = 4.8 µM) (Sheardown, 
Nielsen et al. 1990), however, at the concentration used in these experiments (20 
µM) it is likely that kainate receptors would also be significantly blocked and could 
also contribute to EPSC in FMs. 
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5.4.4 GluR2 receptor contribution to EPSCs 
GluR2 receptors are the most abundantly expressed AMPA glutamate receptors and 
are highly expressed in all cranial motonuclei (Martin, Blackstone et al. 1993). The 
lack of inward rectification of the I/V relationship obtained in the presence of AP-5 
(to block the NMDA receptor contribution) indicates that receptors containing the 
edited form of the GluR2 receptor subunit contribute to EPSCs in FMs (Sato, 
Kiyama et al. 1993).  However, the inward rectification of non-GluR2 containing 
AMPA glutamate receptors is dependent on a block by intracellular polyamines 
(such as spermine and spermidine) (Donevan and Rogawski 1995).  As polyamines 
were not added to the intracellular solution, the dialysis of intracellular polyamines 
during whole cell recordings cannot be ruled out as a factor in the lack of inward 
rectification. 
5.4.5 NMDA receptors are present in FMs 
The contribution of NMDA receptors to EPSCs in FMs was investigated.  NMDA 
receptors are blocked by extracellular Mg2+ at typical resting membrane potentials 
(and more hyperpolarised potentials).  When Mg2+ was removed from the ACSF or 
the FM was voltage-clamped at depolarised potentials, the Mg2+ block was reduced 
and an EPSC was revealed.  This EPSC was sensitive to block by the selective 
NMDA receptor antagonist, AP-5.  Activation of non-NMDA receptors can 
depolarise the postsynaptic membrane sufficiently to remove the Mg2+ block of 
NMDA receptors in vivo and the data obtained here indicates the presence of NMDA 
receptors at all the synapses tested.  Both NMDA and non-NMDA glutamate 
receptor subtypes are expressed in FMs and the data provided here further supports 
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the involvement of both NMDA and non-NMDA receptors at excitatory synapses in 
the FMN.   
NMDA and non-NMDA glutamate receptor activation is involved in the majority of 
fast excitatory synaptic transmission in the mammalian CNS and has been shown to 
mediate synaptic transmission in several motor nuclei (reviewed in (Rekling, Funk et 
al. 2000)).  NMDA and non-NMDA glutamate receptors have been shown to co-
localise at synapses in hypoglossal motoneurones (O'Brien, Isaacson et al. 1997).  
However, one characterisation of glutamatergic inputs into hypoglossal 
motoneurones concluded that only non-NMDA glutamate receptors mediate EPSCs 
in these cells (Bouryi and Lewis 2003).  It is worth noting that the contribution of 
NMDA receptors was only assessed in motoneurones voltage-clamped at –70 mV 
(Bouryi and Lewis 2003).  At this potential NMDA glutamate receptors would be 
blocked by extracellular Mg2+, therefore AP-5 would not be expected to reduce the 
EPSC amplitude.   
5.4.6 NR2B receptor contribution to EPSCs 
The NMDA glutamate receptor mediated EPSC in FMs wa p rtially blocked by 
ifenprodil.  Ifenprodil has 400-fold higher affinity for NR1/NR2B receptors over 
NR1/NR2A receptors and at the concentration used here (1 µM) selectively blocks 
NR2B containing receptors (Reynolds and Miller 1989; Williams 1993).  The 
presence of NR1/NR2B receptors in neonatal rat FM is consistent with the 
developmental pattern of NMDA receptors (Wenzel, Fritschy et al. 1997).  In 
neonatal rats the predominant NMDA receptor subunits are NR1, NR2B and to a 
lesser extent, NR2D (Wenzel, Fritschy et al. 1997).  In juvenile and adult rat 
 170 
brainstem the predominant subunits are NR1, NR2A and NR2D (Wenzel, Fritschy et 
al. 1997).  The data presented here confirms the contribution of NR2B subunits and it 
is proposed that the residual current that is not blocked by ifenprodil is mediated by 
NR1/NR2D receptors.  A developmental change in NMDA glutamate receptor 
composition is also demonstrated in the trigeminal motor nucleus where the number 
of NR2B expressing neurones decreases between postnatal days 3-4 and 11, 
however, NR2D expression was not assessed in this nucleus (Turman JE 2002). 
5.5 Concluding statement 
This chapter provides a characterisation of excitatory synaptic transmission in 
neonatal rat FMs, the nature of which was previously nknown.  Transmission at the 
synapses tested involved the activation of both non-NMDA and NMDA glutamate 
receptors.  In addition, the minimal stimulation protocol utilised in this chapter 
enabled both single and multiple synapses to be record d and identified using paired 
pulse analysis.  The findings of this chapter will assist the interpretation of 





6.1.1 Effects of 5-HT on synaptic transmission 
5-HT is generally accepted to promote FM excitability through postsynaptic actions 
and Chapters 3 and 4 of this thesis investigate the mechanisms underlying this 
excitability and the receptors that mediate these effects of 5-HT (VanderMaelen and 
Aghajanian 1980; Vandermaelen and Aghajanian 1982; Larkman, Penington et al. 
1989).  However, the effect of 5-HT on fast excitatory synaptic transmission has not 
previously been investigated.  Pre-synaptic effects of 5-HT are the focus of this 
chapter. 
6.1.2 Direct inhibitory effect of 5-HT 
The inhibitory actions of 5-HT are mediated by activation members of the 5-HT1 
subfamily (5-HT1A,B,D,E and F).  The 5-HT1 receptors are negatively coupled to 
adenylate cyclase through Gi proteins, however, it has become apparent that the 
hyperpolarisation induced by 5-HT1A receptor activation in central neurones involves 
a direct action of Gβγ subunits on inwardly rectifying potassium (K+) channels 
(Andrade, Malenka et al. 1986; Colino and Halliwell 1987).   
6.1.3 Inhibition of neurotransmitter release by 5-HT 
In addition to a postsynaptic hyperpolarisation, several 5-HT1 receptor subtypes 
can also modulate neurotransmitter release through presynaptic mechanisms.  5-
HT1A, 5-HT1B and 5-HT1D presynaptic autoreceptors have been shown to inhibit t e 
release of 5-HT from the nerve terminal (Barnes and Sharp 1999).   
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Some regions which have high levels of 5-HT1B binding sites do not express 5-HT1B 
receptor mRNA (such as the substanita nigra and globus pallidus) suggesting that the 
receptors are located presynaptically in these regions and function as heteroreceptors 
to modulate release of other neurotransmitters from the nerve terminal (Bruinvels, 
Landwehrmeyer et al. 1994; Barnes and Sharp 1999).  Indeed, 5-HT1B 
heteroreceptors inhibit glutamate release from the pr synaptic terminal in the 
subiculum, cingulate cortex and hypoglossal motor nucleus (Bobker and Williams 
1989; Tanaka and North 1993; Boeijinga and Boddeke 1996; Bouryi and Lewis 
2003). 
The identification of 5-HT1A receptor mRNA in the facial nucleus and the evidence 
for functional 5-HT1A and 5-HT1B heteroreceptors in the hypoglossal motor nucleus 
prompted an investigation into the role of these receptor subtypes in the inhibitory 
actions of 5-HT in the facial nucleus using subtype selective agonists and antagonists 
(Pompeiano, Palacios et al. 1992; Bouryi and Lewis 2003).   
6.1.3 Aims  
The aim of this chapter was to investigate the effect of 5-HT on synaptic 
transmission.  The initial experiments revealed that 5-HT application resulted in a 
decrease in the mean evoked EPSC amplitude.  This in ibitory action of 5-HT was in 
contrast to the known excitatory postsynaptic actions f 5-HT on FMs (see Chapters 
3 and 4) and was therefore investigated further.  A pharmacological approach was 
used to determine that 5-HT1B receptors mediate this inhibitory action of 5-HT and 
analysis of the failure rate, paired pulse ratio and frequency of spontaneous release 
was used to determined that this action occurs presynaptically.  Thus it was 
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determined that 5-HT reduces glutamate release from the presynaptic terminal 
through activation of 5-HT1B receptors. 
6.2 Results 
6.2.1 5-HT reduces EPSC amplitude  
Application of 5-HT (10 µM) reduced the mean EPSC amplitude in a representative 
FM from –31 pA to –4 pA (Figure 6.1).  This reduction in EPSC amplitude was 
coupled with a change in the holding current of –73pA mediated by the postsynaptic 
effects of 5-HT (Chapter 3 and 4).  The mean control EPSC from a sample of 16 
FMs was –40 ± 5 pA and this was reduced to –13 ± 2 pA in the presence of 5-HT (10 
µM).  This represents a significant reduction to 36 ± 7 % of the control (n = 16, P < 
0.0001, one sample t test, Figure 6.4).  The average inward current evok d by 5-HT 
(10 µM) in these FMs was –117 ± 20 pA (n = 16).  In the majority of neurones tested 
this inhibition of EPSC amplitude by 5-HT was reversible and further 
pharmacological experiments were only performed on FMs in which the EPSC fully 































Figure 6.1.  5-HT reduces EPSC amplitude in facial motoneurones. 
A. Mean control EPSC (average of 18 EPSCs including failures) from a facial 
motoneuron voltage-clamped at –70 mV.  The arrow indicates the –130 pA 
level. 
B. Mean EPSC (average of 24 EPSCs including failures), demonstrating that 5-
HT (10 µM) reduces the mean EPSC amplitude compared to control (A).  The 
















6.2.2 5-HT receptor subtypes mediating reduction in EPSC amplitude  
The 5-HT receptor subtype that mediates the reduction in EPSC amplitude was 
investigated using receptor subtype selective agonists and antagonists.  The 5-HT1A 
and 5-HT1B receptors were focussed on due to their inhibitory nature and the finding 
that activation of these receptors mediates a reduction in EPSC amplitude in rat 
hypoglossal motoneurones (Bouryi and Lewis 2003).  
6.2.3 Subtype selective 5-HT1B receptor agonist reduces EPSC 
amplitude  
In a FM in which 5-HT (10 µM) reduced the mean EPSC amplitude from –34 pA to 
–7 pA (reduced to 21 % of control), bath-application of the 5-HT1B receptor selective 
agonist, CP93129 (10 µM) (Macor, Burkhart et al. 1990), reduced the EPSC 
amplitude from –34 pA to –9 pA (reduced to 26 % of cntrol, Figure 6.2).  In a 
sample group of FMs CP93129 (10 µM) application resulted in a reduction in EPSC 
amplitude from –22 ± 5 pA to –4 ± 2 pA (n = 6).  This represents a significant 
reduction to 20 ± 6 % of the control (n = 6, P < 0.0001, one sample t test, Figure 6.4).  
In the same FMs the mean control EPSC was –30 ± 17 pA and this was reduced to –
16 ± 9 pA in the presence of 5-HT (10 µM), representing a significant reduction to 
33 ± 9 % of control (n = 6, P = 0.017, one sample t t st).  The reduction in EPSC 
amplitude by CP93129 (10 µM) was not significantly different to the reduction i  
amplitude observed following 5-HT (10 µM) application (P = 0.27, unpaired t test).  
Partial recovery (to 44 ± 15 % of control EPSC amplitude) was observed in 4 of the 
neurones tested, however this may have been increased if a longer period of wash out 





































Figure 6.2.  CP93129 reduces EPSC amplitude in facil motoneurones. 
A. Mean control EPSC (average of 10 EPSCs including failures) from a FM 
voltage-clamped at –70 mV.  The arrow indicates the –120 pA level. 
B. Mean EPSC (average of 10 EPSCs including failures) d monstrating that the 
5-HT1B receptor agonist, CP93129 (10 µM), reduces the mean EPSC amplitude 











As expected the reduction in EPSC amplitude observed in the presence of CP93129 
(10 µM) was not coupled with a large postsynaptic inward current (-7 ± 16 pA, n = 
6), whereas 5-HT (10 µM) evoked an inward current of –107 ± 19 pA in the same 
FMs (n = 6, P = 0.0076, paired t test). 
Application of the 5-HT1A receptor selective agonist, 8-OH-DPAT (10 µM) 
(Arvidsson, Hacksell et al. 1981; Peroutka 1985), had no effect of EPSC amplitude 
in the FM shown in Figure 6.3 (-23 pA and –24 pA in absence and presence of 8-
OH-DPAT, respectfully).  In the same FM, 5-HT (10 µM) reduced the EPSC 
amplitude from –44 pA to –13 pA (reduced to 30 % of c ntrol).  In a sample group 
of FMs 8-OH-DPAT (10 µM) caused only a very small reduction in EPSC amplitude 
from –25 ± 1 pA to –21 ± 2 pA (n = 3).  This represents a non-significant reduction 
to 85 ± 9 % of the control (n = 3, P = 0.23, one sample t test, Figure 6.4).  In the 
same FMs the mean control EPSC was –47 ± 10 pA and this was reduced to –16 ± 8 
pA in the presence of 5-HT (10 µM), representing a significant reduction to 30 ± 11 
% of control (n = 3, P = 0.02, one sample t t st).  The reduction in EPSC amplitude 
mediated by 5-HT was significantly greater than that observed following 8-OH-
DPAT application (n = 3, P = 0.018, paired t test).  In addition, 8-OH-DPAT (10 µM) 
did not evoke a large inward current (-10 ± 22 pA, n = 3), whereas 5-HT (10 µM) 
evoked an inward current of –77 ± 42 pA in the same FMs.  The 5-HT1B receptor 
agonist, CP93129 (10 µM), but not the 5-HT1A receptor agonist, 8-OH-DPAT (10 


























Figure 6.3.  8-OH-DPAT does not affect EPSC amplitude in facial 
motoneurones. 
A. Mean control EPSC (average of 10 EPSCs including failures) from a FM 
voltage-clamped at –70 mV.  The arrow indicates the –70 pA level. 
B. Mean EPSC (average of 10 EPSCs including failures) d monstrating that the 
5-HT1A receptor agonist, 8-OH-DPAT (10 µM), has no effect on the mean 












































Figure 6.4.  Summary of effects of 5-HT1 receptor selective agonists on EPSC 
amplitude. 
Bar chart summarising the reduction in EPSC amplitude in the presence of 5-HT (10 
µM, n = 16), the 5-HT1B selective agonist, CP93129 (10 µM, n = 6) and the 5-HT1A 
selective agonist, 8-OH-DPAT (10 µM, n =3).  A minimum of 10 EPSCs were 
obtained from each FM under control conditions and in the presence of the agonist.  






























6.2.4 Subtype selective 5-HT1B receptor antagonist blocks reduction in  
EPSC amplitude 
Figure 6.5 demonstrates the effects of the 5-HT1B receptor antagonist, isamoltane (1 
µM) (Waldmeier, Williams et al. 1988).  In an example FM voltage-clamped at –70 
mV, 5-HT (10 µM) reduced the mean EPSC amplitude from –66 pA to –24 pA under 
control conditions, corresponding to a reduction to 36 % of control.  Following 
incubation with isamoltane (1 µM), co-application of 5-HT (10 µM) with the 
antagonist reduced the ESPC from –34 pA to –26 pA.  This represents a reduction to 
only 76 % of control.  In a representative group of FMs, 5-HT (10 µM) reduced the 
EPSC amplitude from –41 ± 11 pA to –14 ± 4 pA (n = 5). Thus, in these FMs, 5-HT 
(10 µM) causes a significant reduction in EPSC amplitude to 30 ± 10 % of control (n 
=5, P = 0.0023, one sample t test).  The mean EPSC following recovery from 5-HT 
was –38 ± 12 pA in amplitude and was not significantly altered by incubation with 
isamoltane (–33 ± 13 pA, n = 5, P = 0.24, paired t test).  In the continued presence of 
the antagonist, 5-HT (10 µM) reduced the EPSC amplitude from –33 ± 13 pA to –20
± 7 pA (n = 5).  This represents a reduction in EPSC amplitude to 64 ± 10 % of 
control (n =5) and although this still represents a significant reduction by 5-HT (P = 
0.024, one sample t test), it is significantly less than the reduction observed under 

































Figure 6.5.  Isamoltane blocks the reduction in EPSC amplitude by 5-HT in 
facial motoneurones. 
A. Mean EPSC (average of 10 EPSCs including failures) in the presence of the 5-
HT1B receptor antagonist, isamoltane (1 µM) from a FM voltage-clamped at –
70 mV.  The arrow indicates the –300 pA level. 
B. Mean EPSC (average of 12 EPSCs including failures) in the presence of 
isamoltane (1 µM) and 5-HT (10 µM) from the same motoneurone as (A).  
Note that the arrow indicates the –400 pA level so the inward current evoked 
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In the presence of isamoltane (1 µM), 5-HT (10 µM) evoked a postsynaptic inward 
current of -71 ± 14 pA which was not significantly different from the inward current 
of -77 ± 26 pA evoked by 5-HT under control conditions (n = 5, P = 0.57, paired t 
test).   
Figure 6.6 demonstrates the lack of effect of the 5-HT1A receptor antagonist, WAY 
100635 (1 µM) (Critchley, Childs et al. 1994).  In an example FM voltage-clamped 
at –70 mV, 5-HT (10 µM) reduced the mean EPSC amplitude from –28 pA to –10 
pA under control conditions, corresponding to a reduction to 36 % of control.  
Following incubation with WAY 100635 (1 µM), co-application of 5-HT (10 µM) 
with the antagonist reduced the ESPC from –22 pA to –4 pA.  This represents a 
reduction to 18 % of control, which is similar to the control response.  In a sample 
group of FMs, 5-HT (10 µM) reduced the EPSC amplitude from –31 ± 5 pA to –9 ± 
0.4 pA (n = 3).  Thus, in these FMs, 5-HT (10 µM) causes a significant reduction in 
EPSC amplitude to 31 ± 5 % of control (n =3, P = 0.0046, one sample t test).  The 
same group of FMs were then incubated with WAY 100635 (1 µM), following which 
5-HT (10 µM) was co-applied with the antagonist.  The mean EPSC amplitude 
before and after incubation with WAY 100635 (1 µM) was –24 ± 4 pA and –18 ± 2 
pA, respectively (n = 3, not significantly different, P = 0.20, paired t test).  In the 
presence of WAY 100635 (1 µM) 5-HT (10 µM) reduced the EPSC to –4 ± 2 pA (n 
= 3).  This represents a significant reduction in EPSC amplitude to 20 ± 8 % of 
control (n = 3, P = 0.0092, one sample t t st) which is also not significantly different 
to the reduction observed under control conditions (n = 3, P = 0.14, paired t test, 

































Figure 6.6.  WAY 100635 has no effect on the reduction in EPSC amplitude by 
5-HT in facial motoneurones. 
A. Mean EPSC (average of 10 EPSCs including failures) in the presence of the 5-
HT1A receptor antagonist, WAY 100635 (1 µM), from a FM voltage-clamped 
at –70 mV.  The arrow indicates the –40 pA level. 
B. Mean EPSC (average of 12 EPSCs including failures) in the presence of WAY 
100635 (1 µM) and 5-HT (10 µM) from the same motoneurone as (A).  Note 
that the arrow indicates the –140 pA level so the inward current evoked by 5-
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Under control conditions 5-HT (10 µM) evoked a postsynaptic inward current of -
102 ± 8 pA which was not significantly different from the inward current of -109 ± 
19 pA evoked by 5-HT in the presence of WAY 100635 (1 µM, n = 3, P = 0.81, 
paired t test). 
6.3 Mechanism for reduction in EPSC amplitude  
5-HT1B receptors can function as heteroceptors to modulate the release of glutamate 
from the presynaptic terminal, however 5-HT1B receptors can also act at the 
postsynaptic membrane (Bobker and Williams 1989; Boeijinga and Boddeke 1993; 
Boeijinga and Boddeke 1996).  The finding that the 5-HT1B agonist does not evoke 
any postsynaptic responses suggests the receptor mediates its effect through 
presynaptic mechanism and this possible location of 5-HT1B receptors in the FMN 
was investigated using three different techniques.   
6.3.1 Activation of 5-HT1B receptors increases failure rate  
Analysis of the rate of failure to generate an EPSC in response to minimal 
stimulation under control conditions and in the presence of 5-HT receptor agonists 
was performed.  The response to a minimum of ten stimuli were obtained from each 
FM under control conditions and in the presence of ach agonist.  In the absence of 
5-HT, stimulation failed to produce an EPSC at a rate of 25 ± 5 % in each neurone (n 
= 18, Figure 6.7).  In the presence of 5-HT (10 µM) this failure rate was significantly 
increased to 65 ± 7 % (n = 16, P < 0.0001, unpaired t t st, Figure 6.7).  Similarly, 






























Figure 6.7.  Summary of effects of 5-HT1 receptor selective agonists on EPSC 
failure rate. 
Bar chart summarising the rate of failure to evoke an EPSC under control conditions 
and in the presence of 5-HT (10 µM, n = 16), the 5-HT1B selective agonist, CP93129 
(10 µM, n = 6) and the 5-HT1A selective agonist, 8-OH-DPAT (10 µM, n =3).  
Minimums of 10 stimuli were applied to each FM under control conditions or in the 
presence of the agonists.  The failure rates in the presence of 5-HT (10 µM) and 
CP93129 (10 µM) were significantly higher than under control conditions.  Statistical 

























(10 µM), the failure rate was significantly increased to 92 ± 6 % (n = 6, P < 0.0001, 
unpaired t test, Figure 6.7).   
The increase in failure rate mediated by CP93129 was not significantly different 
from the increase in failures observed following 5-HT application (P = 0.07, 
unpaired t test).  In contrast the 5-HT1A receptor subtype selective agonist, 8-OH-
DPAT (10 µM), did not significantly increase the failure rate (39 ± 3 %, n = 3, P = 
0.23, unpaired t test, Figure 6.7).  
6.3.2 5-HT1B receptor activation changes the paired pulse ratio  
The ratio between two EPSCs evoked close together can also provide insight into 
whether modulation of the EPSC is due to a pre- or p st-synaptic effect.  As 
described in Chapter 5 when two EPSCs are evoked 50 ms apart in FMs, the second 
EPSC is larger in amplitude than the first (termed paired pulse facilitation).  The ratio 
between the amplitude of these two EPSCs is the paired pulse ratio (ppr = EPSC 
2/EPSC 1).  It is widely accepted that changes in the paired pulse ratio are indicative 
of a presynaptic mechanism (Stuart and Redman 1991). The effect of 5-HT on the 
ppr for glutamatergic EPSCs in FMs was investigated.   Figure 6.8A shows the mean 
control EPSC (with failures) recorded from a representative FM voltage-clamped at –
70 mV.  The paired pulse ratio under these conditions was 1.6.  Figure 6.8A also 
demonstrates that application of 5-HT reduces the mean amplitude of both EPSCs.  
Under control conditions the amplitude of EPSC 1 was -33 pA and in the presence of 
5-HT (10 µM) it was reduced to –5 pA (a reduction to 15 % of cntrol).  The 
amplitude of EPSC 2 was -52 pA and was reduced to –15 pA in the presence of 5-HT 
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Figure 6.8.  Effect of 5-HT on paired pulse ratio in facial motoneurones. 
A. Mean EPSCs (minimum of 10 EPSCs with failures) recorded from a facial 
motoneuron voltage-clamped at –70 mV under control conditions (black) 
demonstrating that when two stimuli are evoked close together (50 ms apart) 
the second mean EPSC is larger in amplitude than the first.  In the presence of 
5-HT (10 µM, grey) both mean EPSCs are reduced in amplitude, however the 
paired pulse ratio (ppr) is increased.  The arrow indicates the –140 pA level. 
B. Identical mean EPSCs as (A) except that the trace obtained in the presence of 
5-HT (10 µM, grey) has been scaled up so that the first EPSCs under each 
condition are equal in amplitude.  Note that the second EPSC is relatively 
larger in the presence of 5-HT.  The arrow indicates the –120 pA level for the 
control response.  The baseline for the scaled 5-HT response has been 
compensated for comparison. 
C. Identical mean EPSCs as (A) except that the trace obtained in the presence of 
5-HT (10 µM, grey) has been scaled up so that the second EPSCs under each 
condition are equal in amplitude.  Note that the first EPSC is relatively smaller 
in the presence of 5-HT.  The arrow indicates the –120 pA level for the control 













In the presence of 5-HT (10 µM) the paired pulse ratio was increased to 3.0.  This 
was coupled with an inward current of –58 pA due to the previously characterized 
postsynaptic effects of 5-HT (Chapters 3 and 4).  In order to demonstrate this change 
in paired pulse ratio the amplitude of the 1st EPSC obtained in the presence of 5-HT 
was scaled up to the same amplitude as the 1st control EPSC.  Note that the holding 
current for the scaled up traces in the presence of 5-HT were compensated for so that 
they were approximately equal to the control holding current.  Figure 6.8B shows 
that when this was done the second mean EPSC in the pres nce of 5-HT is larger 
than control.  The scaled up traces also illustrate that 5-HT does not alter the kinetics 
of the EPSC.  Similarly, Figure 6.8C demonstrates that when the EPSCs in the 
presence of 5-HT (10 µM) are scaled up so that the second mean EPSCs are equal in 
amplitude, the first mean EPSC in the presence of 5-HT is smaller than control.  The 
mean paired pulse ratio under control conditions was 1.5 ± 0.1 and this was 
significantly increased to 2.3 ± 0.2 in the presence of 5-HT (10 µM, n = 8, P = 
0.0081, paired t test).  These data and Figure 6.8 demonstrate that application of 5-
HT (10 µM) changes the paired pulse ratio supporting the suggestion that 5-HT has a 
presynaptic action in the FMs tested.   
Figure 6.9A shows the mean EPSCs from another FM voltage-clamped at –70 mV.  
The paired pulse ratio under control conditions was 2.8.  As shown previously, 
application of the 5-HT1B receptor agonist, CP93129 (10 µM), reduces the mean 
amplitude of both EPSCs.  Under control conditions the amplitude of EPSC 1 was -
33 pA and in the presence of CP93129 (10 µM) it was reduced to –9 pA (a reduction 
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Figure 6.9.  Effect of CP93129 on paired pulse ratio in facial motoneurones. 
A. Mean EPSCs recorded from a facial motoneuron voltage-clamped at –70 mV 
under control conditions (black) demonstrating that when two stimuli are 
evoked close together (50 ms apart) the second mean EPSC is larger in 
amplitude than the first.  In the presence of CP9312  ( 0 µM, grey) both mean 
EPSCs are reduced in amplitude.  The arrow indicates th  –125 pA level. 
B. Identical mean EPSCs as (A) except that the trace obtained in the presence of 
CP93129 (10 µM, grey) has been scaled up so that the peak of the first EPSCs 
under each condition are equal in amplitude.  Note that the second EPSC is 
relatively larger in the presence of CP93129.  The arrow indicates the –100 pA 
level for the control response.  The baseline for the scaled CP93129 response 
has been compensated for comparison. 
C. Identical mean EPSCs as (A) except that the trace obtained in the presence of 
CP93129 (10 µM, grey) has been scaled up so that the second EPSCs under 
each condition are equal in amplitude.  Note that te first EPSC is relatively 
smaller in the presence of CP93129.  The arrow indicates the –100 pA level for 
the control response.  The baseline for the scaled CP93129 response has been 







The amplitude of EPSC 2 was -94 pA and was reduced to –47 pA in the presence of 
CP93129 (10 µM, a reduction to 50 % of control).  In the presence of 5-HT (10 µM) 
the paired pulse ratio was increased to 5.3.  CP93129 ( 0 µM) did not alter the 
holding current (-129 pA and –122 pA in the absence and presence of CP93129, 
respectively).  As for the 5-HT response, the traces obtained in the presence of 
CP93129 (10 µM) were scaled up so that the mean EPSCs were equalin amplitude.  
Figure 6.9B demonstrates that when the EPSCs in the presence of CP93129 (10 µM) 
are scaled up so that the first mean EPSCs are equal in amplitude, the second mean 
EPSC in the presence of CP93129 is larger than control.  Similarly, Figure 6.9C 
demonstrates that when the EPSCs in the presence of 5-HT (10 µM) are scaled up so 
that the second mean EPSCs are equal in amplitude, he first mean EPSC in the 
presence of CP93129 is smaller than control.  The mean paired pulse ratio under 
control conditions was 2.2 ± 0.2 and in the presence of CP93129 it was 5.2 ± 2.1 (n = 
6).  Although there is an increase in the paired pulse ratio in the presence of CP93129 
the data is not significantly different (P = 0.14, paired t test), and it is speculated that 
this may be due to the large variation in the paired pulse ratio within this group of 
FMs. 
As discussed previously, the 5-HT1A receptor agonist, 8-OH-DAPT (10 µM), does 
not alter the amplitude of the first EPSC.  In a representative FM the first EPSC was 
-23 pA and –24 pA in amplitude in absence and presence of 8-OH-DAPT (10 µM), 
respectively (Figure 6.10).  The amplitude of the second EPSC under control 
conditions was –37 pA and –38 pA in the presence of 8-OH-DPAT (10 µM, Figure 



























Figure 6.10.  Effect of 8-OH DPAT on paired pulse ratio in facial motoneurones. 
Mean EPSCs recorded from a FM voltage-clamped at –70 mV under control 
conditions (black) demonstrating that when two stimul  are evoked close together (50 
ms apart) the second mean EPSC is larger in amplitude than the first.  In the presence 
of 8-OH-DPAT (10 µM, grey) both mean EPSCs are similar in amplitude to control.  
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Thus, the paired pulse ratio was unchanged in the presence of 8-OH-DPAT (10 µM, 
1.6 in both the presence and absence of agonist, Figure 6.10).  The mean control 
paired pulse ratio was 1.5 ± 0.1 and was 1.4 ± 0.1 in the presence of 8-OH-DPAT (10 
µM) (n = 3, P = 0.24, paired t test).    
6.3.3 Activation of 5-HT1B receptors alter spontaneous release 
frequency  
Analysis of the frequency and amplitude of spontaneous EPSCs can also be used to 
determine whether an effect occurs through a pre- o post-synaptic mechanism.  
Spontaneous or miniature (mini) EPSCs were recorded from FMs in the presence of 
tetrodotoxin (TTX 0.3 µM) to block action potential dependent-transmitter r lease.  
Thus mini EPSCs are mediated by spontaneous release of neurotransmitter from the 
presynaptic terminal.  A change in mini EPSC amplitude is thought to be due to a 
postsynaptic effect, whereas a change in the frequency at which these spontaneous 
events occur is due to a presynaptic mechanism.  Figure 6.11 shows sample traces 
from a representative FM demonstrating that frequency of mini EPSCs are reduced 
in the presence of 5-HT (10 µM).  Figure 6.12A shows a cumulative probability 
histogram of inter-event interval, which corresponds to mini EPSC frequency.  In 
this FM the control frequency was 4.7 events s-1 and this was reduced to 3.2 events s-
1 in the presence of 5-HT (10 µM).  This represents a significant reduction in 
frequency (P = 0.01, assessed by the Kolmogorov-Smirnov two sample test).  Figure 
6.12B shows the cumulative probability histogram of mini EPSC amplitude.  In this 




































Figure 6.11.  5-HT reduces the frequency of miniature EPSCs in facial 
motoneurones. 
A. Control recording from a representative motoneuron voltage-clamped at –70 
mV in the presence of TTX (0.3 µM).  The downward deflections are 
miniature EPSCs.  The arrows indicate the –43 pA level. 
B. Recording from the same motoneuron as A following application of 5-HT (10 
µM).  The frequency of miniature EPSCs is reduced.  The arrows indicate the –
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Figure 6.12.  Cumulative probability histograms of EPSC frequency and 
amplitude in facial motoneurones. 
A. Cumulative probability histogram of the inter-event interval (corresponding to 
frequency) of miniature EPSCs from a representative motoneuron (sample 
traces shown in Figure 6.11).  The EPSC frequency is significantly lower in 
the presence of 5-HT (10 µM, grey, P = 0.01, Kolmogorov-Smirnov two 
sample test). 
B. Cumulative probability histogram of miniature EPSC amplitude from a 
representative motoneuron (sample traces shown in Figure 6.11) voltage-
clamped at –70 mV.  The EPSC amplitude is not significantly changed in the 
presence of 5-HT (10 µM, grey, P = 0.26, Kolmogorov-Smirnov two sample 
test). 
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following 5-HT (10 µM) application was not significantly different at -67 ± 2 pA (n 
= 730 events, P = 0.26, Kolmogorov-Smirnov two sample test).  As shown 
previously, bath application of 5-HT (10 µM) also evoked an inward current of –107 
pA due to its postsynaptic mechanisms.  In a sample group of FMs the frequency of 
mini EPSCs was significantly reduced from 3.1 ± 0.9 events s-1 under control 
conditions to 2.0  ± 0.7 events s-1 in the presence of 5-HT (10 µM, n = 3, P = 0.02, 
paired t test).  In the sample group of FMs the amplitude of mini EPSCs was 69  ± 11 
pA under control conditions and 55  ± 6 pA in the presence of 5-HT (10 µM), 
representing a non-significant effect (n = 3, P = 0.06, paired t test).  The rise times 
for mini EPSCs were not significantly altered by 5-HT (10 µM) and were 4.5 ± 0.2 
ms and 5.5 ± 0.4 ms, in absence and presence of 5-HT, respectively (n = 3, P = 0.12, 
paired t test).  In addition, the decay times for mini EPSCs were also not significantly 
affected by 5-HT (10 µM) and were 19.0 ± 1.3 ms and 19.4  ± 1.8 ms, in absence and 
presence of 5-HT, respectively (n = 3, P = 0.31, paired t test).  Thus, 5-HT (10 µM) 
significantly reduces the frequency of mini EPSCs but has no effect on their 
amplitude or rise and decay times indicating that 5-HT evokes a presynaptic effect. 
6.4 Discussion 
6.4.1 5-HT inhibits synaptic transmission 
In addition to evoking an inward current as described earlier (Chapters 3 and 4), 5-
HT was found to significantly inhibit the mean amplitude of evoked excitatory 
synaptic transmission in FMs.   
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6.4.2 5-HT1B receptor activation reduces EPSC amplitude  
The pharmacology of this inhibitory action of 5-HT indicates the involvement of 5-
HT1B but not 5-HT1A receptors.  CP93129 is highly selective for 5-HT1B receptors 
(EC50 = 56 ± 5 nM) over other 5-HT receptors (> 150 times lower affinity at 5-HT1A 
and 5-HT1D receptors) and this study has demonstrated that CP93129 mimics the 5-
HT inhibition of EPSC amplitude but does not evoke any of the postsynaptic 
excitatory actions of 5-HT (Macor, Burkhart et al. 1990).  The 5-HT1A receptor 
agonist, 8-OH-DPAT, does not inhibit EPSC amplitude nor was it found to evoke 
any of the excitatory actions of 5-HT.  The lack of an excitatory effect of 8-OH-
DPAT might seem as 8-OH-DPAT has been described as a partial agonist at 5-HT7 
receptors in some studies (Wood, Chaubey et al. 2000).  In Chapter 4 of this thesis 
evidence is provided supporting a 5-HT7 receptor-mediated enhancement of Ih in 
FMs.  As agonist efficacy is likely to reflect both c aracteristics of the tissue (e.g. 
receptor number, coupling mechanisms) and drug-receptor interactions the former 
may explain the lack of effect of 8-OH-DPAT on Ih in FMs.  These observations are 
consistent with previous findings demonstrating a lack of any post-synaptic actions 
of 8-OH-DPAT (Larkman and Kelly 1997). 
The pharmacology of the inhibitory effect of 5-HT on glutamate release was verified 
using subtype selective antagonists.  Isamoltane is an antagonist at 5-HT1B receptors 
and was found to block the inhibition of EPSC amplitude by 5-HT.  Isamoltane does 
show some affinity for 5-HT1A receptors (IC50 = 1070 nM verses 39 nM for 5-HT1B 
receptors), however, it is unlikely that 5-HT1A receptors were significantly blocked at 
the concentration applied in these experiments (1 µM) (Wood, Chaubey et al. 2000).  
 199 
The lack of involvement of 5-HT1A receptors was confirmed by the failure of the 
highly selective 5-HT1A receptor antagonist, WAY 100635, to block the inhibition of 
EPSC amplitude by 5-HT (Critchley, Childs et al. 1994).  A similar inhibition of 
glutamate release from terminals presynaptic to spinal motoneurones and 
hypoglossal motoneurones has been demonstrated, although, in the hypoglossal 
nucleus both 5-HT1A and 5-HT1B receptors are involved (Bouryi and Lewis 2003; 
Honda, Tanabe et al. 2003). 
6.4.3 Synaptic location of 5-HT1B receptors 
5-HT1B receptors function as heteroreceptors to modulate glutamate release in 
several regions including the rat subiculum and the hypoglossal motor nucleus 
(Bobker and Williams 1989; Boeijinga and Boddeke 1996; Bouryi and Lewis 2003).  
There are several lines of evidence to support a presynaptic location for 5-HT1B 
receptors in the FMN.  Firstly, 5-HT and CP93129 increased the rate of failure to 
generate an EPSC at a constant stimulus intensity.  Secondly, 5-HT and CP93129 
altered the paired pulse ratio.  A change in the paired pulse ratio is indicative of a 
presynaptic mechanism and an increase is associated with a presynaptic inhibition of 
neurotransmitter release (Stuart and Redman 1991).  Thirdly, 5-HT alters the 
frequency, but not the amplitude, of mini EPSCs.  Mini EPSCs represent 
spontaneous (in the absence of nerve stimulation) neurotransmitter release at 
synapses across the entire neurone, therefore, it cannot be assumed that these 
synapses are the same population as those that are evok d by electrical stimulation.  
However, the decrease in frequency of mini EPSCs supports the data obtained from 
the evoked EPSCs.         
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6.4.4 Mechanism of inhibition of release by 5-HT1B receptors 
The mechanism underlying the decrease of neurotransmitter release from the 
presynaptic terminal by 5-HT1B receptor activation remains unknown, largely due to 
the inaccessibility of recording from presynaptic terminals.  An increase in the paired 
pulse ratio is also observed when the extracellular [C 2+] is decreased suggesting that 
neurotransmitter release can be inhibited by decreasing the Ca2+ entering the 
presynaptic terminal following stimulation (Stuart nd Redman 1991).  A potential 
mechanism for reducing Ca2+ entry into the terminal is by modulation of the channels 
through which Ca2+ enters the neurone.  An inhibition of N-type Ca2+ channels 
following activation of Gi proteins has been demonstrated in the chick dorsal root 
ganglion and as 5-HT1B receptors activate Gi proteins this could also occur in the 
FMN (Mirotznik, Zheng et al. 2000).  Similarly, at the calyx of Held, activation of 
presynaptic metabotropic glutamate receptors (mGluRs, some of which are coupled 
to Gi proteins) reduces glutamate release by inhibiting P/Q-type Ca
2+ channels 
(Takahashi, Forsythe et al. 1996).   
As Ca2+ influx into the presynaptic terminal following nerv stimulation is through 
voltage-dependent Ca2+ channels, reducing the depolarisation of the terminal 
membrane and the subsequent activation of these channels represents an alternative 
mechanism for modulating transmitter release.  An increase in K+ conductance would 
result in membrane hyperpolarisation and a decrease in membrane depolarisation 
following action potential innervation of the terminal.  Subsequently the reduced 
Ca2+ entry into the terminal would result in a lower release probability of vesicles 
and an inhibition of synaptic transmission.  5-HT1 receptor activation leads to G 
protein βγ subunit (Gβγ) which has been shown to activate K+ conductances in the 
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hippocampus (Andrade, Malenka et al. 1986; Andrade and Nicoll 1987; Colino and 
Halliwell 1987).  Activation of muscarinic acetylcholine receptor from the heart (M2 
receptors that are coupled to Gi proteins), results in the Gβγ subunit activating G 
protein coupled inwardly rectifying K+ (GIRK) channels (Logothetis, Kurachi et al. 
1987; Reuveny, Slesinger et al. 1994).   
A third proposed mechanism for modulating presynaptic release occurs downstream 
of Ca2+ influx into the nerve terminal (Blackmer, Larsen et al. 2001).  Modulation of 
the proteins involved in the fusion of vesicles with the plasma membrane (SNARE 
proteins, (Li and Chin 2003)) and could potentially reduce vesicle release (Blackmer, 
Larsen et al. 2001).  This modulation is downstream of Ca2+ entry into the terminal 
and was first demonstrated in the frog neuromuscular j nction where activation of 
adenosine receptors reduces the affinity of the fusion machinery for Ca2+ (on which it 
is dependent) (Silinsky 1984; Silinsky and Solsona 1992).  At the frog 
neuromuscular junction this inhibition of acetylcholine release is dependent on 
adenylate cyclase activity, however, at the lamprey ticulospinal-motoneurone 
synapse it appears that the Gβγ subunit can bind directly to the fusion machinery to 
reduce neurotransmitter release (Silinsky 1984; Silinsky and Solsona 1992; 
Blackmer, Larsen et al. 2001).  The mechanism mediating the inhibition of glutamate 
release in the FMN is not yet known, however, whether or not this effect is 
dependent on Ca2+ influx into the terminal or an effect downstream of this could be 
investigated using Ca2+ imaging. 
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6.5 Concluding statement 
Chapters 3 and 4 of this thesis have reported the excitatory effects of 5-HT on 
neonatal rat FMs.  This chapter has focused on the in ibitory actions of 5-HT on 
synaptic transmission and has determined that releas  of glutamatergic vesicles (as 
described in Chapter 4) is inhibited by a presynaptic activation of 5-HT1B receptors.  
These multiple actions of 5-HT in the facial nucleus may provide a mechanism by 
which 5-HT exerts fine control over motor output. 
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Chapter 7 General Discussion 
7.1 Thesis summary 
This thesis has investigated the pre- and post-synaptic mechanisms controlling 
neonatal rat FM excitability.  An enhancement of Ih and an inhibition of gKLeak have 
been confirmed as the mechanisms underlying the 5-HT-induced excitation of FMs 
previously observed (VanderMaelen and Aghajanian 1980; Vandermaelen and 
Aghajanian 1982; Larkman, Penington et al. 1989).  The NA-induced excitation was 
also shown to be mediated by an inhibition of gKLeak.  The molecular identity of the 
channel underlying gKLeak was previously unknown, thus making the physiological 
significance of its modulation unclear.  This thesis provides evidence to support a 
TASK-1/TASK-3 heteromeric channel identity.  This i consistent with previous 
studies demonstrating that members of the K2P channel family provide leak currents 
in a variety of neurones and can be inhibited via G protein-coupled receptor 
activation (Goldstein, Bockenhauer et al. 2001; Patel nd Honore 2001).   
Identifying the different receptor subtypes mediating these effects of 5-HT and NA 
was crucial for the understanding of how the agonists exert their different actions in 
FMs.  The mechanism by which 5-HT-receptor activation enhanced Ih was 
previously determined as a direct action of cAMP on the channel (Larkman and 
Kelly 1997).  Here it has been established that 5-HT7 receptor activation mediates 
this enhancement of Ih. 
The receptor subtypes that mediate the 5-HT- and NA-induced inhibition of gKLeak 
have been identified as 5-HT2A receptors and α1-adrenoceptors, although an 
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involvement of 5-HT2C receptors cannot be completely ruled out by the findings 
presented here.  Both 5-HT2A receptors and α1-adrenoceptors are coupled to Gq
proteins, activating the PLC pathway.  Previous studies have demonstrated that 
altering the downstream messengers of this pathway ([Ca2+] i and PKC activation) has 
no effect on gKLeak (Larkman 2003).  It has recently emerged that PIP2 in the 
membrane stabilizes a variety of channels (including TASK channels) and its 
hydrolysis by PLC leads channel closure (Czirjak, Petheo et al. 2001; Chemin, 
Girard et al. 2003; Lopes, Rohacs et al. 2005).  This mechanism for the inhibition of 
gKLeak in FMs was investigated.  PLC-β1 was detected in the mouse FMN and a 
functional role for this enzyme in the NA-induced current was observed in PLC-β1-/- 
mice, however, the 5-HT-induced current did not appear to be affected by the lack of 
PLC-β1.  An attempt to determine whether alternative isoforms of the enzyme 
mediated the 5-HT-induced inhibition of gKLeak was made using the non-selective 
PLC inhibitor, U73122, however no conclusive results were obtained.  This 
suggested that either the inhibitor did not reach its intracellular site of action within 
the experimental time period or that this action of 5-HT does not involve PLC 
activity.  In the latter respect it is pertinent that a recent report suggests TASK 
channels can be inhibited by a direct action of Gαq (Chen and Talley 2006). 
The nature of the fast excitatory synaptic transmision that controls action potential 
firing in FMs was previously uncharacterised.  In order to further understand 
synaptic integration in FMs the neurotransmitter phenotype and the receptor subtypes 
activated were determined.  Glutamatergic EPSCs and EPSPs were evoked in FMs 
by stimulating close to the dendrites of the recorded FM.  A contribution of NMDA 
and non-NMDA (AMPA/kainate) glutamate receptors was identified using selective 
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antagonists.  In addition, GluR2 and NR2B subunit containing glutamate receptors 
were detected at the synapse tested.  Protein for other glutamate receptor subunits 
have been detected in FMs however, their functional contributions could not be 
assessed due to the lack of selective ligands (Martin, Blackstone et al. 1993; Sato, 
Kiyama et al. 1993; Nishi, Hinds et al. 2001). 
It was also determined that by using a minimal stimulation protocol single synapses 
could be activated in FMs.  At these putative single synapses fluctuations in 
amplitude were observed providing evidence that supports the controversial theory of 
quantal release at single central synapses (Sastry nd Bhagavatula 1996; Auger and 
Marty 2000; Stevens 2003). 
Finally the effect of 5-HT on this glutamatergic synaptic transmission was assessed.  
Unlike the excitatory postsynaptic actions of 5-HT it was determined that 5-HT has 
an inhibitory effect on glutamate release from the pr synaptic terminal and that this 
action was mediated by activation of presynaptic 5-HT1B receptors.   
7.2 Possible functional implications of pH-sensitive gKLeak 
Whether the pH-sensitivity of gKLeak is functionally important for FMs is not clear.  
Changes in external pH are known to occur during periods of ischaemia and hypoxia 
but functionally significant physiological changes are less apparent.  A small change 
in external pH may be sufficient to alter the properties of gKLeak however the 
integrated response of the motoneuronal membrane is likely to involve additional 
effects on other conductances.  Experiments performed in the absence ZD-7288 
indicated that changes in external pH across the range pH 6 to 8 also altered Ih (not 
reported here).  The overall change in FM membrane conductance thus reflects the 
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integration of at least these two components.  Nevertheless, modulation of gKLeak by 
endogenous neurotransmitters, particularly NA and 5-HT, indicates an important role 
in the priming and maintenance of FM membrane excitabil y during waking and 
states of sensory arousal.   
7.3 TASK-1 knock out mice  
Mice lacking TASK-1 have been generated and were found to show little 
behavioural differences to their littermate controls except from impaired motor 
coordination (Aller, Veale et al. 2005).  This was reported to be due to the lack of 
TASK-1 in the cerebellar granule neurones which play a key role in motor 
coordination (Aller, Veale et al. 2005).  The resting membrane excitability of the 
CGNs from the knock out mice was not significantly different from their littermate 
controls and the leak current was found to be sensitive to Zn+ and ruthenium red 
suggesting that the absence of TASK-1 was compensatd for by homomeric TASK-3 
channels (Czirjak and Enyedi 2003; Aller, Veale et al. 2005).  It is noteworthy that 
this shift to a homomeric TASK-3 population appears to affect motor coordination in 
the knock out mice, demonstrating the importance of the TASK-1 channel for normal 
CGN function (Aller, Veale et al. 2005).   It would be of interest to investigate the 
sensitivity of the FM gKLeak in these mice to assess whether the proposed 
heteromeric TASK-1/TASK-3 population is also replaced by homomeric TASK-3 
channels.  The lack of a deficiency in motor function suggests that motoneurone 
excitability is not significantly impaired in the TASK-1 knock out mice, this is 
consistent with TASK-1 homomers not playing a dominant role in motoneurone 
excitability (Aller, Veale et al. 2005).  Taken together with the lack of sensitivity to 
ruthenium red, these findings support a TASK-1/TASK-3 heteromeric identity for 
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the gKLeak in FMs.  The generation of a double TASK-1 and TASK-3 knock out mice 
would further allow the role of gKLeak in the contribution to the resting membrane 
potential and its role in synaptic integration in FMs to be further assessed.  
7.3 Role of Ih in FMs  
7.3.1 Functions of Ih 
Pacemaker currents were first identified in the sino-atrial node cells in the heart 
during the late 1970s (Noma and Irisawa 1976).  This current was termed If (‘funny’) 
due to its apparently unique slow activation in response to hyperpolarisation.  In the 
heart, Ih is involved in rhythmic activity by determining the time which elapses 
between action potentials in cardiac cells (Kaupp and Seifert 2001).  In the early 
1980s neuronal pacemaker currents were identified in rod photoreceptors in the eye 
and termed Ih (‘hyperpolarisation-activated’) (Attwell and Wilson 1980).  Evidence 
for a similar current in central neurones was obtained from hippocampal pyramidal 
neurones and was termed Iq (‘queer’) due to its strange electrophysiological 
behaviour (Halliwell and Adams 1982).  The preferred t rm in the central nervous 
system is Ih.    
Ih contributes to a pacemaker current in many central neurones and this action 
particularly well documented for thalamocortical relay neruones (Pape and 
McCormick 1989; Luthi and McCormick 1998; Luthi and McCormick 1998).  
Following an action potential the neuronal membrane hyperpolarises, activating Ih
which provides a depolarising inward current (Pape nd McCormick 1989; Robinson 
and Siegelbaum 2003).  As the membrane depolarises (due to Ih activity) and 
becomes closer to the threshold for action potential fir ng, Ih inactivates (Pape and 
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McCormick 1989; Robinson and Siegelbaum 2003).  Therefore the kinetics of Ih 
activation and inactivation determines the time that elapses between action 
potentials.  Mice lacking the HCN2 subunit suffer from spontaneous absence 
seizures supporting a pacemaker function of Ih (Ludwig, Budde et al. 2003).   
In neurones that do not require an integral pacemakr, Ih can contribute to the resting 
membrane potential and input resistance.  Resting membrane potentials of neurons 
are typically between -50 mV to -100 mV and Ih is active within this range.  As Ih
does not inactivate at hyperpolarised potentials, the sustained depolarising current 
mediated by Ih helps set the resting membrane potential depolarised to the K
+ 
equilibrium potential (Pape 1996).  This is supported by the hyperpolarising shift in 
the resting membrane potential observed in thalamocortical relay neurones in the 
HCN2 deficient mice (Ludwig, Budde et al. 2003).  As FMs are not spontaneously 
active it is likely that contributing to the resting membrane potential is a primary role 
for Ih in these neurones. 
An additional action of Ih is in the integration of synaptic inputs.  Dendrites were 
traditionally thought to act as passive cables and in such systems synaptic potentials 
received in the dendritic network of a neurone would be subject to filtering as they 
travel to the soma (Whitehead and Rosenberg 1993).  Thus the generation of an 
action potential at the cell soma would be dependent on the location of synaptic 
inputs in the dendrites and temporal summation of synaptic potentials.  Ion channels 
can confer active properties to the dendritic membrane and the density of Ih has been 
found to increase in the distal dendrites relative to distance from the soma of 
neocortical and CA1 hippocampal pyramidal neurones (Magee 1998; Cook and 
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Johnston 1999; Williams and Stuart 2000; Gulledge 2005).  In these neurones Ih 
removes the location dependence of synaptic inputs and normalises temporal 
summation (Magee 1999; Williams and Stuart 2000).  The potential role for Ih in the 
integration of synaptic inputs in FMs is discussed further in Section 7.7.1. 
7.4 Effect of 5-HT in FMN 
7.4.1 Multiple 5-HT receptors in FMN 
5-HT exerts several different effects in the CNS due to the diversity of 5-HT 
receptors and from the findings of this thesis it has become apparent that several 
subtypes of 5-HT receptors are present in the neonatal r t FMN (summarised in 





Effect on FM 





Inhibits gKLeak        









Inhibitory         
(reduced synaptic 
transmission) 
Table 7.1.  Summary of actions of 5-HT receptors in FMN. 
Previously it has been generally accepted that 5-HT has an excitatory action in the 
FMN (VanderMaelen and Aghajanian 1980; Vandermaelen and Aghajanian 1982; 
Larkman, Penington et al. 1989; Larkman and Kelly 1992).  However, the findings 
presented in this thesis suggest that if 5-HT is released globally throughout the facial 
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nucleus that preventing glutamate release at the synapse may be dominant over the 
increase in post-synaptic membrane excitability andtherefore 5-HT would have a 
predominately negative action.   
7.4.2 Role of 5-HT, arousal states and motor activity 
The activity of mammalian 5-HT neurones show correlations with arousal state 
(Jacobs and Fornal 1999).  The 5-HT neurone discharge ctivity was found to be 
slow and regular during quiet waking states and increased during the aroused state or 
in response to sensory-stimuli (Jacobs and Fornal 1999).  As animals enter into the 
sleep state the activity of 5-HT neurones declines and can be almost completely 
absent from animals in a deep, REM sleep (Jacobs and Fornal 1999).  These 
correlations were originally observed for 5-HT neurones of the dorsal raphé nucleus 
of the freely moving cat but have also been seen other mammalian species and in 
other groups of 5-HT neurones, including some of thse that innervate the facial 
nucleus (the raphé magnus, obscurus and pallidus nuclei) (Jacobs and Fornal 1991; 
Jacobs and Fornal 1999). 
The firing rates of 5-HT neurones also show strong positive correlations with tonic 
motor activity (Jacobs and Fornal 1997). It has been proposed that the 5-HT system 
facilitates motor activity and when active the processing of sensory information and 
the autonomic and endocrine systems are inhibited (Jacobs and Fornal 1999).  When 
the 5-HT system is inactivated motor function is inhibited and sensory information 
processing is restored (Jacobs and Fornal 1999).  Of particular interest is the 
correlation between the increases in the activity of 5-HT neurones in the dorsal raphé 
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nucleus and repetitive oral-buccal motor activity involving muscles innervated by 
FMs (chewing, biting, and grooming) (Jacobs and Fornal 1997).  
This positive correlation between the activity of 5-HT neurones and motor activity 
argues against a predominately inhibitory action of 5-HT in the FMN.  It is therefore 
anticipated that the 5-HT receptors present in the facial nucleus are not activated 
equally. 
7.4.3 Possible mechanisms for differential activation of 5-HT receptors  
One possible mechanism by which the excitatory effect dominates over the inhibitory 
action of 5-HT is that rather than 5-HT being globally released within the nucleus it 
is focally released onto different sections of the FM.  Thus the excitatory effects 
would be manifested by 5-HT being released onto dendritic regions downstream of 
site where EPSPs are generated.  5-HT released at the synapse would exert the 
inhibitory actions of 5-HT, through activation of the 5-HT1B receptors.  This theory 
could be tested experimentally using the recording protocols described in Chapter 6 
and  instead of applying 5-HT through the superfusing ASCF it could be focally 
applied using micropipettes (via pressure ejection).   
An alternative hypothesis is that 5-HT is globally released in the facial nucleus and 
receptor affinities control the dominating action of 5-HT.  Thus, the receptors that 
mediate the excitatory actions of 5-HT would be activ ted by low concentrations of 
5-HT and if an inhibitory effect was required the amount of 5-HT released would be 
increased, eventually activating the lower affinity, nhibitory 5-HT1B receptors.   
5-HT receptors bind 5-HT with affinities within the nanomolar range and 5-HT1 
receptors bind 5-HT with a high affinity relative to 5-HT2 receptors (an example 
 212 
study determines the Ki for displacement of LSD as 3.5 ± 0.55 nM and 17 ± 2.9 nM 
for 5-HT1 and 5-HT2 binding site, respectively) (Peroutka and Snyder 1979).  The 5-
HT7 receptor has also been found to show high affinity for 5-HT (Kd = 1 nM in CHO 
cells) (Ruat, Traiffort et al. 1993).   
Since the 5-HT2 receptors appear to show the lowest affinity for 5-HT a higher 
concentration would be required to activate them than for the activation of the 
inhibitory 5-HT1B receptors, thus the inhibitory effect would be dominant.  It is also 
apparent that the range of receptor affinities is not that large, therefore, it is unlikely 
that this is the controlling factor in determining the overall effect of 5-HT on FM 
excitability. 
7.4.4 Functional significance of the inhibitory effects of 5-HT 
The functional significance of the 5-HT-induced inhibition of glutamate release 
reported here is unclear (Jacobs and Fornal 1991; Jacobs and Fornal 1999).  In the 
hypoglossal nucleus activation of 5-HT1A and 5-HT1B receptors mediate a similar 
inhibition of glutamate release suggesting that this may be a common mechanism in 
the control of motoneurone activity (Bouryi and Lewis 2003).  It may be that the 5-
HT released at the synaptic cleft is from neurones whose cell somas are located in a 
different raphé nucleus to those which release 5-HT onto the postsynaptic membrane 
and exert its excitatory effects.  This may particularly significant if the same group of 
5-HT neurones innervate opposing muscles, thus when the 5-HT neurone activity is 
increased some motoneurones would be activated whereas synaptic transmission 
onto the other group of motoneurones would be prevent d. 
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7.4.5 5-HT projections into the facial nucleus 
The FMN contains the highest density of 5-HT nerve terminals of all the cranial 
nerve nuclei (Takeuchi, Kojima et al. 1983; Senba 1985).  The origin of these 
projections has been investigated using a combinatio  of immunohistochemistry for 
5-HT and retrograde labelling with Fluro-Gold injection into the FMN (Li, Takada et 
al. 1993).  The majority of 5-HT neurones projecting to the FMN were observed in 
the nucleus raphé magnus, obscurus and pallidus with some in the dorsal raphé and 
the gigantocellular reticular pars alpha (Li, Takada et al. 1993).  However, only small 
numbers of neurones were identified by this study and most likely under-represents 
the serotonergic projections to the FMN.  The available information regarding the 
origin of 5-HT inputs into the FMN is currently not substantial enough to address the 
issue of whether the same FM is innervated by 5-HT neurones from different raphé 
nuclei. 
7.5 Effect of NA in FMN 
7.5.1 Multiple actions of NA in FMN 
NA has been shown to excite FMs by an inhibition of gKLeak, however, unlike 5-HT 
NA does not appear to enhance Ih. The functional significance of this difference in 
action of the two transmitters is not yet apparent.   
The excitatory action of NA in FMs is mediated by an activation of α1-adrenoceptors.  
Whether NA also has an inhibitory action in the facial nucleus has not yet been 
addressed.  The inhibitory effects of 5-HT1B receptor activation appear to be a result 
of receptor coupling to Gi proteins.  Members of the α2-adrenoceptor family also 
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couple to Gi proteins and have been shown to modulate K
+ and Ca2+ channels, a 
potential mechanism for the inhibition of glutamate r lease (Docherty 1998; 
IUPHAR 2000).  A role for α2-adrenoceptors in inhibiting glutamate release in the 
facial nucleus could be examined using the experimental paradigm described in 
Section 6.2.4 and the α2-adrenoceptor antagonist, RX 821002 (Diez-Alarcia, Pilar-
Cuellar et al. 2006).  However, as a positive correlation between motor behaviour 
and NA neurone activity has been observed (see Section 7.5.2) it is likely that if there 
are inhibitory NA receptors in the FMN they would not be activated with equal 
efficacy as the excitatory α1-adrenoceptors (as hypothesized for the multiple eff cts 
of 5-HT).   
7.5.2 NA, arousal states and motor activity 
Similar to the activity pattern of 5-HT neurones, NA neurones (located in the locus 
coeruleus) show regular slow firing activity in quiet waking animals, increased 
activity in behaving animals and reduced firing during deep sleep periods (Aston-
Jones and Bloom 1981).  NA has also been shown to increase motor activity, 
although the effect is not as well documented as tht of 5-HT (Geyer, Segal et al. 
1972 617).   
7.6 Synaptic integration in FMN 
7.6.1 Role of Ih 
Whether action potentials are generated by passive ummation of EPSPs or 
integration of synaptic inputs in FMs is not yet known.  However, Ih is involved in 
the integration of synaptic inputs in neocortical and hippocampal pyramidal neurones 
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and the presence of this current in FMs suggests that some integration may occur 
(Magee 1999; Williams and Stuart 2000).  In these neurones it has been shown that 
the Ih is expressed more highly in the distal dendrites that hose proximal to the cell 
soma and this increased Ih removes the location dependence of synaptic input and 
normalises temporal summation (Magee 1998; Cook and Johnston 1999; Magee 
1999; Williams and Stuart 2000; Gulledge 2005).  It would be of value to determine 
whether FMs also show this distribution of Ih which could be assessed by including a 
low concentration of ZD-7288 (1–10 µM) in the intracellular recording solution 
(without previously incubating the slice).  The time required for the block Ih to occur 
would be indicative of its expression pattern due to the time it takes for ZD-7288 to 
diffuse to the intracellular region of the channel where it exerts its effect (Shin, 
Rothberg et al. 2001).  An alternative and more quantitative method for assessing the 
distribution of Ih across the dendritic membrane would be to use the 
immunohistochemical techniques utilised in this thesis (Section 2.8 and Section 
4.3.1) and the commercially available antibodies to the HCN channel subunits. 
Accurate studies examining the effect of Ih on synaptic integration and temporal 
summation require simultaneous dendritic and somatic recordings in order to 
compare EPSPs at each of these locations (Williams nd Stuart 2000; Larkum, 
Launey et al 1998; Magee 2000).  Making similar dual recordings in FMs would 
allow synaptic integration in FMs to be examined, although this technique would 
require addition experimental apparatus to that used for this thesis.  If this technique 
was available it would also be of interest to examine synaptic integration in mice 
lacking the HCN2 subunit (and the other subunits as the knock-out mice become 
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available) to assess the contribution of these subunits to Ih in FMs and to investigate 
whether individual subunits play different roles in the integration of synaptic events.   
7.6.2 5-HT modulation and synaptic integration  
How the postsynaptic modulatory effects of 5-HT alter synaptic integration is also 
not yet fully understood.  If it is assumed that a role of Ih in FMs is to normalise 
temporal summation of synaptic inputs and that thisoccurs due to the increased 
expression of Ih in the distal dendrites then it can also be assumed that by the 5-HT-
mediated enhancement of Ih will also further prevent temporal summation of synaptic 
inputs.  This would result in a more efficient rate of action potential firing for the 
same number of EPSPs.  This is consistent with the correlation between 5-HT 
neurone activity and motor output. 
The inhibition of gKLeak could also potentially play a role in synaptic integration.  
Inhibition of gKLeak and enhanced Ih results in a membrane depolarisation, therefore 
the depolarisation required by incoming synaptic inputs to push the membrane above 
the firing threshold would be decreased.  Therefore EPSPs which induce 
depolarisations that were previously below the thres old for firing would result in an 
action potential in the presence of 5-HT (and NA for the role of gKLeak).   
7.7 Future directions 
In addition to the possible experiments described previously in this chapter, future 
studies are required to further understanding of the neuromodulatory effects of 5-HT 
and NA.  It is anticipated that the next stage on fr m the work described in this thesis 
would be to examine any effect of NA on modulating glutamate release.  The effect 
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of 5-HT and NA on EPSPs should also be investigated.  The voltage-clamp 
configuration is useful for investigating the conductances that underlie changes in the 
membrane potential, however, this is an artificial situation and neurones in vivo 
would be described as being under current-clamp (Neher, Sakmann et al. 1978).  
Thus evoking EPSPs and applying 5-HT or NA would reveal whether these 
transmitters alter the shape and/or duration of synaptic events.  The receptor subtypes 
which mediate the various actions of 5-HT and NA have been determined in this 
thesis and this information can be utilised to examine the contribution of each of 
these actions to the modulation of FM excitability.  By applying the receptor subtype 
selective agonists and antagonists used in this thesis to FMs in which EPSPs were 
being evoked the role of each action of 5-HT (and NA if there is multiple actions) 
could be further understood. 
The studies described in this thesis provide a solid groundwork for future studies into 
how neuromodulation alters FM function.  In addition t  furthering understanding of 
neuromodualtion in FMs these findings highlight themultiple actions of 5-HT (and 
potentially NA) in the central nervous system.  Motoneurones are good models for 
investigating neuromodulation and synaptic integration due to the functional output 
of their activation being well understood, however, it is anticipated that several (but 
not necessary all) of the findings from studies on FMs could be extrapolated to other 
neuronal subtypes and further general understanding of how neurones function. 
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Abstract
A ‘leak’ potassium (K+) conductance (gKLeak) modulated by amine neurotransmitters is a major determinant of neonatal rat facial
motoneuron excitability. Although the molecular identity of gKLeak is unknown, TASK-1 and TASK-3 channel mRNA is found in facial
motoneurons. External pH, across the physiological range (pH 6–8), and noradrenaline (NA) modulated a conductance that displayed
a relatively linear current ⁄ voltage relationship and reversed at the K+ equilibrium potential, consistent with inhibition of gKLeak. The
pH-sensitive current (IpH), was maximal around pH 8, fully inhibited near pH 6 and was described by a modified Hill equation with a
pK of 7.1. The NA-induced current (INA) was occluded at pH 6 and enhanced at pH 7.7. The TASK-1 selective inhibitor anandamide
(10 lm), its stable analogue methanandamide (10 lm), the TASK-3 selective inhibitor ruthenium red (10 lm) and Zn2+ (100–300 lm)
all failed to alter facial motoneuron membrane current or block INA or IpH. Isoflurane, a volatile anaesthetic that enhances heteromeric
TASK-1 ⁄ TASK-3 currents, increased gKLeak. Ba2+, Cs+ and Rb+ blocked INA and IpH voltage-dependently with maximal block at
hyperpolarized potentials. 4-Aminopyridine (4-AP, 4 mm) voltage-independently blocked INA and IpH. In summary, gKLeak displays
some of the properties of a TASK-like conductance. The linearity of gKLeak and an independence of activation on external [K
+]
suggests against pH-sensitive inwardly rectifying K+ channels. Our results argue against principal contributions to gKLeak by
homomeric TASK-1 or TASK-3 channels, while the potentiation by isoflurane supports a predominant role for heterodimeric TASK-
1 ⁄ TASK-3 channels.
Introduction
‘Leak’ K+ conductances (gKLeak), characterized by no or weak
voltage-dependence and fast kinetics, provide a major determinant in
regulating excitability of many neuronal types. Inhibition of a gKLeak
by both noradrenaline (NA) and serotonin (5-hydroxytryptamine,
5-HT) modulates adult rat facial motoneuron excitability by promoting
membrane depolarization and an associated increase in input resist-
ance that markedly affects responses to synaptic input (Larkman &
Kelly, 1992). Despite the importance of this conductance for facial
motoneuron excitability the identity of the amine-sensitive K+
channels remains to be established.
It has been widely suggested that members of the twin-pore (2P)
domain K+ channel family provide molecular correlates for physio-
logically identified ‘leak’ K+ conductances (reviewed by Goldstein
et al., 2001; Patel & Honoré, 2001). In young rat hypoglossal
motoneurons and adult turtle spinal motoneurons it has been proposed
that members of the TASK (TWIK-related, acid-sensitive, K+) group
of 2P channels underlie an amine-sensitive gKLeak (Talley et al., 2000;
Perrier et al., 2003). The presence of TASK-1 (KCNK3) and TASK-3
(KCNK9) mRNA has been demonstrated in the rat facial motor
nucleus, raising the possibility that TASK channels underlie the
amine-sensitive gKLeak in facial motoneurons (Talley et al., 2000;
Karschin et al., 2001; Vega-Saenz de Miera et al., 2001). Neverthe-
less, a motoneuron-specific inwardly rectifying K+ channel, Kir2.4,
has also been proposed to underlie the amine-sensitive K+ current in
hypoglossal motoneurons and this may also be expressed by neonatal
rat facial motoneurons (Karschin et al., 1996; Karschin & Karschin,
1997; Töpert et al., 1998).
TASK-1 and TASK-3 channels mediate openly rectifying currents
with fast kinetics that can be distinguished by the pH at which they are
half-maximally activated (pK) (Duprat et al., 1997; Leonoudakis
et al., 1998; Kim et al., 2000; Rajan et al., 2000). In addition, the
endogenous cannabinoid, anandamide, preferentially blocks TASK-1
channels and the polycationic compound, ruthenium red (RR)
selectively blocks TASK-3 channels (Czirják & Enyedi, 2003;
Maingret et al., 2001). TASK-1 and TASK-3 also appear to form
functional heterodimeric channels with emergent properties distinct
from the respective homomeric channels (Czirják & Enyedi, 2002a;
Talley & Bayliss, 2002; Kang et al., 2004). In this respect,
acetylcholine inhibits a gKLeak in cultured rat cerebellar granule
(CG) neurons with properties similar, but not identical, to TASK-1
(Watkins & Mathie, 1996; Millar et al., 2000). Single-channel studies
have demonstrated the presence of homomeric TASK-1, homomeric
TASK-3 and heteromeric TASK-1 ⁄ TASK-3 channels in these cells
(Han et al., 2002; Kang et al., 2004).
We have combined pharmacological and biophysical approaches to
investigate the identity of the amine-sensitive gKLeak in neonatal rat
facial motoneurons. We show that external pH, across the physiological
range, modulates a gKLeak with the biophysical and pharmacological
properties of the NA-sensitive conductance. This conductance displays
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some of the biophysical properties of a conductance carried by TASK
channels but has a pharmacological profile distinct from either homo-
meric TASK-1 or homomeric TASK-3 channels. Some of this work has
been presented in preliminary form (Larkman & Perkins, 2003).
Materials and methods
Subjects
Wistar rats, 5–16 days old, of either sex, were used for slice
electrophysiology experiments. Dissociated CG cell cultures were
prepared from 7-day-old Wistar rats. All procedures were approved
under the UK Animals (Scientific Procedures) Act 1986.
Slice preparation
Slice preparation and recording methods were similar to those
described previously (Larkman & Kelly, 1998). Rats were decapitated
without anaesthesia and the hindbrain was rapidly isolated and placed
in ice-cold (4 C), sucrose-containing artificial cerebrospinal fluid
(ACSF) of the following composition (mm): 57 NaCl, 114 sucrose, 3
KCl, 1 CaCl2, 5 MgCl2, 1.25 NaH2PO4, 26 NaHCO3, 11 d-glucose
and 4 lactate. pH was 7.4 when continuously bubbled with a 95%
oxygen, 5% carbon dioxide gas mixture. After mounting the brainstem
on the cutting stage of a tissue slicer (DTK-1000, Dosaka Co., Kyoto,
Japan) slices (120 lm thick) were cut and subsequently incubated at
30 C for 60 min in a total volume of 50 mL ACSF. During this time
the sucrose-containing ACSF was slowly exchanged, at a rate of
approximately 1 mL ⁄min, with standard ACSF containing (mm): 114
NaCl, 3 KCl, 2 CaCl2, 1 MgCl2, 1.25 NaH2PO4, 26 NaHCO3 and 11
d-glucose; pH was 7.4 after bubbling with 95% O2 ⁄ 5% CO2. Prior to
recording, slices were maintained at room temperature (23 C) in
standard ACSF. To inhibit the hyperpolarization-activated current, Ih,
ZD-7288 (5–10 lm) was added to the maintenance chamber at least
30 min prior to recording.
Cerebellar granule cell cultures
Cerebellar granule cells were seeded on glass cover-slips coated with
poly-d-lysine (15 lg ⁄mL) at a density of 7.5 · 105 cells ⁄ cm2 and
cultured in MEM without Ca2+ and Mg2+ (Gibco, Invitrogen, Paisley,
UK) supplemented with 10% fetal calf serum (Gibco, Invitrogen),
9.2 mm glucose, 0.56 mm glutamine, 5.2 mm KCl and 1% penicillin–
streptomycin. Cytosine-arabinoside (10 lm) was added to the culture
medium after 24 h to prevent growth of glial cells. Electrophysiolog-
ical recordings were attempted between 8 and 14 days in vitro (DIV).
Electrophysiology
Individual brainstem slices or cover-slips bearing cultured granule
cells were transferred to a recording chamber and continuously
perfused (3–5 mL ⁄min) with ACSF. Neurons were visualized using a
water immersion objective (40·, Carl Zeiss Ltd, Welwyn Garden City,
UK) and Nomarski differential interference contrast optics. Facial
motoneurons were cleared of debris and connective tissue prior to
introduction of a recording pipette into the chamber. Recording
pipettes were made from thin-walled borosilicate glass capillaries
(GC150TF, Harvard Apparatus Ltd, Edenbridge, UK) using a patch-
pipette puller (Narishige PP-83, Intracel, Royston, UK). The patch-
pipette was coated with sylgard to reduce capacitance. The pipette
solution contained (mm): 122.5 K gluconate, 17.5 KCl, 9 NaCl, 1
MgCl2, 0.2 EGTA, 10 Hepes, 0.3 GTP (Na
+ salt) and 3 ATP (Mg2+
salt), neutralized to pH 7.3 with KOH (4 mm). Occasionally diluting
this solution to 90% improved the maintenance of cell condition. Even
though block of Ih by ZD-7288 is essentially irreversible over the time
required for whole-cell recording (Larkman & Kelly, 2001), ZD-7288
(5–10 lm) was included in the pipette solution during whole-cell
recordings to maintain an effective blocking concentration at its
intracellular site of action (Shin et al., 2001). Perforated-patch
recordings from cultured CG cells were made after including
amphotericin B (250 lg ⁄mL) in the pipette solution. Membrane
currents were recorded with a patch-clamp amplifier (EPC7B, List-
Medical, Darmstadt, Germany) filtered at 10 kHz and stored using a
digital audio tape recorder (Biologic DTR-1404, Intracel). Series
resistance (whole-cell recording, range 14–25 MW; perforated-patch
recording, range 30–60 MW) was monitored with the current response
to a repetitive voltage step ()10 mV, 10 ms) and was compensated by
up to 70%. Motoneuronal conductance was measured using linear
regression across the linear part of the I ⁄ V plot ()60 to )80 mV)
obtained using either voltage step pulses of varying amplitude or ramp
pulses ()50 to +50 mV from the holding potential, 2.4 s duration).
Cerebellar granule cells were voltage-clamped at )20 mV and
conductance was measured by ramping to )120 mV over 900 ms.
Off-line analysis was performed using a CED1401+ interface
(Cambridge Electronic Design Ltd, Cambridge, UK), personal com-
puter and Signal or Patch and Voltage-Clamp software (Cambridge
Electronic Design Ltd). Membrane current responses to voltage steps
were digitized at 1–3 kHz while those evoked by voltage ramps were
digitized at 0.2–1 kHz. All recorded potentials using standard pipette
solutions were corrected for a junction potential of 8 mV.
Recordings from CG neurons and those in slices involving changes
in external pH were made in a modified ACSF containing (mm): 126
NaCl, 3 KCl, 2 CaCl2, 1 MgCl2, 1.25 NaH2PO4, 11 d-glucose and 10
Hepes continuously bubbled with 100% O2. pH was adjusted by
titration with NaOH and checked after each recording. Tetrodotoxin
(TTX; 0.3 lm) was routinely included in all external recording
solutions to block voltage-gated Na+ channels. Changes in the external
K+ concentration were compensated for by equimolar alterations in the
external Na+ concentration. When Rb+ was included in the ACSF it
replaced equimolar K+. Drugs were bath-applied in the ACSF unless
otherwise stated. To prevent precipitation of Zn2+ the ACSF did not
contain NaH2PO4.
External solutions containing isoflurane were prepared as previ-
ously reported (Simon et al., 2001; Ranft et al., 2004). Briefly, a
saturated solution of isoflurane (15 mm; Scheller et al., 1997) was
prepared by adding an excess of anaesthetic to ACSF in a sealed glass
bottle and stirring for 3 h at room temperature. Simon et al. (2001)
found that dilutions between 1 : 30 and 1 : 7.5 of this stock solution
resulted in a final aqueous concentration of 0.2–0.3 mm after bubbling
with oxygen and delivery to the recording chamber. We routinely used
a 1 : 10 dilution in our experiments.
Data analysis
Single exponential fits to the activation and deactivation of subtracted
NA-sensitive current traces were performed using Signal software
(v2.0, Cambridge Electronic Design) according to the equation
It ¼ Aþ Bet=s ð1Þ
where It is current amplitude at time t, A and B are constants and s is
the time constant.
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Chord conductance was obtained by dividing the current by the
electromotive force (V ) Vrev) where V is the membrane potential and
Vrev the reversal potential. The resulting values could be described by
a Boltzmann function of the form
g=gmax ¼ 1=1þ exp½ðV  V0:5Þ=k; ð2Þ
where gmax is the maximum conductance, V is the membrane potential,
V0.5 the potential for half maximal activation and k is a slope constant.
The pH-sensitivity of facial motoneuron membrane current could be
described by a modified (four-parameter logistic) Hill equation
y ¼ ymin þ ðymax  yminÞ=½1þ ðpH=pKÞ
b ð3Þ
where y is the holding current or input conductance, ymax the
maximum response, ymin the minimum response and b ¼
–(b¢ * pK) ⁄ 0.434 where b¢ is the Hill coefficient expressed as a
function of H+ concentration.
The dose–response relationship for phenylephrine could be des-
cribed by the equation
y ¼ ymin þ ðymax  yminÞ=½1þ 10ðlog EC50X ÞnH ð4Þ
where y is the normalized response amplitude, ymax the maximum
response, ymin the minimum response, X is the phenylephrine (PE)
concentration and nH is the Hill coefficient. Fitting was performed
using Graphpad PrismTM software.
Drugs
4-Aminopyridine (4-AP), 5-hydroxytryptamine creatinine sulphate,
amphotericin B, barium chloride, bupivacaine, caesium chloride, NA
(arterenol bitartrate), PE hydrochloride, rubidium chloride, RR,
tetraethylammonium (TEA) chloride, and zinc chloride were all
obtained from Sigma-Aldrich Co. Ltd (Gillingham, Dorset, UK)
Anandamide, arachidonyltrifluoromethyl ketone (ATFK), methanand-
amide, propranolol hydrochloride, prazosin hydrochloride, TTX, WB
4101 [2-(2,6-dimethoxyphenoxyethyl)aminoethyl-1,4-benzodioxane
hydrochloride] and ZD-7288 [4-(n-ethyl-n-phenylamino)-1,2-dimeth-
yl-6-(methylamino) pyrimidinium chloride] were from Tocris Cook-
son (Bristol, UK). Isoflurane was obtained from Abbott Laboratories
Ltd (Maidenhead, UK).
Results
External pH modulates a gKLeak in facial motoneurons
Identification of mRNA for subunits belonging to the TASK and Kir2
families in the rat facial motor nucleus and the knowledge that
channels containing these subunits are sensitive to changes in external
pH prompted us to investigate the functional expression of pH-
sensitive K+ channels in neonatal rat facial motoneurons (Töpert et al.,
1998; Talley et al., 2000, 2001). We evaluated the effects of changing
the external pH on the resting membrane conductance under voltage-
clamp conditions in the presence of ZD-7288 to prevent contamination
by pH-sensitive Ih. Figure 1A illustrates current–voltage (I ⁄ V) plots
obtained in pH 8, 7 and 6 ACSF in the same facial motoneuron. The
I ⁄ V plots indicate that at a holding potential of )60 mV increasing the
external [H+] induced an inward current associated with a decrease in
membrane conductance. The current induced by changing external pH
(IpH), obtained by subtracting I ⁄ V plots obtained in each condition,
reversed close to the predicted EK, supporting the idea that at
potentials depolarized to the K+ equilibrium potential (EK) the net
inward current reflects the inhibition, by external protons, of a resting
outward K+ current. IpH appeared linear over the voltage range )40 to
)90 mV; however, some rectification was seen outwith this voltage
range (Figs 1B, 5B, and 9B and C). These properties are characteristic
of a pH-sensitive gKLeak.
Results summarized from a population of facial motoneurons,
voltage-clamped at )60 mV, indicate that switching from a standard
physiological external pH of 7.4 to pH 6 induced an inward current of
Fig. 1. Altering external pH around the physiological range modulates a leak
K+ conductance in facial motoneurons. (A) I ⁄ V relationships obtained using
voltage ramp commands from a facial motoneuron superfused with pH 6, pH 7
and pH 8 ACSF. Conductance decreases with increasing H+ concentration.
(B) Subtraction of the plots shown in A indicates that altering external pH
modulates a leak K+ conductance. (C) Chart recording showing the effects of
varying the pH of the ACSF on membrane current of a different facial
motoneuron voltage clamped at )60 mV. The horizontal bars indicate the
external pH and duration of application. Vertical deflections represent current
responses to voltage commands not illustrated in this figure. The ACSF
contained 3 mm K+ and the horizontal arrow indicates the zero current level.
(D) Plots of membrane current (left abscissa) and changes in membrane
conductance, normalized to the conductance at pH 7.5 (right abscissa), at
different external pH taken from the facial motoneuron illustrated in C above.
Conductance measurements were obtained by linear regression of the I ⁄ V
relationship between )60 and )80 mV. The sensitivity of changes in membrane
current and conductance to external pH could be described by a four-parameter
logistic function (eqn 3, Methods). pK values of 7.2 and 7.3 and Hill slopes of
1.2 and 1 were obtained for current and conductance changes, respectively.
(E) Averaged data (SEM, n ¼ 8) showing the pH sensitivity of changes in
membrane conductance normalized to the conductance at pH 7. The relation-
ship could be described by eqn 3 with a pK value of 7.1 ± 0.1 and a Hill slope
of 1.5 ± 0.4 (R2 ¼ 0.9874).
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)46 ± 6 pA associated with a decrease in membrane conductance
from 7.13 ± 0.77 nS to 5.29 ± 0.55 nS (n ¼ 12; mean ± SEM).
Under the same conditions, switching from pH 7.4 to pH 8 resulted
in an outward current (22 ± 8 pA) and a conductance increase to
9.2 ± 1.5 nS (n ¼ 4; membrane conductance at pH 7.4 for the same
facial motoneurons was 8.3 ± 1.6 nS). Irrespective of the inward or
outward nature of the change in membrane current the reversal
potential (VpH) was close to the predicted EK (pH 7.4–6,
VpH ¼ )93 ± 1.4 mV; pH 7.4–8, VpH ¼ )89 ± 3 mV). Altering the
external K+ concentration ([K+]o) to 7 mm moved the VpH to
)66 ± 1.3 mV (n ¼ 7), in close agreement with the change predicted
by the Nernst equation.
The pH-sensitivity of gKLeak was investigated further. Figure 1C
shows a representative chart record of membrane current from a facial
motoneuron voltage clamped at )60 mV to which ACSF of varying pH
was applied. The time required for the pH-induced current changes to
reach a steady state varied from 2 to 5 min.We attribute this to the depth
of the recorded facial motoneuron in the slice, the relatively slow
exchange of ACSF in the recording chamber and the H+ buffering
capacity of the slice. The amplitude of IpH and the change in
conductance over a range of external pH could be described by a
modified Hill equation (see eqn 3) (Fig. 1D and E). As illustrated in
Fig. 1D (for the facial motoneuron shown in Fig. 1C) measuring either
parameter gave closely similar values for pH-sensitivity. Data taken
from eight facial motoneurons, each of which was exposed to at least
four changes in external pH, indicated a fit of the pH-evoked
conductance with a pK value of 7.1 ± 0.1 and a Hill slope of
1.5 ± 0.4 (± SEM, R2 ¼ 0.9874). The pH-sensitive K+ conductance
wasmaximal at pH 8.2 and no further decrease in conductance was seen
below pH 6. These data indicate that at physiological pH ( 7.4) the
resting pH-sensitive gKLeak is approximately 70% of its maximal level.
NA inhibits a gKLeak in neonatal rat facial motoneurons
The biophysical properties of the pH-sensitive gKLeak closely
resemble those previously described for the 5-HT-sensitive gKLeak in
neonatal rat facial motoneurons (Larkman & Kelly, 1998). NA had
also been shown to inhibit a similar conductance in adult rat facial
motoneurons (Larkman & Kelly, 1992). Bath-application of NA also
induced an inward current in neonatal rat facial motoneurons voltage-
clamped at )60 mV in standard ACSF containing 3 mm K+ (Fig. 2A,
inset). ZD-7288 (5–10 lm) was again used to block Ih in these
experiments. The NA-induced inward current was unaffected by
external TTX (0.3 lm) or zero Ca2+, 5 mm Mg2+ ACSF. I ⁄ V
relationships indicated that the inward current was associated with a
decrease in membrane conductance (Fig. 2A). In a representative
sample of facial motoneurons, NA (10 lm) induced an inward current
of )58 ± 7 pA (n ¼ 19) associated with a conductance decrease from
9.4 ± 0.8 nS to 7.3 ± 0.7 nS. As seen for IpH, the NA-induced current
(INA) appeared linear over the voltage range )40 to )90 mV; however,
some rectification was seen outwith these voltages (Figs 2B, 4B, 5C–
E, 7A and B, and 8A and B). INA reversed at )96 ± 3 mV (n ¼ 19),
)70 ± 2 mV (n ¼ 16) and )61 ± 2 mV (n ¼ 14) when the ACSF
contained 3, 7 or 12 mm K+, respectively, in agreement with
predictions for the EK obtained from the Nernst equation (Fig. 2B).
These properties suggest that NA inhibits a gK+ with properties very
similar to the pH-sensitive gKLeak. Subtracted current records
(Fig. 2C) indicated that the NA-sensitive gKLeak displayed rapid,
voltage-independent, activation and deactivation kinetics. Subtracted
currents obtained after stepping from )60 mV to )40 mV displayed
activation and deactivation time constants of 9 ± 1.6 ms (n ¼ 7) and
6.6 ± 0.3 ms (n ¼ 8), respectively. Stepping to )90 mV from
)60 mV revealed activation and deactivation time constants of
6.9 ± 1.1 ms and 8.5 ± 0.7 ms (n ¼ 8), respectively.
Application of a maximal concentration of NA (10 lm) or the
a1-adrenergic receptor agonist PE (30 lm), in the continued presence
of a maximal concentration of 5-HT (10 lm) failed to induce any
further inward current (Fig. 2D and E), suggesting that the two
transmitters act on a shared population of leak K+ channels. 5-HT
Fig. 2. Noradrenaline inhibits a leak K+ conductance in neonatal rat facial
motoneurons. (A) I ⁄ V relationships obtained from a facial motoneuron
voltage-clamped at )60 mV in the presence (open triangles) and absence
(filled squares) of NA (10 lm). Inset: the inward current evoked by bath-
application of NA (duration indicated by horizontal bar) to the same facial
motoneuron. Vertical deflections are attenuated current responses to voltage
step and ramp commands (data not shown). (B) Plots of NA-induced current
(INA) in ACSF containing 3 and 12 mm K
+. INA shows a small degree of open
rectification, more prominent at negative potentials, and reverses at the
predicted EK+. (C) Superimposed expanded current responses to voltage step
commands of variable amplitude (lower left) before (control) and during (NA)
application of NA (10 lm). ACSF contained 7 mm K+ and the horizontal arrow
indicates the zero current level. Traces in C (bottom right) are subtracted
records of INA in response to )30 mV (upper trace) and +20 mV (lower trace)
voltage steps. Single exponential curves with the time constants (s) indicated
(eqn 1, Methods) have been superimposed on the activation and deactivation
phases of the currents. (D) Chart records of membrane current from another
facial motoneuron voltage clamped at )60 mV showing the NA-induced
inward current is occluded by the 5-HT-induced inward current. (E) Plots of
NA- and 5-HT-induced current (from the records shown in D) share the same
biophysical properties and occlude over the whole voltage range tested.
Maximal concentrations of bath applied 5-HT (10 lm) and NA (10 lm) were
used. Calibration bars in D are 50 pA and 60 s.
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(10 lm), PE (30 lm) or NA (10 lm) applied alone induced inward
currents of )45 ± 4 pA (n ¼ 5), )45 ± 5 pA (n ¼ 2) and
)34 ± 2 pA (n ¼ 3), respectively (Vh ¼ )50 mV, [K+]o ¼ 7 mm).
Co-application of either 5-HT and PE or 5-HT and NA induced inward
currents of )43 ± 3 pA and )47 ± 8 pA, respectively. The transmit-
ter-induced current over the range of voltage )30 to )90 mV
possessed the same properties whether 5-HT or NA were applied
together or separately (Fig. 2E).
NA and changes in external pH modulate the same gKLeak
If NA and external pH (and 5-HT) alter facial motoneuron excitability
by modulating the same gKLeak, the effects of lowering external pH
and transmitter application should occlude. The NA-induced inward
current was examined in conditions designed to inhibit (pH 6.5) and
activate (pH 7.7) IpH (Fig. 3A). When external pH was increased to
7.7, a maximal concentration of NA (10 lm) induced a robust inward
current of )109 ± 19 pA (n ¼ 5). Lowering external pH to 6.5 led to
a dramatic reduction in INA to )34 ± 9 pA in the same facial
motoneurons. In the example shown in Fig. 3A the response to NA
was almost completely occluded when the external pH was 6.5.
Figure 3B shows that at pH 6.5, INA was occluded over the whole
voltage range examined while at pH 7.7 the amplitude and the
properties of INA were almost identical to those of the current induced
by switching the external pH from 7.7 to 6.5. This supports the idea
that both external pH and NA modulate the same gKLeak and that both
have an equivalent maximal level of inhibition.
Lowering external pH has been shown to alter agonist receptor
interactions for some adrenoceptors. It was therefore important to
confirm the identity of the adrenoceptor mediating these actions in
neonatal rat facial motoneurons. PE mimicked the ability of NA to
inhibit gKLeak with an EC50 of 1 lm (n ¼ 12, Fig. 4A–C). The
b-adrenergic receptor agonist isoproterenol (5–100 lm) had no effect
on gKLeak (n ¼ 3). NA- and PE-induced inhibition of gKLeak could be
abolished by bath-application of the a1-adrenergic receptor antagonists
prazosin (0.5–1 lm, n ¼ 5) or WB-4101 (10 lm, n ¼ 2) (Fig. 4A and
B). Modulation of gKLeak by NA and PE was not blocked by the
b-adrenergic receptor antagonist propranolol (10 lm; n ¼ 3, Fig. 4D).
The effects of TASK channel blockers on the pH-
and NA-sensitive gKLeak
The pH-sensitivity of gKLeak suggested to us that TASK channels
might contribute to this conductance. The pharmacological properties
of facial motoneuron gKLeak are summarized in Table 1. Low
micromolar concentrations of the endogenous cannabinoid ananda-
mide block homomeric human TASK-1 channels (Maingret et al.,
2001). Homomeric TASK-3 channels are blocked by higher concen-
trations of anandamide. Bath-application of anandamide (10–20 lm)
had no effect on facial motoneuron resting membrane conductance at
the holding potential ()50 mV) in pH 7.4 ACSF (n ¼ 4) or on the
decrease in gKLeak induced either by NA (10 lm) or lowering the
external pH from 7.4 to 6 (Fig. 5A). INA at a holding potential of
)50 mV (3 mm [K+]o) was )53 ± 3 pA in the absence of anandamide
compared with )52 ± 3 pA in its presence (n ¼ 3).
It has been reported that anandamide may be metabolically
degraded in certain in vitro conditions and that this can be prevented
by ATFK (Barbuti et al., 2002). When applied alone for up to 20 min,
ATFK (10 lm) had no effect on the pH- or NA-induced currents
(n ¼ 2). Subsequent co-application of anandamide (10 lm) again
failed to induce a membrane current or affect the currents induced by
application of NA or lowering pH. Methanandamide is a metabolically
stable analogue of anandamide that has also been shown to inhibit
TASK-1 channels (Maingret et al., 2001). Methanandamide (20 lm)
also failed to have any effect on the resting membrane current and
failed to inhibit the NA-induced response (n ¼ 4, Fig. 5B).
Homomeric TASK-3, but not TASK-1, channels are inhibited by
RR (Czirják & Enyedi, 2003). Application of RR (10 lm) to facial
motoneurons had no effect on holding current at )50 mV (n ¼ 4). Co-
application of NA (10 lm) in the presence of RR (10 lm) induced an
inward current indistinguishable from the control response obtained in
the absence of the TASK-3 blocker (Fig. 5C). Thus, inward INA at a
holding potential of )50 mV (3 mm [K+]o) was )50 ± 8 pA in the
absence of RR compared with )59 ± 6 pA in its presence (n ¼ 4).
The VNA was also unaffected by the presence of RR.
Actions of ruthenium red and methanandamide on cultured
cerebellar granule cells
The absence of any effects of anandamide, methanandamide, and RR
on facial motoneurons prompted us to examine the activity of our
drugs. We therefore tested the ability of RR and methanandamide to
inhibit putative TASK channel-mediated currents in cultured rat CG
cells (Maingret et al., 2001; Han et al., 2002; Kang et al., 2004).
Fig. 3. Inhibition of the leak K+ conductance by lowering external pH
occludes the effects of NA. (A) Plot of membrane current against time for a
facial motoneuron voltage-clamped at )60 mV. Solid and dashed horizontal
bars indicate the times when the slice was superfused with pH 7.7 and pH 6.5
ACSF, respectively. Arrows indicate points at which NA (10 lm, 15 s) was
added to the ACSF. Note the almost complete occlusion of the NA-induced
inward current in pH 6.5 ACSF. (B) Plots of the current induced by switching
from pH 7.7 to pH 6.5 ACSF and the NA-induced current in both conditions.
Data in A and B are from the same facial motoneuron. Occlusion of the NA-
induced current by pH 6.5 ACSF was independent of membrane potential.
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Lowering pH to 6 from 7.4 induced an inward current in CG cells with
characteristics of a TASK-mediated leak K+ conductance (insets to
Fig. 5B and C). RR (10 lm) also induced an inward current that was
53 ± 2% (n ¼ 3) of the amplitude of tha induced at pH 6. The actions
of RR partially occluded the current induced at pH 6. Bath-application
of methanandamide (20 lm) had a smaller effect on CG cells,
inducing an inward current with characteristics of gKLeak that was
18% of the current induced at pH 6 (inset Fig. 5D). These actions are
consistent with reported effects of RR and methanandamide on
TASK-1 and TASK-3 channels in cultured CG neurons (Maingret et al.,
2001; Han et al., 2002; Lauritzen et al., 2003; Kang et al., 2004). The
insensitivity to anandamide of facial motoneuron gKLeak should not be
Fig. 4. Noradrenaline, acting through a a1 receptor, inhibits the same leak K
+ conductance as 5-HT. (A) Chart records of membrane current from a facial
motoneuron voltage-clamped at )60 mV showing that the inward currents evoked by bath-application of phenylephrine (PE, 30 lm) and NA (5 lm) were inhibited
by the a1 receptor antagonist, prazosin (0.5 lm). The response to 5-HT (10 lm) was unaffected by this antagonist. (B) The NA- and PE-induced currents, obtained
by subtraction of current responses to voltage ramps, share the same biophysical properties and are blocked over the whole voltage range by prazosin. (C) Dose–
response curve for PE. Response amplitude was normalized to the response to 5-HT (10 lm). Data points represent mean ± SEM for five different facial
motoneurons. The solid line represents a fit of the data to eqn 4 (Methods) with an EC50 of 1 lm and a Hill slope of 0.71. (D) Chart records of membrane current
from a facial motoneuron voltage-clamped at )60 mV showing a lack of effect of the b-adrenergic receptor antagonist, propranolol (10 lm), on the currents induced
by NA (5 lm). Calibration bars in A and D are 50 pA and 60 s.
Table 1. Comparative pharmacology of TASK channels and rat facial motoneuron gKLeak
TASK-1 TASK-3 TASK-1 ⁄ TASK-3 Rat FM gKLeak
pK1  7.5 (r)  6.8 (r)  7.3 (r)  7.1
Isoflurane (0.3 mm)1 No effect (r)  +80% (r)  +50% (r)  +55%
Methanandamide (10 lm)1  )85% (r)  )64% (r)  )55% (r) No effect
Ruthenium red (5 lm)3 No effect (r)  – 85% (r) No effect (r) No effect (10 lm)
Zn2+ (100 lm)2,7,8  )40% (r) No effect (r) No data No effect (r)
No effect (h)  )70% (h)  )20% (h)
Bupivacaine (100 lm)7,8  )60% (r)  )50% (r) No data  )30%
Ba2+ 7,9 IC50 400 lm (r) IC50 300 lm (r) No data  )90% (500 lm)
Cs+ 4,7,10  )30% (100 lm, r)  )75% (3 mm, r) No data No effect (300 lm)
No effect (10 mm, h)  )85% (1 mm)
4-AP5,8  )15% (10 mm, r) No data No data  )60% (4 mm)
TEA5,6,7,8  )30% (100 mm, r) No effect (1 mm, r) No data No effect (30 mm)
Values indicated are percentage current increase (+) or decrease (–) in the presence of the drug indicated, except for the sensitivity of TASK-1 and TASK-3
homomers to Ba2+ for which the IC50 is given. Values for Ba
2+ and Cs+ reflect optimal voltage-dependent blocker sensitivity. Species is either rat (r) or human (h).
Where non-uniform drug concentrations are compared the concentrations are given in parentheses in the table. Data for TASK-1 ⁄ TASK-3 heterodimer refers to
concatenated TASK-1 ⁄ TASK-3 construct. Data taken from 1Berg et al. (2004), 2Clarke et al. (2004), 3Czirják & Enyedi (2002a), 4Czirják & Enyedi (2002b),
5Czirják et al. (2000), 6Duprat et al. (1997), 7Kim et al. (2000), 8Leonoudakis et al. (1998), 9Lopes et al. (2001) and 10Meadows & Randall (2001).
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overstated. A recent report suggests that unlike human TASK-1 and
TASK-3 channels the rat homologues are not particularly sensitive to
low concentrations of anandamide and that higher concentrations fail to
discriminate the two channel types (Berg et al., 2004).
The effects of Zn2+ and bupivacaine on the pH- and
NA-sensitive gKLeak
Homomeric human (h)TASK-1 channels, expressed in cell lines,
display little sensitivity to Zn2+ (100 lm) whereas homomeric
hTASK-3 channels are substantially (70%) blocked at this concen-
tration (Leonoudakis et al., 1998; Clarke et al., 2003, 2004). Bath-
application of Zn2+ (100–300 lm) did not significantly affect facial
motoneuron membrane current (+3 ± 1.7 pA at )60 mV) or membrane
slope conductance (5 ± 0.5 to 5.5 ± 0.5 nS in the presence of Zn2+
over the range )90 to )60 mV, n ¼ 5) in pH 7.4 ACSF. In the same
facial motoneurons, superfusion with pH 6 ACSF induced an inward
current of )49 ± 11 pA and decreased membrane conductance to
3.6 ± 0.7 nS. IpH obtained by changing external pH from 6 to 7.7 was
unaffected by the presence of Zn2+. Consistent with its lack of effect on
IpH, Zn
2+ (100–300 lm) also failed to alter INA (Fig. 5D). Thus, inward
INA at the holding potential ()52 mV, 7 mm [K
+]o) was )51 ± 20 pA
(n ¼ 2) and outward INA at )102 mV was 92 ± 28 pA (n ¼ 3). These
values compared with )44 ± 13 pA and 88 ± 29 pA at )52 mV and
)102 mV, respectively, in the presence of Zn2+ (300 lm). Despite this
lack of effect on gKLeak, Zn
2+ did inhibit a small enhancement of gCa2+
seen in some facial motoneurons (Fig. 5D).
The local anaesthetic bupivacaine has been shown to block non-
selectively TASK-1 and TASK-3 channels with IC50 values of about
100 lm (Leonoudakis et al., 1998; Kim et al., 2000). Bupivacaine
(100 lm) induced an inward current in four facial motoneurons tested
but in two further motoneurons bupivacaine (50 lm) failed to alter
membrane current. At a holding potential of )50 mV (3 mm [K+]o)
bupivacaine (100 lm) induced a current of )49 ± 12 pA (n ¼ 4),
which reversed at )87 ± 3 mV and displayed the linear I ⁄ V relation-
ship characteristic of inhibition of gKLeak (Fig. 5E). The NA-induced
inward current was partially and reversibly occluded by bupivacaine.
Thus, NA (10 lm) induced a current of )137 ± 33 pA and
)94 ± 22 pA in the absence and presence of bupivacaine, respect-
ively, representing occlusion by 29 ± 8%.
The effects of isoflurane on gKLeak
In a recent study of rat TASK channels the volatile anaesthetic
isoflurane inhibited homomeric TASK-1 current but enhanced current
carried by homomeric TASK-3 and heteromeric TASK-1 ⁄ TASK-3
channels (Berg et al., 2004). This enhancement was seen even when
the current was optimally activated by external pH. We investigated
the effects of isoflurane on facial motoneuron gKLeak when the
conductance was optimally activated by an external solution of pH 8.
Bath-application of isoflurane (see Methods for solution preparation)
increased gKLeak in four out of five facial motoneurons tested
(Vrev ¼ )63 ± 2 mV in ACSF containing 7 mm K+, Fig. 6A and B).
Expressed as a percentage of the maximal pH-sensitive current at
)100 mV, obtained by exposing each facial motoneuron sequentially
to ACSF of pH 8 and pH 6, isoflurane enhanced the pH-sensitive
current by 55 ± 6% (n ¼ 4). It is noteworthy that in the remaining
facial motoneuron isoflurane reversibly and reproducibly inhibited
gKLeak.
The effects of Ba2+, Cs+ and Rb+ on gKLeak
Block by external Ba2+, Cs+ and Rb+ is a characteristic of inwardly
rectifying K+ channels and the effects of these ions on TASK channels
are subtype dependent. Ba2+ (at concentrations of 0.5–2 mm)
substantially blocks INA at hyperpolarized potentials, where current
flow through gKLeak is inward, but has a much more limited effect at
depolarized potentials where current flow is outward. Thus, at
)117 mV and )40 mV in the absence of Ba2+, INA was
139 ± 81 pA and )74 ± 12 pA whereas in its presence these values
were 16 ± 14 pA and )47 ± 4 pA, reflecting 10 ± 6% and 75 ± 9%
Fig. 5. Homomeric TASK-1 and TASK-3 channel blockers have no effect on
the NA- and pH-sensitive leak K+ conductance. (A) A chart recording
showing membrane current against time for a facial motoneuron voltage-
clamped at )50 mV. Horizontal bars indicate the times when the slice was
superfused with pH 7.4 ACSF, pH 6 ACSF and anandamide (10 lm). The
horizontal arrow indicates the zero current level. Vertical deflections are
attenuated current responses to ramp voltage commands (data not shown) used
to generate I ⁄ V data. Anandamide failed to alter membrane current in pH 7.4
ACSF and had no effect on the amplitude or time course of the inward current
induced by perfusion with pH 6 ACSF. (B) Plots of the methanandamide
(20 lm)-induced current (IMA) and the NA-induced current in the absence
(INA(Control)) and presence (INA(MA)) of methanandamide. Methanandamide
does not inhibit gKLeak or INA. Inset: the currents induced by methanandamide
(10 lm) and pH 6 ACSF in a cultured rat cerebellar granule cell. (C) Plots of
INA in the presence and absence of ruthenium red (10 lm). Note that the
currents superimpose, indicating a lack of effect of ruthenium red. Inset: I ⁄ V
plots from a cultured rat cerebellar granule cell indicating that ruthenium red
(10 lm) and pH 6 ACSF both significantly inhibit a gKLeak in these neurons.
(D) Zn2+ (300 lm) fails to block the actions of NA on facial motoneuron
gKLeak but does abolish an inflection attributable to enhanced gCa
2+.
(E) Plots of the current induced by bupivacaine (IBP, 50 lm), NA (INA
10 lm) and NA in the presence of bupivacaine (INA(BP)). ACSF contained
3 mm K+ in A, B, C and E and 7 mm K+ in D.
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of control values, respectively (n ¼ 4) (Fig. 7A and B). We had
previously suggested that because the Ba2+-sensitive component of I5-
HT (Larkman & Kelly, 1998) and now INA displayed inward
rectification the actions of Ba2+ might represent modulation of an
inwardly rectifying K+ conductance (gKir) (Fig. 7C). However, fitting
a Boltzmann function to the chord conductance of the Ba2+-sensitive
component of INA obtained in different [K
+]o indicated that the V0.5 of
activation was relatively independent of [K+]o, and hence the EK
(Fig. 7D, [K+]o ¼ 3 mm, V0.5 ¼ )23 mV, slope ¼ )8.5 mV;
[K+]o ¼ 12 mm, V0.5 ¼ )29 mV, slope ¼ )10.2 mV), suggesting
properties distinct from gKir.
The effect of Ba2+ on facial motoneuron membrane conductance
does, however, appear to result from inhibition of both gKLeak and
gKir. At pH 6, where IpH is maximally inhibited, Ba
2+ inhibited an
inwardly rectifying component of membrane current that reversed at
the predicted EK (data not shown). When external pH was raised to 7.7
the Ba2+-sensitive current was increased preferentially at hyperpolar-
ized potentials. Figure 7E indicates the properties of IpH obtained by
changing the external pH from 6 to 7.7 in the absence and presence of
Ba2+. As for INA, Ba
2+ displays a preferential block of IpH at
hyperpolarized potentials such that the Ba2+-sensitive IpH showed
similar voltage dependence to that of Ba2+-sensitive INA (Fig. 6F). At
)90 mV Ba2+ (1 mm) inhibited IpH by 84 ± 20% while at )30 mV
inhibition was 13 ± 15% (n ¼ 3, 7 mm [K+]o, VpH ¼ )66 ± 1 mV).
Cs+ (1 mm) induced an outward current of 181 ± 17 pA at
)102 mV without significantly altering the holding current at
)52 mV (10 ± 3 pA, n ¼ 2, pH ¼ 7.4, 7 mm [K+]o). At this
concentration Cs+ significantly reduced INA at )102 mV to 15 ± 3%
of control but had less effect at the holding potential (79 ± 8% of
control INA) (Fig. 8A). The VNA was )67 ± 1 mV and )67 ± 2 mV in
the absence and presence of Cs+, respectively. These effects were also
observed in 5 mm Cs+ (n ¼ 2). Cs+ (300 lm) had a smaller effect on
membrane current at )102 mV, reducing it by 69 ± 2 pA again
without a significant effect at the holding potential ()8 ± 5 pA,
n ¼ 2). This concentration of Cs+ failed to alter INA or IpH at any
potential (Fig. 8B) suggesting at least partial inhibition of gKir but not
the pH- and NA-sensitive gKLeak.
The block of TASK conductances by Ba2+ but not Cs+ displays a
time dependence (Czirják et al., 2001; Czirják & Enyedi, 2002b).
Subtracted current records of Ba2+- and Cs+-sensitive gKLeak in facial
motoneurons evoked by voltage steps to )100 mV were indistin-
guishable in terms of the kinetics of block by either ion, both showing
rapid current block (data not shown).
Low permeability to Rb+ is a characteristic of some inwardly
rectifying K+ channels while several members of the TASK family
show considerable Rb+ permeability (Lopes et al., 2000). Rb+ voltage-
dependently blocked facial motoneuron INA in a manner similar to that
seen for Ba2+ and Cs+ (Fig. 8C). At )50 mV, NA (10 lm) induced an
inward current of )33 ± 5 pA (n ¼ 6) in ACSF containing 7 mm K+
and )23 ± 6 pAwhen this was replaced with 7 mm Rb+ (77 ± 14% of
Fig. 6. Isoflurane enhances the pH-sensitive leak K+ conductance.
(A) I ⁄ V relationships obtained using voltage ramp commands from a facial
motoneuron superfused with pH 6, pH 7, pH 8 and pH 8 with isoflurane
(concentration as indicated in Methods) ACSF. Isoflurane (Iso) increases
gKLeak even when the conductance is optimally activated by pH 8 ACSF.
(B) Subtraction of the plots shown in A indicating greater activation of the
pH-sensitive gKLeak in the presence of isoflurane (pH 6 – pH 8 + Iso) than in
its absence (pH 6 – pH 8).
Fig. 7. Ba2+ ions voltage-dependently block the NA- and pH-sensitive leak
K+ conductance. (A and B) Plots of NA-induced current at different voltages
obtained in the absence and presence of Ba2+ (2 mm) in ACSF containing
3 mm (A) and 12 mm (B) K+. Note the voltage dependence of the Ba2+
block. (C) Plots of the Ba2+-sensitive component of the NA-induced current
(INA) obtained by subtraction of plots shown in A and B. (D) Plots of the
chord conductance (G) of the Ba2+-sensitive component of the NA-induced
current (INA) (obtained as described in Methods) against voltage. Curve fitting
was performed using eqn 2 (Methods). V0.5 were )23 mVand )29 mVand the
slopes were )8.5 mV and )10.2 mV in 3 and 12 mm K+ ACSF, respectively.
Gaps were introduced into the traces because of a large increase in signal noise
as the membrane potential approached the VNA. (E) Plots of current induced
by switching from pH 7.7 to pH 6.5 ACSF at different voltages obtained in the
absence and presence of Ba2+ (1 mm). ACSF contained 7 mm K+. Note again
the voltage dependence of the Ba2+ block. (F) Plot of the Ba2+-sensitive
component of IpH obtained by subtraction of plots shown in E.
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control). At )100 mV, INA was +51 ± 18 pA and )3 ± 11 pA in K
+-
and Rb+-containing ACSF, respectively, reflecting a reduction to
)3 ± 11% of the control amplitude. Replacement of external K+ with
Rb+ also voltage-dependently inhibited I5-HT in facial motoneurons
(Larkman & Kelly, 1998).
The effects of TEA and 4-AP on gKLeak
We have previously characterized the sensitivity of I5-HT to the K
+
channel blockers TEA and 4-AP (Larkman & Kelly, 1998). As can be
seen in Fig. 9 these channel blockers have closely similar actions on
INA and IpH. TEA (30 mm) added to either 3 or 12 mm K
+ ACSF had
no significant effect on INA over the potential range tested (n ¼ 7,
Fig. 9A). The addition of 4-AP (4 mm) did, however, inhibit INA over
the whole voltage range without altering the VNA (n ¼ 3, Fig. 9A).
Thus, at )100 mV, 4-AP reduced INA to 37 ± 22% of the control
amplitude while at )40 mV INA was 31 ± 14% of the control level.
We next evaluated the effects of TEA and 4-AP on IpH evoked by
switching from ACSF of pH 7.5 to pH 6.5. IpH was also unaffected by
TEA (30 mm) but could be inhibited by 4-AP at concentrations
equivalent to those required to block INA (n ¼ 3, Fig. 9B and C). At
)100 mV and )40 mV, in the presence of TEA, IpH was 86 ± 14%
and 103 ± 3% of the control amplitudes, respectively, while addition
of 4-AP (4 mm) to the ACSF reduced these values to 19 ± 11% and
32 ± 8%, respectively.
Discussion
Amine neurotransmitters and external pH modulate the same
gKLeak
Our results characterize a pH-sensitive gKLeak that contributes to the
resting membrane conductance of neonatal rat facial motoneurons. NA
also inhibits a gKLeak in neonatal rat facial motoneurons, as seen
previously in the adult rat, and several lines of evidence support the
idea that this is the pH-sensitive conductance. First, NA and lowering
external pH below the normal physiological level (pH 7.4) inhibited a
current that displayed rapid kinetics, a small amount of rectification
over the potential range )120 to )40 mV and a reversal potential at
the predicted EK. Secondly, lowering external pH occluded the actions
of NA. Responses to NA were also occluded by 5-HT-induced
inhibition of gKLeak. Maximal concentrations of NA decreased
membrane conductance to a level very close to the maximum level
of inhibition obtained by lowering external pH. Thirdly, raising the
external pH above pH 7.4 induced an outward current associated with
an increase in membrane conductance and under these conditions the
amplitude of the inward current induced by NAwas increased. Finally,
the pH- and NA-sensitive gKLeak displayed a common pharmacology
to a wide range of K+ channel blockers. In combination, these results
support a common target of modulation.
One possible explanation for the occlusion of the NA-mediated
response by low external pH is a change in protein structure that disrupts
agonist–receptor interactions. Reports suggest a2- but not a1-adreno-
Fig. 8. Cs+ and Rb+ ions voltage-dependently block the NA-induced current. (A and B) Plots of NA-induced current in the presence and absence of 1 mm
(A) or 300 lm (B) Cs+. Note that Control and Cs+ plots in B superimpose, indicating that 1 mm but not 300 lm Cs+ blocks INA preferentially at hyperpolarized
potentials. (C) Plots of NA-induced current in 7 mm K+- or 7 mm Rb+-containing ACSF. Rb+ voltage-dependently blocks INA. Records in A and B were from the
same facial motoneuron and were obtained in ACSF containing 7 mm K+.
Fig. 9. 4-Aminopyridine (4-AP), but not tetraethylammonium (TEA) blocks NA- and pH-sensitive currents in facial motoneurons. (A) Plots of NA-induced
current in the presence of TEA (30 mm, open squares), TEA and 4-AP (4 mm, filled triangles) and under control conditions with neither drug present (filled squares).
The block observed in the presence of 4-AP showed little voltage dependence. ACSF contained 3 mm K+. (B and C) Plots showing the current induced by changing
from pH 7.5 to pH 6.5 ACSF is blocked by 4-AP (4 mm, B) but not by TEA (30 mm, C). ACSF contained 7 mm K+.
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ceptors display alterations in functional responses associated with
changes in agonist binding affinity over the pH range 6–8 (Curro &
Greenberg, 1983; Nunnari et al., 1987; Tateishi & Faber, 1995). Our
studies indicate an a1-adrenoceptor mediates inhibition of gKLeak in
facial motoneurons. This is consistent with ligand-binding and in situ
hybridization data showing a1-adrenoceptor mRNA and protein
expression in all cranial motor nuclei (Pieribone et al., 1994). It is
therefore unlikely that occlusion of the NA-mediated modulation of
gKLeak by lowexternal pH is due to altered agonist–receptor interactions.
pH-sensitivity of the amine-sensitive gKLeak
The presence of mRNA for the pH-sensitive K+ channels TASK-1 and
TASK-3 in the facial motor nucleus makes these channels potential
candidates for gKLeak (Talley et al., 2000; Karschin et al., 2001).
TASK-1 and TASK-3 channels mediate openly rectifying, non-
inactivating, whole-cell currents similar to the pH- and NA-sensitive
gKLeak in facial motoneurons (Duprat et al., 1997; Leonoudakis et al.,
1998; Kim et al., 2000; Rajan et al., 2000; Talley et al., 2000; Vega-
Saenz de Miera et al., 2001). Activation and inactivation are described
as ‘instantaneous’. For example, TASK-3 channels expressed in
Xenopus oocytes displayed time constants of around 4 ms, not very
dissimilar from the values of 8–9 ms described here (Rajan et al.,
2000). The sensitivity of TASK-1 channels to external pH lies across
the physiological range with a pK of about 7.3–7.5 (Duprat et al.,
1997; Talley et al., 2000). The pK for TASK-3 channels is
approximately one pH unit lower in the range 6–6.7 (Kim et al.,
2000; Rajan et al., 2000; Vega-Saenz de Miera et al., 2001) such that
at physiological pH a TASK-3-mediated conductance should be
maximally activated. The pH-sensitive gKLeak of facial motoneurons
has a pK close to 7.1, between the published ranges for either
homomeric channel. At pH 7.4 it is activated to approximately 70% of
its maximal level, suggesting against a homomeric TASK-3 identity.
The pH-sensitivity of facial motoneuron gKLeak was determined in
physiological external [K+] (3 mm) so the pK cannot be attributed to a
previously described effect of high external [K+] on TASK-1 channels
(Lopes et al., 2000, 2001).
Interestingly, human Kir2.4 is inhibited by external H+ over the
range pH 6–8 with a pK of 7.1 (Karschin et al., 1996; Töpert et al.,
1998; Hughes et al., 2000). Kir2.4 mRNA, along with mRNA for
Kir2.1 and Kir2.2, is expressed in some neonatal rat facial motoneu-
rons. As such, determining pH-sensitivity alone may not be sufficient
to distinguish TASK and Kir2 channel types (Karschin & Karschin,
1997; Töpert et al., 1998). It has, however, been suggested that rat
Kir2.4 channels are only slightly pH-sensitive (unpublished observa-
tions in Talley et al., 2000).
Pharmacology of the amine-sensitive gKLeak
The lack of effect of methanandamide or anandamide, with or without
pre-application of the metabolic inhibitor ATFK, suggests against a
TASK-1 identity for facial motoneuron gKLeak, though as noted earlier
the potency of these ligands against rat TASK-1 channels is lower than
for human TASK-1 (Berg et al., 2004). Equally, the inability of RR to
block gKLeak suggests against a TASK-3 identity. The expected effects
of these ligands observed in cultured CG cells indicate that our
negative results cannot be attributed to factors that might affect the
activity of these drugs or their delivery to our slices. Recently, Zn2+
has been used to discriminate between human TASK-1 and TASK-3
channels (Clarke et al., 2003). Human TASK-1 is unaffected by Zn2+
(100 lm) whereas the same concentration blocks hTASK-3 by greater
than 70% (IC50 ¼ 20 lm). While the insensitivity of the pH- and
NA-sensitive gKLeak to Zn
2+ also argues against a TASK-3 channel
identity there is a suggestion that rat TASK-3 channels are insensitive
to Zn2+ (100 lm) (Leonoudakis et al., 1998; Kim et al., 2000).
Recently, however, the gKLeak in rat CG neurons has been shown to be
substantially blocked by Zn2+ (100 lm) (Clarke et al., 2004).
It is of interest that the local anaesthetic bupivacaine inhibited a
conductance that shared the properties of gKLeak and at least partially
occluded the actions of NA in some facial motoneurons. Bupivacaine
inhibits both TASK-1 and TASK-3 channels with roughly equivalent
potency (Leonoudakis et al., 1998; Kim et al., 2000) and its ability to
block a pH-sensitive gKLeak in thalamocortical neurons appears
sufficient to ascribe this a TASK channel-mediated conductance
(Meuth et al., 2003). Nevertheless, bupivacaine also has actions on
other channels including some voltage-gated K+ channels (González
et al., 2001). Thus, while the current blocked by bupivacaine in facial
motoneurons is consistent with a TASK-like gKLeak, the additional
block of other K+ channels may also contribute to the overall effect of
this drug.
Rb+ voltage-dependently blocks the NA- and pH-sensitive gKLeak
in facial motoneurons; however, the Rb+ permeability of TASK-1
channels is equivalent to that of K+, although with a lower relative
conductance (Lopes et al., 2000). This suggests that if TASK-1
channels underlie gKLeak, Rb
+ might be expected at least partially to
support this conductance. Cs+ (100 lm) partially blocks (30%)
inward TASK-1 currents while inward and outward TASK-3 currents
are much less sensitive to Cs+ (up to 10 mm) (Duprat et al., 1997;
Rajan et al., 2000; Meadows & Randall, 2001; Czirják & Enyedi,
2002b). Block of facial motoneuron gKLeak by Cs
+ again suggests
against TASK-3 channels, although the sensitivity and voltage-
dependent block also differ from TASK-1 channels
Ba2+ blocks a significantly greater amount of inward current than
outward current through TASK-1 and TASK-3 channels (Czirják
et al., 2000; Kim et al., 2000; Lopes et al., 2000, 2001; Millar et al.,
2000; Rajan et al., 2000; Vega-Saenz de Miera et al., 2001). The IC50
for Ba2+ against inward guinea-pig TASK-3 currents is about 300 lm
while against outward current it is greater than 5 mm (Rajan et al.,
2000). Reported IC50 values of around 3 mm for rat and human
TASK-3 almost certainly reflect measurements made against outward
current (Kim et al., 2000; Vega-Saenz de Miera et al., 2001). Ba2+
blocks rat TASK-1 channels with an IC50 of around 400 lm and this is
both voltage- and pH-dependent, block decreasing with increasing
[H+]o (Lopes et al., 2001). The effects of Ba
2+ on facial motoneuron
gKLeak reported both here and earlier (Larkman & Kelly, 1998) are
consistent with a voltage-dependent block at micromolar concentra-
tions that clearly does not discriminate homomeric TASK-1 and
TASK-3 channels. The explanation for the absence of any time
dependence to the block of gKLeak by Ba
2+ is not clear, although our
experiments were performed in relatively low external [K+] compared
with the studies of TASK channels (Czirják et al., 2001; Czirják &
Enyedi, 2002b).
Kir channels, including members of the Kir2 family, display distinct
sensitivities to Cs+ and Ba2+. Block of Kir2.4 by Cs+ is voltage
sensitive with an IC50 of about 100 lm at )100 mV and 1 mm at
)60 mV (Hughes et al., 2000). Cs+ (300 lm) blocked a gKir in facial
motoneurons but at this concentration had no effect on either INA or
IpH even at hyperpolarized potentials. Ba
2+ blocks Kir2.4 (IC50 of
between 100 and 300 lm) with potency similar to that described for
the amine-sensitive gKLeak in facial motoneurons; however, block of
Kir2.4 is relatively voltage-insensitive (Larkman & Kelly, 1998;
Hughes et al., 2000; Liu et al., 2001; Schram et al., 2002). Ba2+ also
blocked a gKir when the pH- and amine-sensitive gKLeak was fully
inhibited by pH 6 ACSF. These results support the presence of a gKir
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in facial motoneurons that is distinct from the pH- and amine-sensitive
gKLeak.
Possible identities of facial motoneuron gKLeak: TASK-1 ⁄
TASK-3 heterodimers
Although our results suggest against homomeric TASK-1 or TASK-3
channels, evidence indicates TASK-1 and TASK-3 interact to form
functional heterodimeric channels (Czirják & Enyedi, 2002a; Talley &
Bayliss, 2002). Could facial motoneuron gKLeak be accounted for by
heteromeric TASK-1 ⁄ TASK-3 channels? The pharmacologies of
homomeric TASK-1, homomeric TASK-3 and heteromeric TASK-
1 ⁄ TASK-3 currents expressed in various systems and facial moto-
neuron gKLeak are compared in Table 1. It has been suggested that
heterodimer formation may be a favoured process when both TASK-1
and TASK-3 subunits are present, although recent studies on cultured
CG cells indicate both homomeric and heteromeric channels can also
coexist in the same cell (Czirják & Enyedi, 2002a; Kang et al., 2004).
It has recently been observed that isoflurane enhances current carried
by heteromeric TASK-1 ⁄ TASK-3 and homomeric TASK-3 channels
while inhibiting homomeric TASK-1 channels (Berg et al., 2004).
Isoflurane enhances facial motoneuron gKLeak while RR, the TASK-3
blocker, has no effect. Heteromeric TASK-1 ⁄ TASK-3 channels are
insensitive to RR because the channel subunits must provide
symmetrical interaction sites for potency (Czirják & Enyedi, 2002a;
Kang et al., 2004). These results are consistent with the suggestion
that heteromeric channels could account for facial motoneuron gKLeak.
The pK for heteromeric channels lies between the values for
homomeric TASK-1 and TASK-3 channels but is nearer that of TASK-1
(Czirják & Enyedi, 2002a; Talley & Bayliss, 2002). The pK for facial
motoneuron gKLeak is also consistent with a heteromeric channel. The
pH-sensitivity of individual facial motoneurons did not differ
significantly from the population average, suggesting a single
population of pH-sensitive K+ channels predominates in these cells.
Nevertheless, the observation in one facial motoneuron that isoflurane
inhibited gKLeak, consistent with a TASK-1 channel identity (Berg
et al., 2004), suggests gKLeak may display some heterogeneity within
the facial motoneuron population.
Further evidence in favour of a heteromeric identity for facial
motoneuron gKLeak is the observation that heteromeric channels share
the Zn2+ insensitivity of TASK-1 homomers (Clarke et al., 2004). The
insensitivity of gKLeak to anandamide should be assessed in light of
the evidence that rat homomeric TASK-1 and TASK-3 channels
expressed in HEK 293 cells show lower sensitivity to anandamide and
methanandamide relative to human channels (Berg et al., 2004). In
addition, these compounds show little selectivity between different rat
channels. Anandamide (10 lm) blocks between 60 and 80% of the
current flowing through homomeric channels and 50% flowing
through heteromeric channels. This latter observation is clearly at odds
with the suggestion that a heteromeric channel mediates gKLeak in
facial motoneurons. However, distinct cellular environments may
promote differences between endogenous channels and those
expressed in cell lines. The sensitivity of the TASK-1 ⁄ TASK-3
heterodimer to bupivacaine and 4-AP is unknown. The lack of effect
of the selective blockers of the homomeric channels precludes any
quantification of the relative contributions of channel isoforms within
individual facial motoneurons similar to that performed elsewhere
(Berg et al., 2004).
The gKLeak in facial motoneurons displays properties of an amine-
sensitive gKLeak described in neonatal rat hypoglossal motoneurons
(Talley et al., 2000). First described as TASK-1, hypoglossal
motoneuron gKLeak displays pharmacological differences to the
cloned rat TASK-1 channel and is also enhanced by isoflurane,
leading to the suggestion that it may be a heteromeric channel (Talley
et al., 2000; Talley & Bayliss, 2002; Berg et al., 2004). It is of interest
that the anandamide sensitivity of this gKLeak has not been described
(Berg et al., 2004).
Could other 2P K+ channels underlie facial motoneuron gKLeak? A
recent study indicates protein for TASK-2 is found in the facial motor
nucleus (Gabriel et al., 2002). TASK-2 gives rise to outwardly
rectifying currents with a pK around 7.8, suggesting activation at
physiological pH. Outward current through TASK-2 channels is
relatively insensitive to Ba2+ and Cs+ and permeability to Rb+ is less
than for K+, unlike TASK-1 (Reyes et al., 1998; Niemeyer et al., 2001;
Talley et al., 2001). TASK-2 is also blocked by bupivacaine (Kindler
et al., 2003). Nevertheless, alone this conductance could not account
for the whole range of pH sensitivity or linearity of the gKLeak. The
CNS distribution of TASK-4 channels has not been established, but
they are activated by alkaline pH, show little activation at pH 7.5 and
have slow activation kinetics which distinguish them from gKLeak in
facial motoneurons (Decher et al., 2001). TASK-5 channels, either in
homomeric or heteromeric (with TASK-1) combinations, have so far
eluded functional characterization, but nevertheless mRNA does not
appear to be present in facial motoneurons (Ashmole et al., 2001;
Karschin et al., 2001).
Inwardly rectifying and voltage-gated K+ channels
The absence of inward rectification in gKLeak might be expected to
preclude the involvement of Kir2.4 (and other Kir) channels.
Nevertheless, block of the amine-sensitive gKLeak by Ba
2+ generates
an inwardly rectifying I ⁄ V relationship. This could represent either the
voltage-dependent block of a single conductance or the block of an
inwardly rectifying conductance that contributes to the overall
properties of the gKLeak. A characteristic of gKir is that the V0.5 shifts
with [K+]o, suggesting that the driving force on K
+ determines
activation rather than voltage alone (Yamaguchi et al., 1990).
Examination of the Ba2+-sensitive component of gKLeak in facial
motoneurons indicated that V0.5 was relatively independent of [K
+]o,
suggesting a predominantly voltage-dependent block, distinct from the
properties of Kir channels. Nevertheless, it is a possibility that Kir2
heterotetramers in association with accessory b subunits show
emergent properties distinct from homomeric channels (Schram
et al., 2002).
The NA- and pH-sensitive gKLeak in facial motoneurons is blocked
by 4-AP (4 mm) but not by TEA (30 mm). TASK-1 and TASK-3
channels are reported to be insensitive to both 4-AP and TEA (Duprat
et al., 1997; Leonoudakis et al., 1998; Czirják et al., 2000; Kim et al.,
2000; Lopes et al., 2000; Meadows & Randall, 2001; Vega-Saenz de
Miera et al., 2001). We have previously shown that 4-AP blocks fast
and slow transient outward K+ currents in facial motoneurons although
neither appears to contribute to the amine-sensitive gKLeak (Larkman
& Kelly, 1998). Rapidly activating, slowly inactivating, 4-AP-
sensitive, voltage-gated K+ conductances have been characterized in
cardiac muscle (Boyle & Nerbonne, 1992). In particular, Kv1.5 has
been suggested to contribute a sustained current at depolarized
membrane potentials (reviewed by Nerbonne, 2000). Kv1.5 channels
are blocked by 4-AP, relatively TEA-insensitive, inhibited by acidosis,
blocked by bupivacaine (EC50 10 lm) and while being sensitive to
Zn2+ the EC50 is close to 800 lm (Clémente-Chomienne et al., 1999;
Steidl & Yool, 1999; González et al., 2001; Kehl et al., 2002). The
presence of Kv1.5 protein in facial motoneurons is unknown, although
it is present in motoneurons at all levels of the spinal cord (Matus-
Leibovitch et al., 1996). Nevertheless, a pK around 6.2 and a restricted
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voltage range for sustained current between at best )60 and 0 mV
both suggest that alone these channels may not be sufficient to explain
the properties of facial motoneuron gKLeak.
Possible functional implications of pH-sensitive gKLeak
Whether the pH-sensitivity of gKLeak is functionally important for facial
motoneurons is not clear. Changes in external pH are known to occur
during periods of ischaemia and hypoxia but functionally significant
physiological changes are less apparent. A small change in external pH
may be sufficient to alter the properties of gKLeak; however, the
integrated response of the motoneuronal membrane is likely to involve
additional effects on other conductances. Experiments performed in the
absence of ZD-7288 indicated that changes in external pH across the
range pH 6–8 also altered Ih (our unpublished observations). The overall
change in facial motoneuron membrane conductance thus reflects the
integration of at least these two components. Nevertheless, modulation
of gKLeak by endogenous neurotransmitters, particularly NA and 5-HT,
indicates an important role in the priming and maintenance of facial
motoneuron membrane excitability during waking and states of sensory
arousal. Inhibition of facial motoneuron gKLeak by NA involves
activation of a1 adrenoceptors and it has been previously shown that
5-HT2 receptors mediate similar actions of 5-HT (Larkman & Kelly,
1992). Both receptor subtypes couple through Gq proteins to
phospholipase C-mediated hydrolysis of phosphatidyl-4,5-inositol-
bisphosphate (PIP2). Consistent with this, Gq-coupled muscarinic M1
and group 1 metabotropic glutamate receptors, but not Gi-coupled
muscarinic M2 receptors, inhibit co-expressed human TASK-1 and
TASK-3 channels through a PIP2 hydrolysis-dependent pathway
(Czirják et al., 2001; Chemin et al., 2003).
Conclusion
While mRNA for TASK-1 and TASK-3 K+ channel subunits is
expressed in the facial motor nucleus and the biophysical properties
and pH-sensitivity of gKLeak are reminiscent of TASK channel-
mediated conductances, the pharmacology of facial motoneuron
gKLeak does not clearly define it as being mediated by homomeric
TASK-1 or TASK-3 channels. Heteromeric TASK channels with
emergent properties could underlie this conductance, a suggestion
reinforced by the enhancement of gKLeak by isoflurane. While the
detection of TASK channel protein in facial motoneurons has proved
elusive, recent studies indicate TASK-1-like immunoreactivity in rat
facial motoneurons (Kindler et al., 2000; Kanjhan et al., 2004).
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Clémente-Chomienne, O., Ishii, K., Walsh, M.P. & Cole, W.C. (1999)
Identification, cloning and expression of rabbit vascular smooth muscle
Kv1.5 and comparison with native delayed rectifier K+ current. J. Physiol.
(Lond.), 515, 653–667.
Curro, F.A. & Greenberg, S. (1983) Characteristics of postsynaptic a1 and a2
adrenergic receptors in canine vascular smooth muscle. Can. J. Physiol.
Pharmacol., 61, 893–904.
Czirják, G. & Enyedi, P. (2002a) Formation of functional heterodimers between
the TASK-1 and TASK-3 two-pore domain potassium channel subunits.
J. Biol. Chem., 277, 5426–5432.
Czirják, G. & Enyedi, P. (2002b) TASK-3 dominates the background potassium
conductance in rat adrenal glomerulosa cells.Mol. Endocrinol., 16, 621–629.
Czirják, G. & Enyedi, P. (2003) Ruthenium red inhibits TASK-3 potassium
channel by interconnecting glutamate 70 of the two subunits. Mol.
Pharmacol., 63, 646–652.
Czirják, G., Fischer, T., Spat, A., Lesage, F. & Enyedi, P. (2000) TASK (TWIK-
related acid-sensitive K+ channel) is expressed in glomerulosa cells of rat
adrenal cortex and is inhibited by angiotensin II. Mol. Endocrinol., 14, 863–
874.
Czirják, G., Petheo, G.L., Spät, A. & Enyedi, P. (2001) Inhibition of TASK-1
potassium channel by phospholipase C. Am. J. Physiol., 281, C700–C708.
Decher, N., Maier, M., Dittrich, W., Gassenhuber, J., Bruggemann, A., Busch,
A.E. & Steinmeyer, K. (2001) Characterization of TASK-4, a novel member
of the pH-sensitive, two-pore domain potassium channel family. FEBS Lett.,
492, 84–89.
Duprat, F., Lesage, F., Fink, M., Reyes, R., Heurteaux, C. & Lazdunski, M.
(1997) TASK, a human background K+ channel to sense external pH
variations near physiological pH. EMBO J., 16, 5464–5471.
Gabriel, A., Abdallah, M., Yost, C.S., Winegar, B.D. & Kindler, C.H. (2002)
Localization of the tandem pore domain K+ channel KCNK5 (TASK-2) in
the rat central nervous system. Mol. Brain Res., 98, 153–163.
Goldstein, S.A.N., Bockenhauer, D., O’Kelly, I. & Zilberberg, N. (2001)
Potassium leak channels and the KCNK family of two-P-domain subunits.
Nat. Rev. Neurosci., 2, 175–184.
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Patel, A.J. & Honoré, E. (2001) Properties and modulation of mammalian 2P
domain K+ channels. Trends Neurosci., 24, 339–346.
Perrier, J.-F., Alaburda, A. & Hounsgaard, J. (2003) 5-HT1A receptors increase
excitability of spinal motoneurons by inhibiting a TASK-1-like K+ current in
the adult turtle. J. Physiol. (Lond.), 548, 485–492.
Pieribone, V.A., Nicholas, A.P., Dagerlind, A. & Hokfelt, T. (1994) Distribution
of a1 adrenoceptors in rat brain revealed by in situ hybridization experiments
utilizing subtype-specific probes. J. Neurosci., 14, 4252–4268.
Rajan, S., Wischmeyer, E., Liu, G.X., Preisig-Müller, R., Daut, J., Karschin, A.
& Derst, C. (2000) TASK-3, a novel tandem pore domain acid-sensitive K+
channel. An extracellular histidine as pH sensor. J. Biol. Chem., 275, 16650–
16657.
Ranft, A., Kurz, J., Deuringer, M., Haseneder, R., Dodt, H.U., Zieglgansberger,
W., Kochs, E., Eder, M. & Hapfelmeier, G. (2004) Isoflurane modulates
glutamatergic and GABAergic neurotransmission in the amygdala. Eur. J.
Neurosci., 20, 1276–1280.
Reyes, R., Duprat, F., Lesage, F., Fink, M., Salinas, M., Farman, N. &
Lazdunski, M. (1998) Cloning and expression of a novel pH-sensitive two
pore domain K+ channel from human kidney. J. Biol. Chem., 273, 30863–
30869.
Scheller, M., Bufler, J., Schneck, H., Kochs, E. & Franck, C. (1997) Isoflurane
and sevoflurane interact with the nicotinic acetylcholine receptor channels in
micromolar concentrations. Anesthesiology, 86, 118–127.
Schram, G., Melnyk, P., Pourrier, M., Wang, Z. & Nattel, S. (2002) Kir2.4
and Kir2.1 K+ channel subunits co-assemble: a potential new contributor
to inward rectifier current heterogeneity. J. Physiol. (Lond.), 544, 337–349.
Shin, K.S., Rothberg, B.S. & Yellen, G. (2001) Blocker state dependence and
trapping in hyperpolarization-activated cation channels: evidence for an
intracellular activation gate. J. Gen. Physiol., 117, 91–101.
Simon, W., Hapfelmeier, G., Kochs, E., Zieglgansberger, W. & Rammes, G.
(2001) Isoflurane blocks synaptic plasticity in the mouse hippocampus.
Anesthesiology, 94, 1058–1065.
Steidl, J.V. & Yool, A.J. (1999) Differential sensitivity of voltage-gated
potassium channels Kv1.5 and Kv1.2 to acidic pH and molecular
identification of pH sensor. Mol. Pharmacol., 55, 812–820.
Talley, E.M. & Bayliss, D.A. (2002) Modulation of TASK-1 (Kcnk3) and
TASK-3 (Kcnk9) potassium channels. Volatile anesthetics and neurotrans-
mitters share a molecular site of action. J. Biol. Chem., 277, 17733–17742.
Talley, E.M., Lei, Q., Sirois, J.E. & Bayliss, D.A. (2000) TASK-1, a two-pore
domain K+ channel, is modulated by multiple neurotransmitters in
motoneurons. Neuron, 25, 399–410.
Talley, E.M., Solorzano, G., Lei, Q., Kim, D. & Bayliss, D.A. (2001) CNS
distribution of members of the two-pore-domain (KCNK) potassium channel
family. J. Neurosci., 21, 7491–7505.
Tateishi, J. & Faber, J.E. (1995) Inhibition of arteriole a2- but not a1-adreno-
ceptor constriction by acidosis and hypoxia in vitro. Am. J. Physiol., 268,
H2068–H2076.
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